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ABSTRACT
Direct-to-physician advertising is an important field to study because it has the ability to
effect patient’s health. Historically, the marketing and advertising structure of the pharmaceutical
industry has rewarded high decile prescribers. This incentive based system is inherently flawed
as it encourages irrational prescribing behaviors. Since the 1950s, there has been a concern
regarding the correlation between advertised promotion and physician’s prescribing behaviors. A
central argument in this study is that there is a strong relationship between promotion and
prescribing and that physicians are influenced by advertising. One class of medications that
appear to influential via advertising is antidepressants. Previous research has indicated that
women are most likely to be prescribed an antidepressant due to the over representation of
women in medical journal antidepressant advertising. This study presents a narrative analysis of
antidepressant advertising between 1990 and 2010. This timeframe is selected because it
represents the rise of SSRIs, the biomedical model of science, and the deregulation of direct-toconsumer pharmaceutical advertising. It is shown that the models depicted in antidepressant
advertising over represent women by a ratio of 6:1 as compared to men. Additionally, the
depiction of women is a distorted one as the model is positioned as being rather glamorous,
educated, and quite wealthier than the depression candidate. According to epidemiology reports,
people who live in poverty and have less of an educational attainment tend to suffer from
depression. However, these are not the people who are depicted within the promotions which can
mislead physicians about the depression patient. These portrayals further reflect the notion that
depression has become regarded as being fashionable and some perceive it to be a lifestyle
accessory. This is a disturbing consideration. The over representation of women in antidepressant
iv

advertising may result in the inappropriate prescribing and misdiagnosis of women for
depression. Currently, women are misdiagnosed 30-50 percent of the time for depression.
Through the re-evaluation of the biomedical model, the rethinking about the graphic design of
advertisements and through the education of medical and health care students, the tendency for
women’s health to be compromised may be reduced.

v

TABLE OF CONTENTS

CHAPTER I: INTRODUCTION AND GENERAL INFORMATION ......................................... 1
Introduction ..................................................................................................................................... 1
Direct-to-Physician Advertising ..................................................................................................... 3
Depression....................................................................................................................................... 5
Critical Paradigm ............................................................................................................................ 7
Textual Analysis .......................................................................................................................... 9
Narratives .................................................................................................................................. 10
Research Design and Methodology .............................................................................................. 10
Medical Journal Advertisements as Historical Documents....................................................... 10
Data Selection and Collection ....................................................................................................... 11
Sampling.................................................................................................................................... 11
Justification of the Study .............................................................................................................. 14
CHAPTER II: LITERATURE REVIEW DIRECT TO PHYSICIAN ADVERTISING ............. 18
Introduction ................................................................................................................................... 18
The Direct-to-Physician Advertising Founders ............................................................................ 18
The Practice of Medical Advertising ............................................................................................ 20
Pharmaceutical Life After World War II .................................................................................. 23
The Pharmaceutical Sales Force ............................................................................................... 24
The Initial Pharmaceutical Blitz ................................................................................................ 26
Creative Design and Copywriting ............................................................................................. 27
The Pioneer of Direct-to-Physician Advertising ....................................................................... 30
Marketing of Terramycin .......................................................................................................... 32
Promotional Effects on Prescribing........................................................................................... 34
Psychotropic DTP Advertising ..................................................................................................... 36
Miltown ..................................................................................................................................... 36
Valium ....................................................................................................................................... 38
At-a-Glance Diagnosis .............................................................................................................. 40
The Closing of an Era ................................................................................................................... 41
Current Direct-to-Physician Advertising ...................................................................................... 42
vi

Purpose of Pharmaceutical Advertisements .............................................................................. 44
Medical Journals as Sources of Information ............................................................................. 44
Medical Journal Ads as Sources of Pharmacological Education .............................................. 45
Influence of Medical Journal Advertising on Prescribing Behaviors ....................................... 46
Misleading Promotions and Inappropriate Prescribing ............................................................. 47
Depression..................................................................................................................................... 48
Neurasthenia .............................................................................................................................. 48
Modern Day Depression ............................................................................................................... 53
Psychotropic Drug Advertising Stereotyped Imagery, Prescribing and Diagnosing .................... 55
Stereotypes in Psychotropic Drug Advertisements ................................................................... 56
Segmenting the Market and Gendering Medical Conditions .................................................... 58
The Rise of SSRIs between 1990 and 2010 .................................................................................. 59
The Creation of Prozac .............................................................................................................. 60
The Bio-Medical Model ............................................................................................................ 62
DTC Advertising ....................................................................................................................... 63
The Debate .......................................................................................................................................... 63

Psychotropic DTCA .................................................................................................................. 65
Reflection Between DTC and DTP Advertising .................................................................................... 65

Narratives ...................................................................................................................................... 69
Narrative Inquiry ....................................................................................................................... 69
Visual Analysis ......................................................................................................................... 70
Conclusion .................................................................................................................................... 71
CHAPTER III: CREATING THE DEPRESSION AUDIENCE.................................................. 73
Abstract ......................................................................................................................................... 74
Introduction ................................................................................................................................... 74
The Creation of the Advertised Audience .................................................................................... 77
The Virtual Audience ................................................................................................................ 77
Product Placement ..................................................................................................................... 79
Modeled Stereotypes ................................................................................................................. 80
Gendering the Consumer Market .............................................................................................. 82
Fictionalization of the Audience ................................................................................................... 83
vii

Gender ....................................................................................................................................... 83
Race ........................................................................................................................................... 84
Epidemiology ............................................................................................................................ 85
Advertising Narrative Plot ........................................................................................................ 87
The Glamorization of Depression ................................................................................................. 88
Prozac and SSRIs ...................................................................................................................... 88
1990s Glamorization of the Individual...................................................................................... 90
2000s the Glamorization of Lifestyle ........................................................................................ 93
Consumption and Sense of Identity .............................................................................................. 98
Conclusion .................................................................................................................................... 99
CHAPTER IV: THE TYPICAL ANTIDEPRESSANT PATIENT AND AT-A-GLANCE
DIAGNOSIS ............................................................................................................................... 102
Abstract ....................................................................................................................................... 103
Introduction ................................................................................................................................. 103
Direct-to-Physician Advertising and the Patient......................................................................... 105
The Hypothetical Patient Profile ............................................................................................. 106
The Product Model of Advertising and Theory of Congruence.............................................. 107
The Typical Patient and At-a-Glance-Diagnosis ........................................................................ 108
The Typical Patient ................................................................................................................. 108
Diagnosis At-A-Glance ........................................................................................................... 109
Cognition ................................................................................................................................. 110
Diagnostic Heuristics .............................................................................................................. 111
The Narrative of the Typical Patient ........................................................................................... 114
Introducing the Antidepressant Patient ................................................................................... 114
Symptoms and Text................................................................................................................. 118
Imagery and Hidden Meanings in Advertising ........................................................................... 120
Conclusion .................................................................................................................................. 122
CHAPTER V: CONCLUSIONS AND IMPLICATIONS ......................................................... 124
Introduction ................................................................................................................................. 124
Direct-to-Physician Advertising ................................................................................................. 125
The Objectives of This Study ..................................................................................................... 126
viii

Representations of the Mental Health Patient and the Conceptions of Mental Health ............... 127
Historical Presentation of Depression and the Advertised Patient .......................................... 127
Virtual Depression Audience .................................................................................................. 129
Representations of the Consumer in Antidepressant Advertisements ........................................ 132
The Antidepressant Patient...................................................................................................... 132
Recommendations for Changes in Medical Journal Antidepressant Advertising ...................... 134
Biomedical Model of Medicine and the Brain ........................................................................ 134
Medical School Education Regarding Advertising ................................................................. 136
The Creative Side .................................................................................................................... 138
Concluding Remarks ................................................................................................................... 140
LIST OF REFERENCES ............................................................................................................ 143
APPENDIX ................................................................................................................................. 177
VITA ........................................................................................................................................... 203

ix

LIST OF FIGURES

Figure A-1 Wellbutrin Janet the Librarian Advertisement ....................................................................... 178
Figure A-2 Pamelor Laboratory Scientist Advertisement ......................................................................... 179
Figure A-3 Sinequan Woman Shopping Advertisement ........................................................................... 180
Figure A-4 Wellbutrin Advertisement of Jogging Couple ........................................................................ 181
Figure A-5 Wellbutrin Advertisement of Woman Playing Tennis ........................................................... 182
Figure A-6 Wellbutrin Advertisement of Woman Dressing for the Evening ........................................... 183
Figure A-7 Remeron Advertisement of Ladies Having Afternoon Tea .................................................... 184
Figure A-8 Lexapro Advertisement of Ladies Lunching .......................................................................... 185
Figure A-9 Zoloft Advertisement of Family Hiking ................................................................................. 186
Figure A-10 Serzone Woman Exercising on the Beach............................................................................ 187
Figure A-11 Prozac Advertisement of Kristen’s Travels .......................................................................... 188
Figure A-12 Serzone Advertisement Featuring a Love Life ..................................................................... 189
Figure A-13 Remeron Advertisement of Couple with Flowers in Heart Shape ....................................... 190
Figure A-14 Zoloft Advertisement of Couples Embracing....................................................................... 191
Figure A-15 Effexor Advertisement of Dancing Couple .......................................................................... 192
Figure A-16 Paxil Advertisement of Julie ................................................................................................ 193
Figure A-17 Prozac Advertisement of Nell Knitting ................................................................................ 194
Figure A-18 Prozac Advertisement of Barb Golfing ................................................................................ 195
Figure A-19 Prozac Advertisement of Chris Making Lunch for the Kids ................................................ 196
Figure A-20 Prozac Advertisement of Sue Playing with the Kids............................................................ 197
Figure A-21 Prozac Advertisement of Fatigue ......................................................................................... 198
Figure A-22 Prozac Advertisement for Energy ........................................................................................ 199
Figure A-23 Serzone Advertisement that Lists Vague Symptoms ........................................................... 200
Figure A-24 Paxil Advertisement of a Depressed Female Patient ............................................................ 201
Figure A-25 Prozac Thank You Advertisement to Physicians ................................................................. 202

x

CHAPTER I: INTRODUCTION AND GENERAL INFORMATION
Introduction
Since the Victorian era and the development of Neurasthenia (an illness that serves as the
precursor to depression), depression has been affiliated with the more fashionably chic person. It
is glamorized as a mental condition that afflicts a person of a certain social class and gender in
which men and women have customarily received different medical treatment (Wessely, 1991).
It is a tradition that continues today as more women receive a prescription for antidepressants
two to three times more than men in most age groups (Metzl & Angel, 2004). One reason for this
difference in prescribing patterns may be due to the stereotyped models and lifestyles that are
depicted within pharmaceutical medical journal advertisements.
It has been suggested that the models portrayed within medical journal pharmaceutical
advertisements depict the common person who will suffer from such medical conditions since it
is common for advertisements to feature the intended product end user (Hawkins & Aber, 1993).
Contrary to this conviction, it is argued in this study that the advertised depression person most
likely does not suffer from the advertised condition, and is simply representative of the
individual who the physician can expect to enter his or her office. Consequently, this person may
not be the clinically depressed individual but is, instead, the intended consumer of the advertised
product. For psychotropic medications, the person most frequently portrayed within medical
journal advertisements is posed as being fairly stylish as she is associated with a higher social
status that is exemplified through jewelry, clothing, and lifestyle imagery (Herzberg, 2009). A
persona that is refined and reinforced through the pharmaceutical companies artificially
conceived hypothetical patient profile (Applbaum, 2009).
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The hypothetical patient profile is a narrative regarding the typical patient that is
carefully crafted by the pharmaceutical, medical, and advertising industries in an effort to sell
prescription medications (Applbaum, 2009). This story tells the physician about the personal
characteristics, behaviors, gender, and symptoms of the typical patient so that the physician can
conveniently categorize and diagnose patients based upon this hypothetical prototype
(Applbaum, 2009, Spielmans, 2009). As a result, patients are frequently classified and diagnosed
in terms of their social status, personality, behavior, appearance, and gender.
Physicians are further encouraged to cognitively recall these advertised prototypes during
the physician-patient interview, and to diagnose the patient at-a-glance (Rubin, 2004; Stimson,
1975). However, these cognitive cues are inherently flawed as they contain gender and class
biases that lead to the belief that the advertised medical condition is affiliated with the gender
and class of the model portrayed within the advertisements (Croskerry, 2002 & 2003). This is a
premise that may lead to the inappropriate prescribing and misdiagnosis of people, especially
women.
This study presents the argument that psychotropic drug advertisements in medical
journals provide a narrative about the depression audience and the typical antidepressant patient.
This story gives a false portrayal as pharmaceutical companies and advertisers intentionally
create audiences through sophisticated audience segmentation and targeting tactics to increase
profits (Dyer, 1982; Frascara,1997; Pope, 2003). Thus, the depiction of the depression audience
is shaped as being comprised of a rather trendy and more sophisticated individual than the actual
depression candidate. This portrayal provides an inaccurate picture of the true depression patient.
This chapter serves as an introduction to the current study and presents the concepts of direct-to-
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physician advertising, depression, the critical paradigm, and the research design and
methodology. The chapter concludes with a discussion regarding the justification for this study
along with a delineation of the remaining chapters.
Direct-to-Physician Advertising
Throughout history, pharmaceutical companies and advertising firms have established an
exceedingly profitable industry. One of the primary channels that has been effective in
generating substantial revenues is Direct-to-Physician (DTP) advertising (Pedan & Wu, 2009). It
has been documented that DTP advertising has the power to influence physician prescribing
behaviors, although physicians would argue otherwise (Avorn, Chen & Hartley, 1982). However,
the pharmaceutical industry spends a colossal amount of time and money into discerning the
physicians who most frequently prescribe (Fugh-Berman & Ahari, 2007). These physicians,
referred to as high decile prescribers, are heavily targeted for promotional purposes as they
provide a solid Return on Investment (ROI) that positively affects the pharmaceutical bottom
line, both of which suggest that advertising does in fact influence physician prescribing
behaviors (Fugh-Berman & Ahari, 2007).
Since the late 1940s, pharmaceutical companies have finessed their marketing and
advertising practices in an effort to influence prescribing patterns and in doing so, they have
carved out niche audiences for specific medical conditions and treatments (Greene, 2007). The
audience has become defined in a similar manner to any traditional product advertising strategy,
through the perceived product end-user (Lynch & Schuler, 1994). According to pharmaceuticals,
women have historically been the end-user of psychotropic medications (Peppin & Carty, 2001;
Riska & Heikell, 2008). Through the repetitive use of specific imagery that depicts one gender,
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the viewer of advertisements may become convinced that this depicted person is representative
of the actual audience (Clarke, vanAmerom & Binns, 2007). However, this perception is a
distorted one that may have significant societal ramifications, including the misdiagnosis of
patients.
Since there is a lack of physical laboratory tests for the diagnosis of mentally ill patients,
it is of vital importance that physicians are provided with factual information to assist them with
adequately diagnosing these individuals (Hardall, Freeman & Norwood, 1982). This material
includes advertising that is presented in an objective manner not only in text but in imagery as
well. If the communication provided is inaccurate then the physician may misdiagnose
individuals which has serious public health implications. Currently, there is a tendency for the
misdiagnosis of people in the United States that can be avoided (National Academies of Science,
Engineering, and Medicine, 2016). One way this may be prevented is through advertising that is
responsible and accurate in its depictions of true patient populations. Although this request may
appear to be a great feat, as advertising tends to ignore any discussion regarding people and
audiences that it does not opt to target (Benson, 2013; Gee, 2005).
Historic and contemporary studies of American society have revealed that the portrayals
of race, class, and gender have been skewed (Pope, 2003). Advertisements consistently depict
scenes of prosperity, material comfort, and luxury that extend outside of most Americans’
lifestyles (Pope, 2003). It seems to be a simple truth, that if advertising did in fact accurately
reflect reality that many products would not sell, and therefore there has to exist some level of
distortion in the advertised story (O’Sullivan, 2005; Schudson, 1984). One such advertised
narrative concerns the depressed patient who is characterized as being a well attired and styled
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middle-aged and upper class, white female, and the person most well-suited for Selective
Serotonin Reuptake Inhibitor (SSRI) therapy (Kempner, 2006). This is a depiction of the typical
SSRI end user that has been commonly painted in medical journal psychotropic drug
advertisements.
Depression
Mental health is defined by the Centers for Disease Control (CDC) as “a state of wellbeing in which the individual realizes his or her own abilities, can cope with the normal stresses
of life, can work productively and fruitfully, and is able to make a contribution to his or her
community.” It is estimated that only 17 percent of the U.S. adult population is in optimal mental
health (http://www.cdc.gov/mentalhealth/basics.htm). Consequently, mental health has become a
U.S. government and public health concern.
Mental illness is defined by the CDC as “collectively all diagnosable mental disorders” or
“health conditions that are characterized by alterations in thinking, mood, or behavior (or some
combination thereof) associated with distress and/or impaired functioning.” The most common
mental illness is depression that affects over 26 percent of the U.S. adult population. It is
predicted that by the year 2020, depression will become the second leading cause of disability
worldwide (http://www.cdc.gov/mentalhealth/basics.htm). Along with this prediction, mental
illness has become big business from a pharmaceutical perspective as psychotropic sales
escalated to over a staggering $70 million in 2010 (Greenberg, 2013).
Currently 20 percent of American adults take a minimum of one psychotropic drug which
represents a 22 percent increase in usage from 2001-2010. In 2010, Americans spent over $16
billion on anti-psychotics, $11 billion on antidepressants and $7 billion on ADHD medications.
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Since the introduction of Prozac in the late 1980s, antidepressant usage has quadrupled in the
U.S. (Smith, 2012). In addition, women are more likely than men to take prescription
medications; 25 percent of women compared to 15 percent of men. Antidepressant usage is also
higher among women in which a 29 percent increase has occurred since 2001 (Bindley, 2011).
Antidepressants are the third most common class of prescribed medication in the U.S.
and are used most frequently by adults between the ages of 18 and 44. Most patients are
prescribed at least two if not three antidepressants. It is estimated that half of these prescriptions
are written for people who do not have a psychiatric diagnosis. Most people who do qualify for
mental disorder diagnosis do not receive treatment (Deacon, 2013).
Epidemiological studies have suggested that the prevalence rates for such mental
disorders as depression and anxiety have steadily increased while rates for schizophrenia have
remained rather low. However, a study by Kessler et. al (2005) indicated that between the
decades of 1990 and 1992 and 2001 and 2003, the rates of prevalence for mental disorders
remained the same; rather it was the treatment of such conditions that increased. Additionally,
Olfson & Marcus (2009) found the percentage of people who received antidepressant treatment
increased from 5.84 percent in 1996 to 10.2 percent in 2005 or from 13.3 to 27 million people in
the US. One reason for the rise in antidepressant prescriptions may be attributed to the medical
specialty of the physician who frequently prescribes anti-depressant medications.
Most of the anti-depressant prescriptions, 81 percent, are written by a general practitioner
(GP) or a primary care physician (PCP) in the US. Approximately 80 percent of prescriptions are
written by a physician and not a psychiatrist (Boseley, 2004; Goode, 2002; Smith, 2012).
According to Metzl & Angel (2004), most prescriptions are written by pediatricians, internists,
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obstetricians, and family practitioners. Further, 60 percent of people who visit a physician are
diagnosed with a mental health disorder rather than a physical one (Koellhoffer, 2008).
The pharmacological treatment of depression has become the preferred therapeutic course
for depression. It has been estimated that three-fourths of individuals who receive treatment for
depression are prescribed an antidepressant either alone or in combination with counseling.
However, the treatment of depression with anti-depressants has increased while psychotherapy
has decreased (Larson, Miller, Fleming, 2006). A pattern that reinforces the notion that perhaps
the prevalence of depression has not increased, but rather, the treatment of depression with
antidepressants has increased, particularly for women.
Critical Paradigm
During the 20th century and particularly since the 1960s, there has been a paramount shift
in the critical paradigm in which western societies such as the United States have not been
regarded as being wholly democratic and egalitarian. From a critical perspective, American
society is deemed as being vulnerable to subordination and domination in which few groups of
individuals are privileged. These groups have been criticized for maintaining the status quo in
order to preserve their advantage. Studies that investigate privilege are frequently concerned
with issues surrounding race, gender, class, and sexuality (Kincheloe & McLauren, 2000).
Therefore, critical researchers are interested in pursuing critical enlightenment in order to reveal,
“the winners and losers in particular social arrangements and the process by which power plays
operate” (Kincheloe & McLauren, 2000, p. 281). Critical researchers further contend that society
is more influenced by social and historical forces than has previously been thought by critical
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theorists. As a result, a central focus of critical research is upon the connection between culture,
power, and domination.
According to Gray (2009), the critical paradigm presents a critical form of research that is
a meta-process of investigation concerned with values and assumptions that challenge social
structures. It is predicated upon the concept that ideas are mediated by power relations in
society. Croucher and Cronn-Mills (2015) describe the critical paradigm as a moral philosophy
since it is less concerned with providing descriptions and explanations of social phenomena and
is more concerned with evaluating freedom, justice and the happiness of societies.
The critical researcher is somewhat grounded in a conflicting framework since the
paradigm is focused upon power, inequalities, and social change. Critical theorists surmise that
the world is not objective and value-free, therefore, it is impossible to be truly impartial and
devoid of biases as the researcher plays a vital role in research and has the explicit goal of
engendering social change (Blackstone, 2012). These researchers believe that participants are
experts in their knowledge, and thus, it is their role and duty to facilitate and stimulate change.
Therefore, the primary objective of research is to bring about change (UK Essays, 2015).
The critical paradigm has a historical ontology that suggests that reality is obtainable.
(Lindlof, & Bryan, 2011). Critical theorists use a historical realism to define reality and maintain
that realities are shaped by social, political, economic, cultural, ethnic, and gender factors and
that these elements are responsible for oppression. The understanding of phenomena is
facilitated by power relations that are socially and historically constructed (Blackstone, 2012).
While critical theorists indicate that the linguistic discovery was a defining moment in
their history because it was with this discovery that it became apparent how reality is
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interactively construed through language. It is a dominant thought in critical studies that
society’s conceptual systems and the manner in which things are defined in society are shaped by
language. And that it is language that both directs and limits the observational process (Lindlof,
& Bryan, 2011). According to Guba and Lincoln (1994), knowledge is comprised of historical
and structural understandings that are altered throughout time, and knowledge is established
upon a dialogic and dialectic interaction.
However, language is not perceived to mirror society; instead meaning in language is
dependent upon the context in which it is predicated. Critical researchers view language as not
being objective, neutral or “reflective of the ‘real world’” (Kincheloe & McLauren, 2000, p.
284). Language is studied as a form of discourse that specifically examines what is being said
and not being said, who is able to speak from an authoritarian perspective and who should listen,
whose social constructions are accurate and whose are false and unimportant (Kincheloe &
McLauren, 2000).
Textual Analysis
It has been argued that history is the study of both the past and the present in which we
look at the past in order to make sense of the present (Nerone, 2011; Nord, 1989). We analyze
the successes, failures, and lessons that have prevailed throughout time and in doing so, history
tells us a story about ourselves and our world (Johnstone, 2004; Zelizer, 2008). Textual analysis
is a methodological tool used to understand media messages, its producers and its consumers.
This method provides ways for analyzing context, audiences and media texts in a productively
and historically accurate manner (Zelizer, 2008). According to Douglas (2008), textual analysis
is concerned with, “context, repetition, intertextuality, contradiction, skepticism and empathy”
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(p. 71). She further contends that the researcher is tasked with looking for patterns, repetition
and contradictions within the text in order to identify themes and for developing an analytical
framework (Douglas, 2008). However, Douglas cautions that textual analysis cannot by itself
tell us about audiences, and, therefore, intertextuality is essential in which both text and context
are taken into consideration in order to assess audiences and their evolution (Douglas, 2008).
Therefore, this paper includes a narrative analysis which will examine such elements as the
events, plots, and characters of text.
Narratives
Historical accounts naturally tell a story which are typically recounted in a narrative
form. The past is revealed in a story form in which narratives provide an accurate account in that
they describe what actually occurred (Nerone, 2010). Narratives are considered to be a form of
historical explanation that present a causal connection through a chronological sequence where
events are connected with one another, thus, giving them meaning (Johnstone, 2004; Nord, 1989;
Wharton, 2015).
Research Design and Methodology
Medical Journal Advertisements as Historical Documents
There is a strong correlation between art, culture, and advertising in which advertising is
able to communicate the past and present accomplishments (Wharton, 2015). Advertisements
serve as important historical documents that speak about the past and present societal standing
that can be revealing (Belk & Pollay, 1985; Fellow, 2012; Harper, 2012; Marchand, 1985; Pope,
2003). According to Fox (1997), advertisements are “visible manifestations” of American life (p.
330). Although many advertisements may present a distorted reality of society, they continue to
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tell us something about society (Marchand, 1985; Pope, 2003). Advertisements are reflective of
culture in a couple of ways: 1) they show the products and services that were available at one
point in time; 2) they depict such products as fashion, technology, and furniture that were
popular during a particular time and 3) they create a photo album regarding society that tells
people how they wish to view themselves and gives instructions about how to live (Belk &
Pollay, 1985; Marchand, 1985; Ohmann, 1996).
Photos and illustrations further provide a historical account regarding society as they are
evidence of material culture that are not intended to be reflections of reality but are to serve as
representations of that reality (Burke, 1991; Marchand, 1985). They provide information about
our existence (Phoenix, 2010). Photography has the power to capture a moment in time that
represents the past and the present. As the click of a camera represents the past and the picture
the present. The photograph is considered to be a past tense medium that tells the audience about
something that existed in time (Mirzoeff, 1999). However, photographs are not perceived to be
manifestations of memories, but are considered to be pieces of information (Mirzoeff, 1999).
Data Selection and Collection
Sampling
Data generation was accomplished through the collection of medical journal advertising
through the University of Tennessee library system during the 1990-2010 timeframe. A
purposive sampling of psychotropic drug advertisements in the medical journals was conducted
as this method allows for a longitudinal comparison and documentation of historical changes in
the depiction and characterization of mental health from 1990-2010. Hence, this sampling
method allows for the collection of data from historical sources (Harper, 2012). Such sampling
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can be based upon such factors as source, date, place, and type. The advertisements were
sampled for every fifth year and were collected for the years of 1990, 1995, 2000, 2005 and 2010
in order to maintain a manageable sample size (Harper, 2012).
The printed advertisements were defined as a full single page or a spread which were
considered to be two full pages facing one another (Grow, Park & Han, 2006). Any duplicate
advertisements were discarded. Current FDA regulations mandate that pharmaceutical
advertising must include a brief summary, important safety information and prescribing
information within the advertisement. These regulatory requirements were not included within
this analysis since the focus of the study emphasizes the overall message and imagery contained
within the promotional materials and not the regulatory statements. Therefore, such items as
promotional headlines, visual imagery, body copy, taglines and the placement of copy were
surveyed (Grow, Park & Han, 2006).
A total of 298 advertisements were collected for analysis. The breakdown consisted of 73
advertisements from the American Journal of Psychiatry; 105 advertisements from The General
Archives of Psychiatry; 49 promotions from the Journal of the American Medical Association;
17 from the New England Journal of Medicine; and 54 from the American Family Physician.
After reviewing the advertisements for the promoted medical condition and duplicates, a total of
70 advertisements for products that were indicated to treat depression were selected for
examination.
During the 1990s, the ease of dosing and the relatively favorable safety profile of SSRIs
contributed to them becoming the number one drug prescribed by psychiatrists (Metzl & Angel,
2004). In addition, other categories of physicians prescribed SSRIs including internists, family
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and general practitioners, and primary care physicians (Mutalik, 2014; Potash, 2007; Stone,
2014). It has been estimated that over 70% of all psychotropic drug prescriptions are written by
general practitioners, internists and surgeons (Hadsolf, Freeman & Norwood, 1982). Therefore,
the medical journals employed for this analysis targeted a diverse physician audience. The
publications were selected based upon their targeted audience and circulation levels and included
the Journal of the American Medical Association, the New England Journal of Medicine, the
American Family Physician, The General Archives of Psychiatry, and the American Journal of
Psychiatry.
The Journal of American Medical Association (JAMA) is one of the oldest and most
prestigious publications that was established in 1883. It is the official journal for the American
Medical Association with an audience of 320,000 readers worldwide. It is one of the most
widely circulated international publications that is directed toward physicians in office-based
practice, hospital based practice and other professional activities. The journal is published forty
eight times per year (http://jamanetwork.com/DocumentLibrary/Marketing/jamacirc.pdf;
http://jamanetwork.com/DocumentLibrary/Advertising/jama_rates_2016.pdf).
The New England Journal of Medicine (NEMJ) is also a well-established and renowned
journal that was founded in 1812 as the New England Journal of Medicine and Surgery and the
Collateral Branches of Sciences which was renamed the NEMJ in 1828. The journal is the most
read and cited publication that reaches over 600,000 people worldwide spanning 177 countries.
The audience is comprised of physicians, educators and the global medical community. It is
published by the NEMJ Group which is a division of the Massachusetts Medical Society. The
journal is published every Thursday for a total of fifty-two issues per year
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(http://www.nejm.org/page/media-center/fact-sheet; http://www.nejm.org/page/aboutnejm/history-and-mission; http://www.nejm.org/page/about-nejm/how-to-advertise).
The American Family Physician (AFP) is the official clinical journal of the American
Academy Family of Physicians, one of the largest medical societies dedicated to primary care
physicians, therefore it is primarily read by PCPs. The circulation of over 186,702 readers
represents 107% of the family physician audience. The journal is published twice a month for a
total of twenty four annual issues (http://www.aafp.org/journals/afp/advertisers/ratespolicies.html).
The Archives of General Psychiatry (now entitled JAMA Psychiatry) is part of The
Journal of American Medical Association Network and is an international publication that is
targeted towards scholars, clinicians, and research scientists in the fields of psychiatry, mental
health, behavioral health and allied fields. The journal is a monthly publication for a total of
twelve issues per year that is read by over 29,000 people
(http://archpsyc.jamanetwork.com/public/About.aspx
; http://jamanetwork.com/DocumentLibrary/Advertising/psych_rates_2016.pdf).
The American Journal of Psychiatry (AJP) was selected based upon its level of
circulation of 27,862 to psychiatrists and other mental health professionals. The journal is
regarded to be a prominent monthly publication that was recently recognized as one of the 100
most influential journals in biology and medicine (http://ajp.psychiatryonline.org;
http://ajp.psychiatryonline.org/about).
Justification of the Study
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Advertising plays a significant role in the dissemination of health related information and
is regarded as an essential form of public health messaging (Curry & O’Brien, 2006; Kempner,
2006). Although medical advertisements can serve a positive role, their proclivity is to reinforce
the concepts of health, illness, and treatment that are maintained and promoted within parts of
the health industry, including pharmaceuticals. It has been suggested that some advertisers use
images and texts to reinforce the pharmaceutical industry’s views (Foster, 2010; Kleinman &
Cohen, 1991).
There are predominately more women than men represented within psychotropic drug
advertisements (Kempner, 2006; Munce, Robertson, Sansom, & Stewart, 2004). The
stereotypical positioning of one gender over another results in physicians assuming that the
advertised medical condition should be attributed to the gender of the model (Peppin & Carty,
2001; Saiz, Cantero, Galvez, 2012). The depictions of women in psychotropic advertising may
result in unequal treatment within the healthcare system. Physicians tend to treat men and
women’s health differently (Hansen & Osborne, 1995). Results of studies have suggested the
prescribing and diagnosis of depression may be excessive for women based upon the stereotyped
imagery presented within psychotropic medical journal advertising (Hansen & Osborne, 1995;
Munce, Robertson, Samson & Stewart, 2004).
The stories contained and reflected within psychotropic advertising in medical journals
warrant examination because they may present an inaccurate depiction of mental health and the
mental health patient which is problematic from a societal perspective for a few reasons. First,
physicians are influenced by such types of promotion as advertising has been correlated with
prescribing practices. Second, the depiction of the advertised typical patient tells the physician
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about that specific person. Through advertised imagery and texts, physicians are informed about
a particular patient, medical condition, and treatment. An account that may be imprecise. Finally,
the storied account that is depicted in advertising may in fact be distorted and may lead to the
misdiagnosis of patients.
The purpose of this study is to examine the representations of the mental health patient,
the conceptions of mental health, and the consumer who is featured in medical journal
antidepressant advertisements. Additionally, these advertised representations and conceptions
will be compared to epidemiology data to illuminate the differences between the advertised
reality and the actual reality regarding depression. These aspects of antidepressant advertising
are studied in order to assess the promoted representations of the mental health patient and the
mental health condition that may affect physicians’ prescribing and diagnostic decisions.
Proceeding this introduction, Chapter two will serve as the basis for the current study. It
will provide a comprehensive discussion regarding the literature review that presents a historical
perspective about direct-to-physician advertising, the use of stereotypes in advertising, and
prescribing and diagnosis, depression, and narratives.
Chapter three provides an exploration of the advertising audience of psychotropic
medications in medical journals. Advertisements weave stories about society that appear to
provide insight into a lived reality, however, these narrative accounts are often flawed and
imprecise (Marchand, 1985). One such distortion that may exist is the depiction of the model and
the lifestyle of the person portrayed within psychotropic medical journal advertisements.
Through such primary marketing strategies as targeting and segmentation, advertisers create
audiences of consumers that are reflected vis-a-vis through advertisements. For products, such as
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toys, cosmetics, and clothing, these tactics may be effective but for psychotropic medications,
these tactics may be detrimental as the person advertised may not be the person who necessitates
such medications.
Chapter four presents a discussion regarding the typical antidepressant patient and at-aglance diagnosis that may contribute to the misdiagnosis of women for depression.
Pharmaceutical, medicine, and advertising industries create hypothetical patient profiles that are
turned into the typical patient who a physician can easily identify, diagnose, and treat. The
hypothetical profiles are constructed upon personal characteristics and lifestyles, and symptoms
and advertised textual elements, all of which contribute to the diagnosis and misdiagnosis of
depression in women.
Finally, chapter five discusses the findings and conclusions of the study including the
creation of the depression audience, the glamorization of depression as a mental health condition,
and the development of the antidepressant patient. The study is completed by delineating with a
few recommendations for DTP advertising.
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CHAPTER II: LITERATURE REVIEW DIRECT TO PHYSICIAN ADVERTISING
Introduction
Effective Direct-to-Physician (DTP) advertising is predicated upon influencing
prescribing and diagnostic behaviors that result in increased product sales. This stimulus has
been traditionally accomplished through the targeting of physicians and the segmenting of the
consumer audience. The intended consumer audience is typically advertised through
stereotypical, gendered imagery, and textual components that may lead to the inappropriate
prescribing and misdiagnosis of certain groups of people. As a result, DTP advertising may
contribute to health inequalities that exist in American society. This chapter begins with a
historical analysis of medical and DTP advertising to demonstrate the development of the
modern day DTP psychotropic advertising campaigns that have customarily relied upon the use
of blockbuster drugs, a gendered medical condition, stereotypes, and stories to sell their
advertised product.
The Direct-to-Physician Advertising Founders
This study provides a historical account of direct-to-physician advertising to demonstrate
the manner in which modern day pharmaceutical promotional practices were established. There
is a relatively small amount of literature that connects the history of pharmaceutical advertising
with the founders of medical advertising. This chapter commences with a historical discussion
regarding the founders and the development of modern day pharmaceutical advertising in an
attempt to bridge this literary gap. This story further shows the complex intertwined relationship
between scientific truth, pharmaceutical promotion, physician prescribing behaviors, and
physician education that has traditionally afflicted the pharmaceutical industry.
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The advertising of medicine has consistently earned enormous profits and garnered wide
attention. From the beginning, the advertising of medicine has been compromised by the
concepts of greed and veracity. Thus, the question, ultimately becomes, how can the motivation
for profit, bottom line, and truthfulness work together in the world of medical advertising? As
the truth in advertising is not always as appealing as the fanciful fantasy and the play upon
words. For medical advertising, the playing field was slanted from the start with the advent and
promotion of patent medications in which these products provided for inexpensive production,
facile distribution, and an immense profit margin. The ads for patent medicines were some of the
first products to be nationally and intensely displayed to consumers and physicians (Fox, 1997;
Starr, 1982).
The claims inherent in patent medicine advertisements were fraught with false
information that had the potential to mislead physicians into prescribing the heavily promoted
products. According to Starr (1982), by the late nineteenth century the use of proprietary drugs
had become more widely prescribed and used. A historical New York survey of drugstores
indicated an increase in nostrums and machine made tablets and the number of prescriptions
dispensed. Prescriptions for these products increased from less than one percent in 1874 to 2025 percent by 1902. And by the turn of the century, the patent-medicine industry had earned $75
million (Fox, 1997).
This trend of creating questionable medical advertising appears to have come full circle
as modern day pharmaceutical advertising affects prescribing, and quite frequently these
promotions have been deemed to be false and misleading. How did we get to nearly the same
place that started medical advertising? The place where truth, and particularly scientific
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accuracy, appears to be as elusive as the mythical unicorn. Through a discussion regarding the
founders of medical advertising, it is suggested that although some of these men brought positive
insights and noble accomplishments, others simply envisioned profits and personal wealth. The
emphasis upon the latter is what motivates the current pharmaceutical industry to the detriment
of society.
The founders serve as important historical figures because of the unique abilities they
contributed helped to shape the American pharmaceutical advertising industry. From scientific
and ethical concerns to the designing and writing of promotional campaigns, these individuals
provided their entrepreneurial spirit, training, strong skill set, and for some, an even stronger
personality. Industry founders, such as, Harry Phibbs, Arthur Sackler, Paul Klemtner, Arthur
Sudler, Matthew Hennessey, Ludwig Wilhelm Frohlich, and Dean Burdick created agencies that
were rooted within different advertising philosophies and provided alternative perspectives.
The Practice of Medical Advertising
A debate has ensued for over 100 years regarding the accuracy and practicality of
medical journal advertising. Critics censure these journals and their advertisements for being
misleading, incomplete, and inaccurate (Smith, 2012; Spielmans, 2008; Lexchin, 2009). While
proponents maintain that the information included within journals and their advertisements are
scientifically accurate and serve a post-educational purpose (Avorn, Chen and Hartley, 1992;
Meyer, 1988). This debate may have originated with the invention and promotion of the patent
medicine and direct-to-physician advertising.
Prior to WWII, and the development of antibiotics, steroids, antihistamines, and
psychotropic drugs, the pharmaceutical industry had a rather modest beginning. The advertising
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of medicine was typically accomplished through patent medicines that were promoted through
the popular press and medical journals. These advertisements for patent medications were
notorious for providing false claims, information, and promises. Often times, physicians were
unaware of the lingering dangers hidden within patent medications and would prescribe them to
patients (Starr, 1982). The concern over the prescribing of patent medications prompted the
American Medical Association, muckraking journalist, women’s clubs, physicians, and other
Progressives to become concerned and to advocate for the governmental regulation of patent
medications and their promotions (Fox, 1997; Starr, 1982). Thus, there were 100 bills that had
been presented for the Congressional regulation of food and drugs by 1879. And on June 30,
1906, President Roosevelt signed the Pure Food and Drug Act which demarcated the
commencement of federal regulation of prescription advertising in America
(http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm054819.htm; Starr, 1982).
According to the law, product labeling for food and drugs could not be false or misleading and
had to list such dangerous ingredients as alcohol, heroin, and cocaine. The bill provided
provisions for the prevention of the misbranding of products
(http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm054819.htm).
However, the law did not safeguard against advertising claims regarding a drug’s effectiveness
or statements that were promoted in the newspaper. Therefore, due to this oversight, the drug
makers continued to assert bold claims and resumed with their businesses (Fox, 1997; Starr,
1982). By 1912, the law was amended to include the fraudulent claims that could be made
regarding the effectiveness of a drug, and by the 1920s, it was further extended to include
newspaper advertising in addition to labels. These regulations helped to reduce the erroneous
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patent medication claims while allowing scientific medicine to come to the forefront (Starr,
1982).
Harry Phibbs was greatly worried about the ethical quality of medical advertising and
would be incensed when he encountered a promotion that he deemed to be dishonest. He was
particularly interested in preserving the health of the public as he once admonished a young
copywriter, “You are not writing for advertising. You are saving lives!” (www.mahf.com/mahfinductees). His emphasis upon honest advertising prompted him to establish the first medical
advertising agency in 1921 that was in Chicago, near the American Medical Association (AMA)
(www.mahf.com/mahf-inductees).
Phibbs had an artistic background that included his membership in the famous Abbey
Theater Group. When he decided to move from Dublin, Ireland to America, he initially landed in
Newfoundland with very little money. Therefore, he put his artistic talents to use and pursued his
design skills in stained glass windows. Subsequently, he moved to Montreal to work a myriad of
jobs as a stage manager, a newspaper man, and as a sales representative with Borroughs
Wellcome. The company transferred him to New York and eventually he ended up at an
advertising agency in Chicago (www.mahf.com/mahf-inductees). However, despite his artistic
experiences, Phibbs was more concerned with the science of advertising rather than the art.
Phibbs, along with his personal friend Dr. Morris Fishbein (an editor for The Journal of
the American Medical Association), and the AMA had been crusading against the false patent
medication promotions. At the suggestion of Dr. Fishbein, Phibbs started his advertising agency
in an effort to stymie the patent medicine false advertising. This endeavor proved to be Phibbs
calling as he had a background in “ethical drugs” and decided to seize upon this opportunity.
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Harry C. Phibbs Advertising Co. was born with Phibbs as the only employee, with $200 in his
pocket, and his wife as his secretary (www.mahf.com/mahf-inductees).
His sharp focus upon ethical promotion allowed him to emphasize the technical and
clinical information associated with medicine. This motivation paved the way for the
development of the scientific model that was to be used in medical advertising. Advertisements,
he felt, should include the scientific information, therefore, he eschewed the use of exaggeration
and the overstatement of benefits, a tactic that has subtly crept back into contemporary
advertising (www.mahf.com/mahf-inductees). This quest for scientifically based advertising
would contribute to the enduring debate regarding the veracity of pharmaceutical advertising.
After World War II, the industry would focus more on sales and less upon the quality of the
claims that were made in promotions.
Pharmaceutical Life After World War II
Following World War II, medical research greatly increased and a plethora of
breakthrough products hit the market for sale. The burgeoning of the pharmaceutical science
after the war transformed the marketing of drugs. The older advertisements that featured
packaging photos in medical journals were replaced with big budgets and sophisticated graphics
and copywriting (Castagnoli, 1996). The founders of medical advertising provided new
promotional philosophies and styles, and they helped to launch the pharmaceutical industry’s
“Golden Age” (mahf.com/industry-chronology). This timeframe was replete with novel sales
tactics, the creation of the pharmaceutical sales forces and advertising campaigns, the branding
and design of promotional materials, and the insidious effects of promotion upon prescribing.
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The Pharmaceutical Sales Force
Detail men (salesmen who personally visited physicians in their offices and provided
samples of products) were important to medical advertising because they provided acute intuition
into the personalities, prescribing behaviors, and the profits derived from the physician audience.
Through prescriptions and sales, detail men showed the pharmaceutical industry just how
lucrative physicians were to their business (Greene, 2007).
As direct-to-physician advertising was beginning to take shape by the 1940s, the primary
method for pharmaceutical advertising was with the sales force and detail men. Paul Klemtner
was a quiet, shy man who had a financial background as he attended business school in Chicago
while working part time for G. D. Searle. During his time at Searle, he became the comptroller
and developed the cost accounting and financial control systems for the firm. This experience
provided him with the practical knowledge of virtually all aspects of the pharmaceutical industry
(www.mahf.com/mahf-inductees).
Klemtner is well known for his remarkable vision to predict industry trends as he played
a revolutionary role in changing pharmaceutical sales tactics that were focused upon the personal
sales of pharmaceuticals to physicians. Due to his expectation that the pharmaceutical industry
would move away from producing and distributing generic drugs to one of creating and
marketing patented, branded medications he advised the pharmaceutical companies to realign
their sales forces in order to prepare for this change in distribution. Klemtner ingeniously guided
the sales forces to concentrate upon selling to those physicians who prescribed branded drugs
(Medical Marketing & Media, 2006; www.mahf.com/mahf-inductees). His keen insights resulted
in his becoming a consultant for the industry and the creation of his agency, Paul Klemtner and
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Company that was established in Newark, New Jersey in 1934. Ten years later he developed
Paul Klemtner Advertising and recruited Tom Jones, an expert in detailing and field force
management. Klemtner had an eye for talent, and hired an outstanding staff who were given the
freedom to take charge of areas outside of their expertise, thus providing them with invaluable
experiences (www.mahf.com/mahf-inductees).
During the 1940s, with the sales emphasis placed upon directing promotions to specific
physicians, the beginnings of pharmaceutical audience segmentation and targeting began to
emerge. Physicians were parceled by detail men in two manners, by their personality type and
their prescribing patterns. Through caricature representations, detail men would decipher
between physician personality types that allowed them to determine the level of receptivity a
physician would have to their sales tactics. Physicians were ultimately characterized based upon
their personality traits and behaviors and were described as “Dr. Snob,” “Dr. Resistant,” and
“The Backslapper” (Greene, 2007). Further, in order to target the most profitable physicians to
visit, the detail men would utilize a visit log to rate physicians based upon their practice size,
receptivity to salesmen, and their interest in novel medications. This data not only informed
detail men about profitability but is also assisted sales managers in developing more effective
sales strategies (Greene, 2007).
Prior to the development of sophisticated instruments that could measure data, the rates
of prescribing by physicians were unscientifically calculated by detail men. The salesmen would
employ the pharmacy as sources of data collection. Every month they would request a list of
prescriptions that had been filled. This information provided them with specifics as to who the
large and small volume of prescribers were (Greene, 2007). The correlation between
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prescriptions, sales, and profits began to converge during the 1940s detail men’s efforts. The
sales efforts further spurred a new way for adverting to physicians that continues to be a common
practice today. The delivery of samples to physicians via sales representatives.
The Initial Pharmaceutical Blitz
The sales force during the 1940s was an important element to DTP advertising, but the
development of the DTP advertising campaign that incorporated salesmen into the marketing
mix also played a significant role. Lederle Laboratories is considered to have created the DTP
advertising ‘blitz’ in 1948 with the advent of its antibiotic, Aureomycin (Podolsky, 2015). The
initial direct-to-physician advertising campaign could be considered modest by today’s
standards, yet the money spent and the channels pursued were unprecedented. The advertising
campaign focused upon the distribution of product samples and the founding of an in-house
publication.
Ten carloads of samples were shipped to approximately 142,000 physicians at an
estimated $2 million for the product alone. Beginning in January of 1950, Lederle published and
mailed their in-house periodical, Aureomycine Digest, to physicians on an almost monthly basis.
This publication’s bibliography grew from 321 titles in January to an impressive 1,859 by
December (Podolsky, 2015).
Lederle did not stop with this initial campaign, as it refined DTP advertising with the
introduction of its tetracycline, Achromycin. Lederle upped the ante as Achromycin was
supported by a $2.5 million ‘blanketing’ advertising campaign. This promotion included a multichannel marketing approach that placed advertising in front of the physician through multiple
touches and this paved the way for current pharmaceutical advertising (Podolsky, 2015).
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Lederle allocated, $1 million for detailing, $851,000 for a direct mail campaign (105
mailings to each physician in the US), $470,000 for medical journal advertising and $100,000 for
exhibits at medical meetings. Additional promotional items, such as tongue depressors, pens,
and brushes were included as well (Podolsky, 2015). Through the emergence of the creative
personnel, the pharmaceutical advertising campaign increased to include printed promotions.
Creative Design and Copywriting
Arthur Sudler and Matthew Hennessey are known for creating a graphic look that has
become known as being the “pharmaceutical advertising design.” This design promoted the fullpage advertisement that contained provoking elements and headlines. The artwork and copy
were both dramatized as they translated the human characteristics, the technical features of the
product, and the competitive claims, a format that is consistently utilized today. Sudler and
Hennessey, further, believed in the power of visual communication, and it was their contention
that the use of visual imagery could separate a product from its competition
(www.mahf.com/mahf-inductees).
An employee of E.R. Squibb and Sons, Arthur Sudler was interested in the visual arts,
and he was able to identify with artists, and he was a painter who had a deep influence on the
style of medical advertising that remains today. Sudler was educated as an artist at the Maryland
Institute of Fine and Applied Art where he studied with eminent artists John Sloan and Robert
Henri. His works have been displayed in New York galleries and in museum collections. While
he was at Squibb, he advanced to the position of creative director, and in 1936, he left the
company to open his own art studio (www.mahf.com/mahf-inductees).
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Matthew Hennessey, also an employee of Squibb joined Sudler and became his partner in
1942, thus establishing Sudler & Hennessey. Hennessey was born in Brooklyn, New York, and
demonstrated an active entrepreneurial spirit by the age of thirteen. As a teenager, he delivered
telegrams all over the upper west side of Manhattan for Western Union while wearing roller
skates (strunkfuneralhome.com). Hennessey was known for his acute business sense and was
regarded as an exceptional judge of character. Since medical advertising had not become of
importance to pharmaceutical companies at this time, Sudler and Hennessey created quality
designs through the assembly of a talented staff of art directors that included George Lois,
Helmut Krone, Ernie Smith, Herb Lubalin, and for a short period, Andy Warhol. Hennessey
challenged the staff to craft bigger, better, and more memorable ideas. As a result, the studio
produced a broad range of design work that included logos, sales promotions, image products,
packaging, and corporate advertising programs. Although Hennessey exhibited an aggressive
personality, he was unable to fire people from his staff and would ask other people to remove
employees from the payroll. A trait that hinted at his generous and caring side (Castagnoli, 1996;
www.mahf.com/mahf-inductees).
Another creative designer to join the group of founders was Ludwig Wilhelm Frohlich.
He contributed to pharmaceutical advertising by establishing design formats for direct mail,
detail aids, journal advertising, samples, and educational materials. Additionally, he expanded
his operations overseas before any of his competitors and opened offices in London, Paris,
Frankfurt, Madrid, Milan, and had the foresight to open an office in Tokyo. He was a pioneer of
the global advertising of pharmaceuticals (www.mahf.com/mahf-inductees).

28

Frohlich was educated at the University of Frankfurt and in Paris. He travelled to
America in 1931 as an exchange student and became a citizen in 1938 (New York Times
Special, 1971). Subsequently, he opened his art studio in 1939 in New York and entered into the
medical communication field during the early 1940s. His talents were in type design and art
direction which he applied to the pharmaceutical industry. By 1943, he created his ad agency,
L.W. Frohlich, Inc. that employed only five people. The agency client roster quickly grew and
featured such companies as Schering, Mead Johnson, Ortho, Parke-Davis, and Ethicon
(Castagnoli, 1996; New York Times Special, 1971; www.mahf.com/mahf-inductees).
During the time, graphic design was considered to be Avant guard in medical advertising,
Dean Burdick brought writing skills to match the graphics that were as contemporary and
imaginative in scope. Burdick was renowned for his writing skills and his headlines that could
communicate the main idea of the program. For an Ayerst ampicillin advertisement, he wrote,
“Wanted: Dead Not Alive!” (www.mahf.com/mahf-inductees). His agency, Burdick, Becker &
Fitzsimmons, introduced Inderal, the first betablocker in the U.S. which garnered awards and
profits. The advertisements won readership prizes, best ad in the cardiovascular category, and the
best pharmaceutical ad for the year (Castagnoli, 1996). Burdick was a shy man who did not
present his ad ideas to clients; instead he opted to socialize on the golf course. He was talented in
attracting young, top talent and provided a training ground for many pharmaceutical executives
who had successful careers within the industry (www.mahf.com/mahf-inductees). Burdick
worked with the innovator of direct-to-physician pharmaceutical advertising, Arthur Sackler.
Although Lederle is eminent for creating the DTP advertising ‘blitz,’ it is Arthur Sackler and
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Charles Pfizer who finessed it through an aggressive advertising campaign produced for Chas.
Pfizer and Company during the 1950s (Podolsky, 2015).
The Pioneer of Direct-to-Physician Advertising
Arthur Sackler, a physician and clinical psychiatrist, is regarded as the person who
revolutionized pharmaceutical marketing and direct-to-physician advertising through personal
and non-personal tactics that incorporated fact-based medical advertising (Leonard, 2016;
sackler.org/about). He has been described as “’the’ industry giant” who was a force to be
reckoned with as he stepped on other people’s toes (Castagnoli, 1996). According to a long time
William Douglas McAdam’s executive, Sackler was, “controversial, unsettling, difficult, but…a
pioneer and visionary who broke new ground in…perfecting the effectiveness of medical
communication” (Castagnoli, 1996, p. 44).
Sackler joined the small, four person William Douglas McAdams agency in 1942 and
purchased it in 1947. The agency was based in Chicago and was established in 1926 by a
journalist, William Douglas McAdams. Originally the consumer agency represented such
accounts as Van Camp Beans, Mother’s Oats, and E.R. Squibb & Son’s cod liver oil. McAdams
advised Squibb that in order to increase product sales the advertising for the product should be
directed towards physicians along with consumers. After the company agreed with McAdams, an
advertisement was placed in a medical journal, a promotional move that was unprecedented and
yet, wildly successful (Dougherty, 1985). This decision to advertise directly to the physician
through journal advertising prompted McAdams in 1939 to devote all of the agency’s resources
to medical advertising directed exclusively to physicians. This transformation from a consumer
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agency to a medical one resulted in the McAdams agency as being one of the earliest and most
influential in medical advertising (Dougherty, 1985; Elliot, 1991; Herzberg, 2009).
Arthur Sackler was born in Brooklyn, New York and had a difficult childhood as his
parents lost their money during the depression. As a result, Sackler went to work at the age of
thirteen to support his family. He paid for medical school for himself and his two younger
brothers Raymond and Mortimer, all of whom became psychiatrists. Arthur was a resident at the
Creedmore State Hospital in Queens, New York, where he founded the Creedmore Institute of
Psychobiological Studies. The Sackler brothers purchased a small, struggling drug manufacturer
in New York in 1952 that became Purdue Pharmaceuticals. Originally the company sold
laxatives and earwax remover, but over time, would produce a generic painkiller now known as
OxyContin (Encyclopedia Britannica, 2016; Morrell, 2015; sackler.org/about; Tuck, 1986).
Based upon Sackler’s medical background, he understood how the drugs worked and was
able to successfully communicate with physicians (Dougherty, 1985). His strategy focused upon
marketing directly to physicians through glossy medical journal advertising and personalized
detailing. He further engendered personal relationships through the sponsorship of all-expensepaid, luxurious medical education courses, by providing lucrative speaking fees to doctors, and
in the distribution of fancy trinkets.
Arthur Sackler formally established the DTP advertising machine through the use of
robust marketing campaigns that featured medical journals that used slick graphics, thoughtprovoking copy, and heavy stock inserts (Quinones, 2015). His use of medical journals was a
savvy business decision since the 1938 Wheeler Lea Act granted the Federal Trade Commission
(FTC) jurisdiction for the regulation of drug advertisements that precluded medical journal
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advertisements. Physicians were deemed as being capable of evaluating the accuracy of drug
advertisements in medical journals, and as a result, these publications were exempted from the
FTC regulatory authority (Donohue, 2006).
Additionally, the Federal Drug Administration (FDA) was able to regulate
pharmaceutical promotion through the Food Drug & Cosmetic Act (FDCA) labeling provision,
however, its power to do so was also limited. Consequently, the FDA was able to regulate such
promotional materials as direct mail sent to physicians but not advertising in medical journals
(Donohue, 2006). Sackler’s career was enhanced by his work with Pfizer in that he successfully
positioned, designed, and branded an antibiotic advertising campaign that resulted in
skyrocketing sales.
Marketing of Terramycin
Pfizer hired the William Douglas McAdams Advertising Agency to handle the promotion
for their antibiotic Terramycin. This campaign was led by Sackler who met with the sales
director, Thomas Winn in 1951. During this meeting, Sackler told Winn that if he was provided
with a large enough budget, he could make Charles Pfizer and Company a household name for
physicians. Winn reciprocated and allotted the largest advertising budget of any company for the
marketing of a drug (Quinones, 2015). After receiving his advertising budget, Sackler
comprehensively promoted the product through medical journal advertisements, direct mail, and
detailing (the combination of salesmen visiting physicians in their offices and the publication of
promotional materials in medical journals) (Quinones, 2015).
One of the initial obstacles Sackler had to overcome was the fact that there were three
primary antibiotics that were competing for the same market shares, Aureomycin, Chloromycin,
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and Aureomycin. Each of these compounds were essentially identical and therefore, mandated
some product differentiation. In order to accomplish this distinction, Sackler and Pfizer worked
with future Noble Prize Winner Chemist, Robert Burns Woodward of Harvard, and crafted the
positioning of the drug based upon its molecular structure. This difference was perceived to be
“the medical discriminator” or the McAdam’s agency’s version of the Ted Bates agency’s
“unique selling proposition” that highlighted the unique qualities of a drug that could be
emphasized in its advertising (Elliott, 1991). Accordingly, the promotional materials, through
advertising copy, informed physicians about the theriac-like qualities of the drug as being
“unusual, differing markedly from the structure of other antibiotics…one of the most complex
structures to ever be found in nature” (Podolsky, 2015). The messaging and positioning
emphasized the drug’s exclusive structural qualities. In contrast, Aureomycin was originally
promoted in broad terms as, “the most versatile antibiotic yet discovered with a wide range of
activity than any other known remedy” (Podolsky, 2015).
Moreover, Sackler elevated the DTP advertising campaign through the design of colorful,
glossy medical journal advertisements which featured a play on the word “Terra.” Upon FDA
approval of the drug, he placed similar glossy ads reflecting the same font and color featured
along with the product’s name, thus providing some branding elements associated with the
product (Quinones, 2015). Beside journal advertisements, the insertion of Pfizer’s in-house
publication Spectrum, an eight-page glossy promotion, was placed into the Journal of American
Medical Association (JAMA).
In addition to advertisements, direct mail also played a significant role in the initial DTP
campaign. A series of postcards was produced that featured exotic places around the globe in
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which Terracymin had been utilized. The postcards featured The Great Barrier Reef, the Sphynx
and Pyramids, a hillside pasture in Malta, and the Bitter Root in Montana. The postcards were
introduced as “Dear Doctor” and signed off with “Sincerely Yours, Pfizer” (Fortunato, 2005).
Other direct mail pieces included file cards, technical brochures, folders, and letters
directed to general practitioners, pediatricians, surgeons, ophthalmologists, etc. A high decile
physician could receive two to three Pfizer mailings every day throughout a calendar year
(Fortunato, 2005). This DTP campaign was effective, and Arthur Sackler was acknowledged for
showing Pfizer, “how intelligently written, strikingly illustrated, and designed advertising used in
volume could greatly influence the success of a product” (Podolsky, 2015, p. 25).
By 1952, sales for Terramycin were extraordinary as they amounted to $45 million
(Quinones, 2015). One reason the product sales were remarkable was due to Sackler being one of
the first people to recognize the marketing potential of the medical journal in influencing
physician prescribing behaviors (Hanania-Freeman, 2016). This relationship between
pharmaceutical promotion and prescribing behaviors would become hotly contested and debated.
Promotional Effects on Prescribing
During the early 1950s, the Business Division of JAMA took an interest in studying the
effects of pharmaceutical promotion on physician education and prescribing behavior.
Consequently, the AMA hired Ben Gaffin Inc., a Chicago based Opinion Research firm to
examine these effects. The first study incorporated focus groups with representatives from 78
prominent marketing and advertising firms to examine the correlation between pharmaceutical
promotion and the educational value of these materials (Greene & Podolsky, 2009). Robert
Lyon, the Head of Advertising Department as the AMA stated that, “when asked the reasons for
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their thinking these advertisers explained that when the physician leaves school and goes into
practice, only a small percentage carefully follow all of the advances in numerous medical
journals. Accordingly, much of their information must come from promotion” (Greene &
Podolsky, 2009). The AMA mailed the analysis to leading firms in the pharmaceutical industry
that detailed the influence of pharmaceutical marketing on practicing physicians (Greene &
Podolsky, 2009). Based upon the affiliation between DTP promotion and prescribing, physicians
were inundated by pharmaceutical promotional materials by the late 1950s.
There were 3,790,809,000 pages of medical journal advertisements that were produced,
741,213,700 direct mail pieces were mailed and approximately 20 million calls were made by
detail men to physicians and pharmacists (Donohue, 2006). Many new prescription products
were brought to market and this overflow of compounds further contributed to the excess of
promotional materials that were used for educational purposes (Greene & Podolsky, 2009). As a
result, criticism regarding pharmaceutical marketing practices began to take shape as Harry
Dowling, Chair at the Department of the University of Illinois contended that “the bewildered
physician prescribes by suggestion and not from information” (Podolsky & Greene, 2008).
Pharmaceutical marketing had become thought to be deceptive and wasteful, causing irrational
and emotional prescribing. Ernst Dichter explained at the 1955 Pharmaceutical Club in New
York, “’the physician expects himself to make up his own mind on the basis of objective
evidence. And yet he finds himself confronted, like a housewife in a supermarket aisle, with a
misery of choice which he tends generally to resolve with irrational and emotional factors”
(Podolsky & Greene, 2008). Pharmaceutical marketing would subsequently emphasize the
dichotomy between rational and emotional factors through advertising practices that were
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concerned with influencing prescribing behaviors, to which physicians denied that such influence
could occur (Greene & Podolsky, 2009).
However, Arthur Sackler steadfastly defended pharmaceutical advertising practices and
the industry’s role in educating physicians about new drugs. Sackler wrote, “’neither is so
obtuse as to be deceived for long claims which are even inferentially incorrect. There exists a
common gap in information supply…pharmaceutical advertising has made one of the major
contributions in the rapid dissemination of new therapeutic information’” (Greene & Podolsky,
2009). This argument must have been accepted as physicians would not wish to view themselves
as anything but experts. Thus, by the 1960s, over 90 percent of pharmaceutical marketing
spending was allocated for DTP promotion (Donohue, 2006).
Sackler was regarded as being the inventor of “the wheel of pharmaceutical advertising”
(Dougherty, 1985). He created the modern day DTP advertising and marketing machine which
may increase profits, but in a rather harmful manner. Sackler resurrected the false marketing and
advertising tactics that are evocative of the days of patent medicines in addition to creating his
own strategies that appear to be somewhat scientifically uncertain. One of these methods that
seems unscrupulous is one of his greatest achievements, the glamorization of psychotropic drugs
as quick fixes (Eban, 2011; Skolek, 2010). This glamorization of pharmaceutical medications
began with the Miltown advertising campaign.
Psychotropic DTP Advertising
Miltown
The advent and marketing of Miltown was important for the development of DTP
advertising. Miltown contributed to current pharmaceutical advertising practices by enshrouding
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the product with a Hollywood gloss, by expanding the physician and consumer marketplace, and
by gendering the consumer market.
During the 1950s, Miltown, a minor tranquilizer, was developed and brought to market
and with its auspicious beginnings it revolutionized the way Americans perceived of and used
prescription drugs. The media and Hollywood played a significant role in defining Miltown as it
received the public’s attention through the health sections of popular magazines, gossip columns,
consumer and lifestyle pages, and business and economic pages (Herzberg, 2009). Hollywood
stars added a sort of luster to the drug, thus elevating its status, as they relished taking and
talking about their experiences with Miltown. And in doing so, gossip columnists generously
wrote about the stars’ comments and behaviors, especially when they imbibed a particularly
popular drink, the Miltini (Miltown and Martini mix) (Tone, 2009). Journalists also contributed
to the Miltown rage as they reported on medical and technical advances which allowed drug
manufacturers to shape media coverage (Herzberg, 2009). Subsequently, the early advertising
campaigns for psychotropic advertising were created by journalists, scientists, pharmaceutical
executives, and advertising personnel that stressed psychotropic drugs as the solution to
everyday ailments.
Through normalizing the use of psychotropic drugs for everyday complaints, the drug
expanded the physician marketplace from the psychiatrist to the family doctor. Miltown’s
everyday message and emotional appeal made it acceptable to visit the family physician for a pill
that could make a person feel better about life, and yet was not necessarily prescribed to treat a
disease. This proved to be a profitable decision, as family physicians tend to see more patients
than psychiatrists.
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The gendering of psychotropic drugs emerged with the introduction of Miltown that was
based upon the dominate ideology of the assigned roles of men and women within society in
which men were perceived as being masculine and women were naturally feminine. In advertised
representations, men were portrayed in business settings adorned in suits and ties while women
were depicted in a home setting and were surrounded by such symbols of wealth as pearl
necklaces, stylish attire, and new appliances (Herzberg, 2009). Advertiser’s continued to sell
masculinity to men as campaign messages promised that tranquilizers would return men to
properly masculine vigor and decisiveness (Herzberg, 2009). Conversely, messages that targeted
women emphasized femininity while promising the America people the return of happy women
to house wife settings (Herzberg, 2009). The gendering of the patient marketplace assisted
Arthur Sackler with defining the typical psychotropic patient as being a woman.
Valium
In 1963, the FDA approved Valium which subsequently became the first psychotropic
drug to become a cultural icon due to its aggressive marketing campaigns (Cooper, 2013;
Quinones, 2015). Through the marketing of Valium, a few trends emerged. First the messaging
emphasized the physical pain associated with mental conditions. Second, physicians were asked
to look for specific patients rather than for symptoms or ailments which expanded the consumer
market. Third, physicians were provided with descriptions regarding the typical patient, so that
they could easily identify and diagnose h/she upon entering the examination room.
It has been remarked that one of Sackler’s paramount achievements was in his discovery
of various uses of Valium (Eban, 2011; Mariani, 2015). One of these uses included physical pain
which made the messaging strategy of the Valium campaign very important. The success of the
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drug, relied in part, upon urging and convincing physicians to perceive patient’s pain as being
physical in origin and to prescribe Valium as the solution. This message was reinforced through
the connection between physical pain and stress as Valium was positioned as the de-stressor.
This messaging offered the connotation that depression was somehow connected to a physical
condition, thereby, rendering the product’s meaning as being more scientifically based.
In addition to messaging, Sackler was able to “manufacture demand” through the
development of the consumer audience (Hanania-Freeman, 2016). The true consumer audience is
made up of actual consumers, and this is the audience that, it can be argued, was established by
Sackler who pursued not only the patient but included someone in addition to the patient. For
example, if a child was ill, perhaps it was the mother who was tense, thus, she was also a
candidate for medication. Sackler, in essence, through his practical experience, established the
advertised end-user of Valium. Thereby, the patient and the consumer became distinctly different
audiences. The consumer was the person who was considered to be the buyer, while the patient
was the person who received health-care services (Donohue, 2006).
Valium was intentionally marketed towards women and was pitched as being a treatment
for the stress of lives as wives and mothers (Quinones, 2015). The typical advertised patient was
predicated upon this target audience. Therefore, the typical patient was established through the
categorization and labeling of the intended target audience. Consequently, Valium ads were
comprised of women who were described as neurotic singles, tired middle class mothers,
exhausted business women, and irritable menopausal women (Tone, 2009).
The script that was provided to physicians to familiarize them with the typical patient and
to convince physicians to prescribe Valium, was akin to,’” The patient would walk in. ‘” I’m
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nervous all day long doctor” or “My son is in the army” (Quinones, 2015, p. 30). Further, the
script might depict a scenario including, a college educated woman in her 30s who was a mom
struggling with dealing with the stresses of a busy everyday life. When she discussed her
condition with her physician, he would prescribe Valium and when the drug was ineffective for
her treatment, the physician would prescribe more.
According to Riska and Heikell (2008), psychotropic advertisements inherently contain
gendered scripts that have taught physicians a way of seeing. The gendering of medical
conditions has resulted in the creation of the typical patient that is based upon embedded
advertising and medical textbook imagery. Pharmaceutical and medical institutions have
provided physicians with a textual and visual representation of the typical patient, so the
physician can diagnose at a glance.
At-a-Glance Diagnosis
At-a-glance diagnosis is based upon the premise that a physician’s actions are influenced
by his interactions throughout the day in which he cognitively uses shortcuts to diagnose
patients. Gaffin suggested that a physician’s interactions in the morning could affect his daily
actions, which infers to include prescribing as well as diagnosis. Gaffin advised, “his morning
contacts with his wife and children affect in a greater or lesser degree his attitude toward
patients, toward co-workers, and toward detail men. His basic temperament, modified by his
daily interpersonal relations, influence all his actions and attitudes to some extent. His humanbeingness is modified by his being a physician” (Greene & Podolsk, 2009). These morning
contacts could also include advertising which could color perceptions.
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According to Belkin (2012), a physician may be influenced by advertisements through
their stereotyped gendered imagery. She argues that the physician who reviews a specific
advertisement that features an image of a distressed woman during a morning reading session
may throughout the day, listen to women’s complaints of housework and drudgery. These
grumbles will lead to the recollection of the particular ad and, ultimately, to the decision that a
psychotropic medication is the best treatment for this patient. Thus, the physician will prescribe
a promoted brand, not based upon any clinical or scientific merit but rather on the perceived
stereotyped gendered image. This visual cue then becomes perceived as being the typical patient
who is assigned to the advertised medical condition. Through such marketing and advertising
tactics, Valium became the first $100 million drug and subsequently the first $1 billion drug
(Leonard, 2016).
The Closing of an Era
By the 1960s and 1970s, the agency owners began to retire and pass away leaving their
agencies to be either acquired by larger entities or they simply closed. One of the most
impressive traits of the founders was their ability to establish their agencies and to work with
skeleton crews and to accomplish the extraordinary amount of work they produced in such a
short period of time. Harry Phibbs’ agency was eventually acquired by BBDO (Arnold, 2009;
www.mahf.com/mahf-inductees). The William Douglas McAdams agency was ultimately
acquired in 1996 by Interpublic’s Lowe Group. At the time of the acquisition, William Douglas
McAdams was the sixth largest medical agency in the U.S. with billings of approximately $170
million (Advertising Age, 1996). Klemtner Advertising was acquired by Saatchi & Saatchi Co.
(Advertising Age, 2003; www.mahf.com/mahf-inductees).
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Arthur Sudler passed away in 1968 and was survived by Matt Hennessey who was able to
establish Sudler & Hennessey as the largest medical agency, a distinction it was able to keep for
twenty years (sudlerdigital.com). L. W. Frohlich’s agency, L.W. Frolich Intercon International
became a health industries agency that had offices in seven countries and clients in twenty-eight
countries (Dougherty, 1970; New York Times Special, 1971; www.mahf.com/mahf-inductees).
In 1972, the agency joined Benton and Bowles’ medicus communications division to provide the
marketing, advertising, and communication needs of the health care industry. Dean Burdick
passed away in 1984 and his agency closed (www.mahf.com/mahf-inductees).
The founders of medical advertising contributed significantly to current day
pharmaceutical advertising and marketing. Although most of these men provided beneficial
contributions, Arthur Sackler also offered some rather dubious practices that are reminiscent of
patent medication promotions. These tactics continue today as false promises, diseases,
symptoms, and cures are advertised. Lawsuits for false and misleading marketing continue to be
filed, including those pertaining to the Sackler brothers company, Purdue Pharmaceuticals
(Armstrong, 2016; Morrell, 2015). However, it is important to recognize the founders of the
industry as most of their agencies were acquired by larger institutions and their work continues
to influence, in a positive and negative fashion, the contemporary direct-to-physician
pharmaceutical advertising standards and practices.
Current Direct-to-Physician Advertising
Direct-to-physician (DTP) advertising is considered to be a chief promotional strategy for
pharmaceutical companies as it helps to keep the pharmaceutical industry competitive
(Manchanda & Honka, 2005; Pedan & Wu, 2009; Spiller & Wymer, 2001). DTP activities
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account for most of U.S. pharmaceutical spending on marketing and promotion (Conners, 2009;
Mizik & Jacobson, 2004). Such advertising tactics include detailing, advertising in medical
journals, online ads, events and meetings. From 1998 to 2004, pharmaceutical promotional
expenditures more than quadrupled from $12.7 billion to $57.5 billion. Additionally, in 2009,
pharmaceutical companies spent 60% of their marketing expenditures on DTP promotion in the
U.S. (Pedan & Wu, 2009). Finally, in 2012, pharmaceutical companies spent $24 billion on DTP
advertising while in stark contrast, only $3 billion was spent on Direct-to-Consumer advertising
(DTCA) (Pew Report, 2013).
For every dollar that is spent on medical journal advertising there has been a positive
correlation between the ads Return on Investment (ROI) equating to a range from $2.30-$12.20
depending on the type of drug that is advertised. Consequently, medical journal advertising has
the potential to provide a greater ROI than detailing, DTCA, and physician meetings and events.
On average, journal advertising ROI is $5 higher in comparison to other forms of pharmaceutical
promotion (Spielmans, Thiegles, Dent & Greenberg, 2008).
Pharmaceutical companies prefer journal advertising as a marketing strategy because this
media channel increases sales in a cost effective manner as advertising increases prescriptions
for targeted drugs in a dose-related manner. That is to say, that physicians have the ability to
prescribe a product multiple times whereas a patient is restricted in the number of times he/she
can refill a prescription (Fugh-Berman, Alladin & Chow, 2006).
Physicians are regarded as being key decision makers and an important audience because
of their ability to prescribe medications to patients (Gonul, Carter, Petrova & Srinivasan, 2001).
One way in which physicians learn about these medications is through medical journal
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advertising. These publications are important to the physician-pharmaceutical-advertising
relationship because it has been suggested that physicians utilize these publications for sources
of information and for educational purposes which ultimately influences prescribing behaviors.
Purpose of Pharmaceutical Advertisements
Pharmaceutical advertising provides physicians with a comprehensive and organized
system for accessing information related to drug availability, efficacy, safety, hazards,
tolerability and techniques for using the medication (Levy, 1994). The information contained in
medical journals is intended to persuade physicians to prescribe drugs while further educating
health professionals about the benefits and risks associated with treatment (Spielmans, Thiegles,
Dent & Greenberg, 2008). Previous research has indicated that 1-6% of physicians first become
acquainted with new drugs via journal ads and a notable 62% of physicians first discover a
drug’s existence from journal advertising (Krupka & Vener, 1985). Physicians further actively
employ ads to match drug therapies with patient needs as journals are considered to be an
unbiased and informative form of information regarding drugs (Fugh-Bergman, Alladin &
Chow, 2006).
Medical Journals as Sources of Information
Despite the emergence of digital sources of information, print continues to be a source
commonly used by physicians as they rely upon this type of information and view medical
journal ads as being valuable sources of information (Hawkins & Aber, 1993; Knutsen, 2015).
Drug advertisements provide a primary source of information for physicians and medical
journals are one major channel through which physicians learn about medications and therapies
(Levy, 1994). Furthermore, a March 2013 Kantar Media’s Sources & Interactions study revealed
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that 89% of physicians read print versions of current issues of medical journals in comparison to
51% who viewed digital editions (Kantar Media, 2013). Another March 2013 Kantar Media’s
Sources and Interactions report indicated that physicians value their colleagues, Continuing
Medical Education (CME) and print medical journals for sources of information (Brewster,
2014). Additionally, 80 percent of high prescriber physicians rated medical journals as
important sources of information. Physicians positively respond to medical journal advertising
by writing more prescriptions (Spiller & Wymer, 2008).
Medical Journal Ads as Sources of Pharmacological Education
A majority of physicians contend that they are immune to pharmaceutical advertising and
therefore, pay little attention to such forms of promotion. However, a study by Avorn, Chen and
Hartley (1992) demonstrated the opposite effect. The authors found that physicians’ beliefs
about the effectiveness of drugs portrayed in ads were actually quite high. Although physicians
deny the importance and influence of pharmaceutical advertising, they tend to rely upon the
pharmaceutical industry for drug information via conferences, representatives, and medical
journals (Spiller & Wymer, 2008).
Journal ads have become a source of education in pharmacology for American physicians
(Avorn, Chen and Hartley, 1992; Meyer, 1988). It has become common knowledge that the
pharmaceutical industry itself is a primary source of pharmacology education for American
physicians (Levy, 1994; Lexchin, 2009). Physicians may also perceive journal ads as being a
source for staying abreast of such claims as efficacy, safety, cost, convenience and quality of life
thus, drug promotion has become a vital communication channel in which to educate physicians
(Levy, 1994; Lexchin, 2009).
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Physicians are not required to be recertified after graduation and some proponents believe
that medical journals and their ads could serve as a post-graduate form of education (Avorn,
Meyer, 1988). Meyer maintains that once a physician has graduated and completed officer
training they are not exposed to information that is not necessarily biased as they have become
reliant upon the pharmaceutical industry for pharmacology information. Thus, they seek out
sources of information from random places, including medical journal advertisements. Levy
(1994) states that these drug promotions serve a vital importance as a communication channel as
they educate physicians about the efficacy, safety, tolerability, hazards and benefits of drug
therapy.
Influence of Medical Journal Advertising on Prescribing Behaviors
Previous studies have indicated a positive association between an increasing number of
ads for a drug and an increase in prescriptions (Foster, 2010). The drug industry influences the
prescribing rates, patterns and control of drug information (Kleinman & Cohen, 1991).
While Wilkes, Doblin and Shapiro (1992) contend that “‘pharmaceutical manufacturers can have
confidence that…when sales messages are communicated through journal advertising, market
shares of new prescriptions will increase.’” Marketing practices influence the manners in which
physicians prescribe medications (Ferner & Scott, 1994).
Moreover, journal advertising has been related to prescribing behaviors as effective
advertising has increased prescription rates. Additional data show that drug ads influence
physician practices and patient care as there is a link between drug ads and the number of
prescriptions filled for the product advertised (Ahmed, Grace, Stelfox, Tomlinson & Cheung,
2004). In a study by Walton (1980), he found that awareness of journal ads had favorable
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influence on the prescribing behaviors of physicians. Moreover, journal advertising has been
related to prescribing behaviors as effective advertising has increased prescription rates. These
findings have resulted in the plea for the critical examination of the role and responsibility of
pharmaceutical advertisers in the education of physicians and the impact of advertising on
prescribing behaviors (Hawkins & Aber, 1993).
Misleading Promotions and Inappropriate Prescribing
Not all critics agree that medical journals and advertising provide accurate information
that adequately educates physicians. According to Spielmans (2009), if drug advertisements are
to serve an educational purpose they should at a minimum provide accurate information. Some
marketing practices can deceive physicians about the safety and effectiveness of a drug product,
thereby resulting in potentially unsafe prescribing behaviors at the detriment of public health.
According to FDA Risk Guidelines, all promotional material directed to physicians must
present, “appropriate risk disclosures [to] help healthcare professionals by giving them some of
the information they need to know about the product that will enable them to safely use or
prescribe it” (FDA Guidance for the Industry: Presenting Risk Information in Prescriptive Drug
and Medical Device Promotion document, 2009, p. 2). This sentence seems to suggest that
advertisers are responsible for providing information that is factual and educational to healthcare
professionals (HCP) in an effort to preserve safe prescribing practices. Misleading advertising
can have serious harmful consequences to society as it can lead to inappropriate prescribing
(Kusserow, 1992). The messages that overstate benefits may place physicians in an adverse
position that affects their prescribing behavior (Lexchin & Holbrook, 1994). In addition,
Lexchin argues that there is evidence to suggest that physicians who rely upon medical journal
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advertising as information sources may in fact prescribe less appropriately than those who do not
rely on these sources. Christensen and Bush (1981) maintain that over-prescribing and misuse of
drugs exist within the pharmaceutical industry that is fueled by pharmaceutical companies’
promotional practices. The authors suggest that prescribing behavior is in general poor, and that
physicians are not properly educated about the drugs they are prescribing to patients. Further,
Moynihan, Dast & Henry (2012) state that people are being overdosed, over treated, and over
diagnosed.
Depression
Neurasthenia
Neurasthenia was an illness that serves as a predecessor to the modern concepts of
anxiety, depression, obsessive compulsive disorder (OCD), and eating disorders (Beck, 2006).
The historical account of neurasthenia tells about the proclivity of medical practitioners,
scientists, and patients to cooperatively influence and reinforce socially defined illnesses as
medical conditions that affect a particular segment of society. The history of neurasthenia reveals
the manner in which mental health has been culturally defined and socially supported that has
resulted in the creation of the patient who is prejudicially identified, diagnosed, and treated by
the physician. The story further demonstrates that mental health has been established upon
discriminatory medical practices through the coloring of judgement and the use of stereotypes
that can affect a physician’s decision regarding patients. As it will be shown, neurasthenia
favored a certain gender and class of people that hindered physicians because it allowed social
prejudices to influence medical thinking (Wessely, 1991).
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During the 1870s, men and women living in large cities began to visit their neurologists
armed with complaints regarding physical pain. In an effort to explain this new phenomenon of
physical pain, two neurologists, George Miller Beard of New York and S. Weir Mitchell of
Philadelphia, created an illness called neurasthenia. This illness was developed through the
amalgamation of the European science of nervous energy along with the vast social changes that
were occurring in America (Schuster, 2003). As a result of this combination, neurasthenia was
based upon the discovery and rise of the telegraph, periodical press, steam power, and science.
Neurasthenia was conceived to be due to the stresses of modern society and the fast-paced
American lifestyle which was deemed to be a malady that originated out of social and
environmental factors (Schuster, 2003).
Beard and Mitchell established the clinical and diagnostic profile for neurasthenia based
upon the assumption that the condition was affiliated with the stresses of modern society. Beard
contended that neurasthenia manifested itself when people drained their bodies of nervous
energy thereby causing organs to malfunction, resulting in such symptoms as fatigue,
indigestion, depression, and irrationality (Schuster, 2003). Other vague symptoms included
anxiety, headache, lethargy, and insomnia. Subsequently, the illness was categorized and labeled
as “nervous energy” and “tired nerves.” However, the cause of the illness had to be based upon
clinically observable scientific merit in order to render a proper diagnosis. Consequently,
neurasthenia was classified as a clinically observable illness that was simply due to overworking.
This etiology assumed that the physician could directly identify the overworked patient, a person
who resided within a certain class.
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The patient became defined through physician office visits and the complaints the
patients expressed. Further, through simplified typifications and pictorials, the patient was easily
identified as the bank manager, most likely to be a man, who had a stressful job and a demanding
schedule. While, a young woman was depressed because of the mental strain of attending a
newly founded co-educational university where she had to compete for grades. These depictions
were created by physicians and scientists that were based upon metaphors associated with
business and new technology. These allowed physicians to accurately diagnose the overworked
patient (Wessely, 1994).
Mitchell categorized two primary groups of people who were most vulnerable to the
illness, the ultracompetitive businessman and the socially active woman. Both groups were
characterized as being the educated, cultured, bright intellects, leaders, and masters of men
(Schuster, 2003; Wessely, 1991). Other groups of people who were predisposed to develop
neurasthenia included members of the urban professional class who Beard referred to as the
“brain workers,” a group that was distinctly different from the labor class “muscle workers.”
The “brain workers” were perceived to be mentally fatigued from working while it was believed
that the “muscle workers” did not suffer from “brain work” and thus were less prone to
developing nervousness (Wessely, 1991). Because of these class distinctions, the illness and
diagnosis became associated with the upper class that was worn like a badge of honor (Schuster,
2003; Wessely, 1991).
The diagnosis that a patient received was based upon the physician’s perception of the
person which led to discriminatory medical practices. Physicians determined nervous exhaustion
to be more justified in some groups of patients. Consequently, gender and class biases influenced
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physicians’’ decisions regarding the people who had a “right” to be sick (Gosling & Ray, 1986).
In Gosling and Ray’s (1986) study of physicians’ diagnostic statements, they contend that the
Victorian medical records were based upon cultural and social bases rather than scientific
knowledge in which the physicians’ diagnoses were founded upon their beliefs in social
stereotypes.
The gendered treatment of patients was further influenced by the manner in which
physicians perceived patients. The most famous therapy prescribed was the “rest cure” which
was suited for female patients. As a result, a myriad of ‘retreats,’ private clinics and rest homes
appeared in America between the years of 1880-1900 (Wessely, 1991). Physicians also
recommended “camp cures” in which people, primarily men, were sent into the forest or to a
western ranch to eat roasted meat, breathe in fresh air, and to live in nature in an effort to restore
their nervous energy. Similar to today’s lifestyle recommendations, physicians advocated for
patients to take vacations, eat more vegetables, and to refrain from excessively drinking alcohol.
For the patients who could not afford the rest or camp cures they would seek out temporary relief
through minor electric shock therapy or patent medications (Schuster, 2003). As a result,
pharmacists and patent medicine manufacturers were quick to produce a variety of products that
could restore people’s nerves as they developed “nerve revitalizers” which were laced with
opiates, cocaine and alcohol.
By the turn of the 20th century, the number of cases of neurasthenia peaked due to the
social elite who embraced the disease. Neurasthenia was an illness that was touted through the
testimonial endorsements of well-known personalities, in the pages of popular literature, and by
religious entities. Advocates for neurasthenia played a central role in explaining and defining the
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illness within the public realm and included such notables as sociologist Max Weber, social
reformer Jane Addams and feminist Charlotte Perkins Gilman. Additionally, characters in
popular literature were depicted as having neurasthenia, thus the illness became in vogue and
stylish. Finally, the Christian Science and Emmanuel religious movements gave the illness a
boost as these religious entities claimed to heal neurasthenia through religious faith which helped
to make neurasthenia a fashionable disease (Schuster, 2003; Wessely, 1994).
However, by 1906 neurasthenia began to fall out of favor when it was documented that
the working class were suffering from the illness as well, therefore, it became a diagnosis that
was no longer exclusively reserved for the upper class elites. According to the New York
Vanderbilt Clinic’s medical records, neurasthenia had become a disease of the lower social class
(Wessely, 1991). In his 1906 presidential address, W. C. Steadman asked that more attention be
given to the needs of the neurasthenia poor. As a result of these findings, the diagnosis decreased
throughout the population as neurasthenia lost its once illustrious social status. As a
consequence, the industrious businessman was replaced with the stereotype of the work-shy
laborer and the hypochondriacally upper class female invalid (Wessely, 1991).
Neurasthenia was supplanted by psychiatric diagnoses, especially for depression and
anxiety. This transformation into a psychological paradigm was attributed, in part, to Sigmund
Freud. Freud played a significant role in the redefinition of neurasthenia through his varied
discussions with female patients who suffered from conditions similar to neurasthenia. He
deduced that their feelings of dreed and worry were psychological and not neurological. The
treatment he prescribed was psychotherapy which was provided by a psychiatrist. By the 1930s,
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neurasthenia was a condition that fewer physicians were diagnosing and has since served as a
cultural phenomenon (Schuster, 2003).
Neurasthenia’s history intimates that psychiatric patients were born from social and
technological advancements in American society which produced a cultural ailment that was
legitimized through the development of a diagnostic label or category, in which a range of vague
symptoms was validated, and treatments were developed based upon such socially defined
criteria as gender and class. Neurasthenia was regarded as the ‘disease of the century’ that
favored the elites and marginalized the labor-classes (Wessely, 1991). Today the illness serves
as a reminder as to the affiliation between medicine and American culture in which healthcare
both influences and is influenced by societal developments (Schuster, 2003).
Modern Day Depression
It has been suggested that dramatically more women than men suffer from mental illness.
However, according to the World Health Organization (WHO, 2016), the epidemiology rates of
mental health disorders for both men and women are similar to one another yet there exist gender
differences in the patterns of mental illness. As epidemiology surveys have surmised that the
prevalence of Major Depressive Disorder has increased over the past few decades among both
men and women (Kessler, 2003). Further, reports have suggested that a sizable number of
individuals who suffer from mental health disorders are not treated while a significant number of
patients who are at risk for or suffer from a mental disorder are not properly diagnosed (WHO,
2016). According to the World Health Organization (WHO, 2016), certain groups of people and
individuals are at a higher risk for mental health problems including those living in poverty and
people with chronic health conditions. Additionally, gender is associated with risk,
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susceptibility, time of onset of disorder, diagnosis, treatment and adjustment to mental health
(WHO, 2013).
Epidemiological studies have suggested that the prevalence rates for such mental
disorders as depression and anxiety have steadily increased while rates for schizophrenia have
remained rather low. However, a study by Kessler et. al (2005) indicated that between the
decades of 1990 and 1992 and 2001 and 2003, the rates of prevalence for mental disorders
remained the same; rather, it was the treatment of such conditions that increased.
Depression has become a common disorder amongst Americans. Critics claim that antidepressant advertising only makes depression appear to be more widespread than it may be. As
60 percent of people who visit a physician are diagnosed with a mental health condition rather
than a physical one. Currently, there are 50,000-100,000 people who suffer from depression per
million worldwide, making depression more common than cardiovascular disease. Prior to the
development of SSRIs, depression affected only 100 people per million (Koellhoffer, 2008).
Currently, most people will receive a pharmacological treatment for depression rather
than other types of therapy as it has been estimated that three quarters of patients who receive
treatment for depression will be given a prescription for an anti-depressant alone or with
counseling (Larson, Miller & Fleming, 2007; Olfson & Marcus, 2009). Therefore, it has become
important to study correlates associated with depression as previous studies have indicated that
the percentage of anti-depressant users did not increase from 1996 to 2005, however, the number
of people receiving anti-depressant medications increased from 1996 5to 2005. The rate for antidepressant therapy increased from 5.84% in 1996 to 10.2% in 2005 which represents an increase
from 13.3 to 27 million people (Olfson & Marcus, 2009).
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By 2006, anti-depressants were the most prescribed class of drugs in America comprising
$13.5 billion in sales (Greenberg, 2010; Spielmans, Thiegles, Dent & Greenberg, 2008).
However, not all of these prescriptions were written for people who needed treatment for
depression. As depression has become a public health emergency that costs society
approximately $43 billion annually for the under treatment of patients (Greenberg, 2010).
Psychotropic Drug Advertising Stereotyped Imagery, Prescribing and Diagnosing
It has been suggested that the images depicted in psychotropic drug advertisements in
medical journals serve a particularly vital role because they are visually appealing and, thus,
have the power to influence prescribing and diagnostic behaviors (Lexchin, 2013; Leppard,
Ogletree & Wallen, 1993). However, many of these ads have been regarded as presenting
stereotypical images which can lead to bias and negatively affect physician prescribing and
diagnostic behaviors. There inherently exists a gender and social class bias that results in the
overrepresentation of middle-class white women. As Seidenberg (1974) suggests, the attitudes
toward a group of people, in this case women, can be influenced through an excessive amount of
pictures which can lead viewers to see them as being sick or disturbed. The lack of gender and
social class diversity within advertisements may result in discriminatory practices that influence
the prescribing and diagnosis of over and under-represented groups of people.
Advertisements employ stereotypes in an effort to foster identification with an audience.
The stereotyped images in psychotropic medical journal ads serve to culturally reinforce the
hopes, aspirations and perceptions of the intended audience. Therefore, physicians are flooded
with medical and pharmaceutical referent signs in which they can identify, thus producing
identificatory consumption (Barbercheck, 2008; Metzl, 2003). The representations within the
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ads serve to construct both the perception of the patient and the doctor in a manner that can be
effectively articulated and redirected to the medical audience (Lupton, 1993). These ads,
through the use of stereotypes, simply reinforce medical practitioners’ ideals and conceptions
surrounding illness and treatment (Kleinman & Cohen, 1991). The use of stereotypes in
advertising is a necessary condition as it serves as a form of ordering and provides simplified
cognitive short cuts which are easily recollected by the viewer, thus stereotypes are considered to
be prototypes of ‘shared cultural meaning’ (Dyer, 2000; Kitch, 2001). As such, advertising helps
people, and in this case, physicians to make sense of the world (Mittler, 2007).
Stereotypes in Psychotropic Drug Advertisements
Previous studies have demonstrated the universality of such stereotypes in psychotropic
drug advertisements, as women are represented as suffering from emotional symptoms and
ineffective coping mechanisms; conversely, men suffer from organic or work-related stresses and
illnesses and display effective coping strategies (Hawkins & Aber, 1993; Leppard, Ogletree &
Wallen, 1993; Munce, Robertson, Sansom & Stewart, 2004). These binary depictions are rooted
in Victorian era constructions of gender and visually communicated through imagery of women
at home, in the garden, taking care of children, or in a social setting which implies that she
occupies a dependent work status. Additionally, women are viewed as participating in
submissive or passive activities including sleeping, shopping, and cooking. Men, on the other
hand, are shown in the work environment, being productive, independent, and possessing a
higher socio-economic status (Kempner, 2006; Munce, Robertson, Sansom & Stewart, 2004;
Saiz, Cantero & Galvez, 2012).
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According to Kempner (2006), the prototype featured in psychotropic drug advertising is
the white middle class woman who is attractive with styled hair, expensive clothing and jewelry
and well-applied makeup. She further contends that the portrayals of men, women, and
healthcare providers are depicted as being white, affluent middle-class with white collar jobs. As
Andreas Eggert, VP and Global Business Manager for Pristiq described the typical depressed
person as being, “a woman that has a job, has family and she gets stuff done, but it’s a constant
struggle” (Arnold, 2009). Therefore, it only makes sense for these ads to target white, affluent
and professional managerial women (Herzberg, 2006; Othman, Vitry & Roughead, 2009).
The effects of such stereotyping result in men and women as being medically treated and
perceived to be mentally different from one another despite the fact that peoples’ brains are
similar physically. Yet, women are regarded as suffering from emotional problems while men’s
complaints are taken more seriously. Based upon advertising, physicians may have the false
perception that men are in more need of medical care than women, and consequently female
related health conditions are overlooked (Krupka & Vener, 1985). Often is the case that women
suffer from the same set of symptoms as men, yet they are more likely to be treated differently
and prescribed a specific type of drug, especially an anti-depressant (Hansen & Osborne, 1995;
Peppin, 1995). Women are more commonly over-diagnosed then men for depression as women
are more likely to be prescribed an anti-depressant even in the absence of an appropriate
diagnosis (Hansen & Osborne, 1995; Peppin & Carty, 2001).
These stereotypes and prescribing behaviors have resulted in the coining of such terms as
the “harried women syndrome” which is utilized to diagnose over-stressed American women
suffering from a sort of pre-depression (Hodges, 2003, p. 14). As, a result, physicians fail to
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diagnose or misdiagnose women’s conditions because they presume women’s health issues to be
more emotional in nature as is depicted in psychotropic drug advertisements (Leppard, Ogletrree
& Wallen, 1993).
Segmenting the Market and Gendering Medical Conditions
Several studies have concluded that the over-representation of a specific gender in
pharmaceutical advertising may result in the conception that the advertised condition is
commonly present in the advertised gender. Hence, medical conditions are gendered based upon
the depicted models which can result in the over and under-diagnosis of the gender most and
least represented. Such conditions that have been gendered include heart disease which is
thought to be a man’s ailment in which the person who suffers from a heart attack is perceived to
be a successful man in a high paying job (Clarke, vanAmerom & Binns, 2007). Male models are
three to four times more likely to be portrayed in pharmaceutical advertising than women for
cardiovascular disease (Ahmed, Grace, Stelfox, Tomlinson & Cheung, 2004). These depictions
have resulted in the under-diagnosis of women, especially in the early stages. As epidemiology
studies have shown that the under-representation of women in the media has resulted in the
under-representation of women’s heart disease in the clinical setting (Clarke, vanAmerom &
Binns, 2007).
Depression and anxiety are considered to be women’s diseases and consequently,
pharmaceutical advertisements target the female population. In this emphasis upon women,
advertisements tend to portray women as the prototypical antidepressant patient. A study by
Curry and O’Brien (2006) revealed that depression was portrayed as being “natural to women”
(p. 1974) and that more women (85.7%) than men were depicted in Irish medical journal
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advertisements. Further studies have indicated that more women than men are featured in
psychotropic drug advertisements. This over-representation of women may result in men and
women to be medically treated differently, thus creating health inequalities (Cambronero-Saiz,
2013; Munce, Robertson, Sansom & Stewart, 2004). Finally, the gendering of medical
conditions has lead physicians to interpret symptoms differently based upon whether they are
present in a man or a woman (Chilet-Rosell, 2014).
According to the World Health Organization (2016), the gendering of health can have
significant repercussions upon the quality of healthcare a person receives. Inappropriate
healthcare includes the prescription of psychotropic drugs to a particular audience.
Consequently, gender inequalities may determine women’s emotional well-being as it influences
social roles, health status, culturally patterned behavior, and access to quality healthcare.
The Rise of SSRIs between 1990 and 2010
During the 1990s and 2000s there were several SSRIs and SNRIs antidepressants that
entered and soon crowded the prescription drug market. These medications included Wellbutrin
in 1985, Prozac in 1987, Zoloft in 1991, Paxil in 1992, Effexor in 1993, Remeron in 1996,
Celexa in 1998, Lexapro in 2002, Abilifty in 2002, Cymbalta in 2004 and Pristiq in 2008.
SmithKline initially introduced the acronym SSRI to the marketplace because it emphasized the
fact that these medications were selective in that they precisely targeted serotonin. Marketers
were quick to pick up on the acronym and its meaning and used this distinction to their
advantage (Greenberg, 2010).
In the first Prozac ad in JAMA in 1988, the message resonated with this selective theme
as the ad read, “the first highly specific, highly potent blocker of serotonin uptake,” and
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throughout the 1990s, the pharmaceutical industry utilized selectivity as the main component of
their advertising campaigns (Greenberg, 2010). In medical journal advertisements, SSRIs were
touted as being clean, strong, high tech drugs that were effective without causing addiction. The
drugs were portrayed as “magic bullets” that could destroy depression without causing
dependence in patients (Fitzpatrick, 2010; Greenberg, 2010). By 2006, antidepressants were the
most common prescribed class of medications in the US and 3:10 of the best-selling psychiatric
drugs worldwide (Greenberg, 2010; Spielmans, Thieges, Dent & Greenberg, 2008). The rise in
popularity of these medications resulted in an explosive growth in anti-depressant use in the US,
in which there was a 400 percent increase in use from 1988-1994 through 2005-2008 (Pratt,
Brody & Gu, 2011).
The increased trend in popularity of SSRIs that occurred between 1990 and 2010 is
important for a few reasons: 1) the development of the SSRI transformed national discourse
regarding mental health; 2) the emphasis upon serotonin levels in the brain facilitated the
transformation of the medical model of science to a biomedical model and 3) the onset of Directto-Consumer Advertising (DTCA) for psychotropic products was ushered in that redefined the
patient and the consumer of the psychotropic market (Mukherjee, 2012; Preston, 2013;
Spitalewitz, 2012).
The Creation of Prozac
Prozac is considered to be a term, a concept and a product that caught national attention
as it had a profound effect upon American culture (McKelvey, 2013). It is perceived to be a
powerful entity that sparked a cult following, fostered a sort of revolution, and ignited a public

60

debate. Prozac, in essence, led the way to altering the manner in which people in society thought
about mental health (Preston, 2013).
It has been remarked that Prozac opened up the conversation and reduced societal
stigmas. It was believed that the social stigmas affiliated with mental health had been lifted.
Consequently, manufacturers encouraged physicians to look for depression in patients and
simultaneously, people were encouraged to seek help by visiting their physician. This symbiotic
relationship fueled prescriptions during the 1990s, as diagnosis and treatment doubled
(Pharma.org).
Boyd (2013) claims that Prozac “opened up a public debate about happiness/depression
and ‘cures.’” This debate was in part fueled by the fashion industry that primarily targeted
women. Through the creation of t-shirts, jewelry, and handbag accessories, Prozac made
depression fashionable. Clothing and jewelry designs that were inspired by Prozac included Tshirts that featured such taglines as, “Gimme some Prozac and No One Gets Hurt” and “Prozac.
Tastes Better, Less Bitchy.” According to the clothing line president at the time, Skyler Thomas,
the shirts were to serve as an impetus for candid discussion as he stated, “it’s okay to have
problems, admit them openly and be able to laugh at yourself.” He further remarked, “our stuff
says something much more personal about the individual,” (Pirisi, 1998).
Jewelry designer Colleen Wolstenholme created sterling silver earrings, rings, bracelets
and pendants in the shape of antidepressants as her creations were to also inspire Prozac candor
as she claimed, “wearing these pieces is about being honest as a society” (Pirisi, 1998). Finally,
the popular handbag designers, Fendi, created the pharmaceutical handbag that encouraged
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people to carry around their medications (Moore, 2007). As McKelvey (2013) stated, “Prozac
gave an almost chic gloss to mental illness.”
Prozac was created as the answer to the biomedical model of science and brain
functioning and from its development, Prozac and depression have become intimately linked to
one another. Prozac was considered to be the next “wonder drug for the mind” and served as the
antithesis to Valium as it was a stimulant and not a relaxant (Herzberg, 2006). Prozac further
shifted the popular medical condition at the time from one of anxiety to one of depression and
from an emotional state to a chemical imbalance (Metzl, 2003).
The Bio-Medical Model
The 1990s signaled a turning point in psychiatric medicine, in which it was considered to
be the Decade of the Brain (Schwartz & Corcoran, 2010). The medical model of science
embraced the bio-medical model in which brain malfunctioning was cited as a primary cause for
such mental disorders as depression. It has been argued that SSRIs have been considered to be
effective drugs because they applied a more directed approach to fluctuating the many levels of
chemicals in the brain. SSRIs were popular because they affected only one neurotransmitter,
serotonin, in the brain. The serotonin stays active longer by blocking its delivery to another nerve
cell (Bonander, 2013; Moore, 2007).
The biomedical model places health responsibility upon the individual, hence the patient
as it ignores the social implications inherent to health. Over the past three decades the biomedical model has prevailed in that mental disorders are considered to be brain diseases and
treated with psychotropic medication. During this time period, psychiatric medications and
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mental disorders have increased (Deacon, 2013). It has further been argued that another reason
for a rise in medications and diagnoses, is due to direct-to-consumer advertising (DTCA).
DTC Advertising
The Debate

In 1997, the Federal Drug Administration (FDA) permitted Direct-to-Consumer
Advertising of pharmaceutical products and since this deregulation, antidepressants have become
one of the most frequently advertised drug category (Grow, Park & Han, 2006). DTCA
advertising has thrived since 1997 as it has increased from a $579 million industry to $1.3 billion
in 1998 to over $4 billion in 2008, and is expected to increase to $11.4 billion by 2017 (Global
Industry Analysts, 2011).
However, DTCA has traditionally fostered a heated debate in which some proponents
declare that this form of advertising is beneficial because it educates, informs and empowers
consumers thus enabling them to have a more interactive role with their physicians. Gellad and
Lyles (2007) contend that DTCA encourages patients to discuss the under diagnosed and under
treated medical conditions with their physicians which results in the potential to improve health
outcomes. In similar terms, Griffiths, Christensen and Evans (2002) state that access to health
information allows patients to participate in managing their own health care. Through a
conversation, a dialogue can take place when visiting a physician. Thereby providing patients
with more power a factor that is no longer skewed in favor of the physicians which may
contribute to improving health literacy and health outcomes.
On the other hand, others argue that the intention of DTCA is quite simply to advertise
drugs to consumers. It does not exist to educate and empower but simply to promote and sell
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products (Wolfe, 2002). It has been maintained that the DTCA mislead audiences by
disproportionately overstating the benefits of the featured drug which causes the ad to be
inaccurate and unbalanced in content. Unbalanced information can result in inappropriate
promotional statements which can further result in misuse of a drug with dangerous
consequences (Greene and Kesselheim, 2010). Additionally, DTCA has been accused of
consisting of poor quality due to biased, inaccurate and incomplete information (Griffiths,
Christensen and Evans, 2002). Liang and Mackey maintain that “patient safety may be
compromised in that some DTCA may overemphasize benefits and patients may not adequately
assess the risks” (p.825). Additionally, they suggest that some people may lack sufficient
understanding and an appropriate level of knowledge to adequately evaluate an advertised
product. This may be valid for such drugs as biologics which require scientific messaging and
detailed consumer education (Liang and Mackey, 2011).
DTCA has been criticized for intentionally creating ads that are laden with emotional
appeals rather than empirical evidence and information which results in unbalanced advertising.
As Hollon (2005) claims, DTC ads characterize the benefits in vague, qualitative terms and
leaves out important evidence to bolster benefit claims. A finding that Woloshin, Shwartz,
Tremmel and Welch (2001) concur as their study results indicated that risk information in ads
was presented in a quantified form while the benefits were enshrouded in more emotional
appeals rather than concrete numbers.
Direct-to-Consumer advertising is influential, through emotional appeals, robust
narratives that inflate a drug’s greatness and unbalanced effectiveness and safety information, in
convincing people that the advertised products are better than they truly are (Wolfe, 2002;
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Frosche et al, 2010). As Frosch et. al (2010) state, “in effect, DTCA amounts to a large and
expensive uncontrolled experiment in population health” (p. 24). In a survey conducted by
Harvard Mass General Hospital and Harris Interactive indicated that one-fourth of adult patients
who viewed a DTCA received a new diagnosis for high cholesterol, hypertension, diabetes, and
depression (PhARMA.org, 2008).
Psychotropic DTCA
Reflection Between DTC and DTP Advertising

DTCA and DTP advertising work in concert with one another, in the form of reflection,
in an effort to increase prescriptions through the expansion of the audience. Advertisements
mirror the intended audience through the use of the spokesperson who appears within the ad.
Through the product model of advertising and the theory of congruence, the model depicted
within an advertisement represents the product’s end user. From a pharmaceutical perspective,
this advertising strategy of congruence between model and product end-user serves a dual
purpose. DTCA advertising invites the viewer inside the advertisement to enjoy a world that is
enhanced by the advertised product. Hypothetically, as a result of this invitation, the person
consults their physician for a diagnosis. On the other hand, the physician views this same type of
patient through DTP advertising which also reflects the product end-user, who happens to be the
same person. Thus, DTC and DTP advertising work together to reinforce the image of the typical
patient who can be diagnosed at-a-glance. An example of this tendency is an advertisement
campaign by Eli Lilly that ran in both physician and consumer print materials.
In mid-1997, Eli Lilly hired the Leo Burnett Advertising Agency (Greenberg, 2010) to
create an advertising campaign that placed people within the untreated category. This first
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campaign was titled, “Prozac Can Help,” and it was Eli Lilly’s goal to expand the market by
increasing the audience. It was Eli Lilly’s contention that 2:3 depressed people were in need of
treatment. The Director of Public Relations for Eli Lilly, Mike Grossman explained that he saw
this project as one of “assisting people in their depressed stupor to raise their hand for
help...They might not recognize their condition or know that help is out there” (Sunset, 2008).
In this Prozac advertisement, the viewer may see herself reflected within the
advertisement, thereby deducing that she suffers from the advertised condition. While, the
physician may see this patient in the examination room, and based upon the advertisement,
prescribe the promoted brand and diagnose accordingly. A 2005 Cymbalta campaign further asks
the viewer to see herself reflected within such advertising.
Cymbalta, a SNRI, was approved by the FDA in 2004 for MDD and diabetic peripheral
neuropathy. It was entering into an already crowded market, therefore, the marketing team had
to differentiate beyond the pain indication so the product would stand out from its competitors.
The DTCA campaign was launched with the unbranded message, “Depression Hurts” tagline.
According to the Manager of Patient Marketing for Neuroscience and an Associate Marketing
Consultant on the Depression Hurts Campaign, the campaign was intended to, “the issue we
were trying to address was that…there was still a lot of stigma out there and people not getting
the treatments they need.” The goal of the campaign was to get people to look at depression
differently. “It’s about finding more accurate ways to help people recognize themselves,” stated
Stacy Miller, Consumer Marketing Manager for Cymbalta. The targeted audience of this
campaign was women (Arnold, 2008). The advertised reflection of the intended product end user
is exemplified by the idea that pharmaceutical promotion is concerned with having people
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recognize who they are. This recognition prompts one to ascertain the medical disorder from
which she naturally suffers.
Although this recognition of oneself within the ad is relevant, it is also the recognition of
one’s symptoms that helps to shape the characterization of the suffering patient. According to the
advertising agency that handled the Cymbalta account, Draftfub and Eli Lilly, the “Depression
Hurts” campaign was effective and successful. The agency explained that the campaign’s goal
was to “change the dialogue” and “redefine the condition” emphasizing the broad range of
symptoms and “to motivate our target to seek treatment, we use a mirror to show them how
they’re suffering.” The representative for the agency continued to state, “our TV spot brings to
life the range of individual depression symptoms” (Medical Marketing & Media, 2009). It is the
concept of reflection as intimated through the utilization of the mirror that is suggestive of the
intentional creation of the audience as reflected within DTCA for psychotropic medications.
The marketing and advertising efforts of pharmaceutical companies have been criticized
for being overly aggressive in which the lines ordinary life and treatable illness has become
blurred (Moore, 2007). Throughout time, DTP advertising has positioned a drug as being the
cure to everyday problems and have been primarily predicated upon social and emotional
distress and not necessarily disease states. These lifestyle or psych-social ailments are frequently
associated with common health problems including sexual activity, sleep disorders, social
anxiety, hyperactivity and depression (Abraham, 2010). According to Healy (1997) the discovery
of antidepressants was the invention of marketing for depression, and thus, there is a fuzzy line
dividing the marketing of scientific ideas and the marketing of psychotropic drugs. Additional
audiences are defined through targeting, labeling and everyday ailments.
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The ideal consumer is reflected within a September 1999, SKB consumer campaign for
Paxil that targeted a specific demographic titled, “Your Life is Waiting.” SK Beecham hired
McCann-Erickson Consumer Health in New York and the PR Firm, Cohn and Wolfe to spread
awareness about SAD. The agencies targeted professionals between the ages of 18-34. As a
result, Paxil’s advertising campaign featured attractive men and women, who despite appearing
to be ‘normal,’ overwhelmingly suffered from fear in the social and work environments (Goetzl,
2000).
During the 2000s, Pfizer created a series of comic book ads that portrayed specific
individuals as suffering from certain mental health conditions in an attempt to establish the
‘medical consumer.’ Thus, such characters as Kathy who was 41, Joanne who was a ‘depressed
divorcee’ and Cindy ‘a depressed office worker’ all sought out Zoloft to help them with their
disorders. The pharmaceutical companies constructed narratives to create specific depictions of
patients through advertisements (Oldani, 2012).
A $40 million advertising campaign for Zoloft began to frame SSRIs as a panacea as the
2003 Zoloft message exemplified that “Zoloft [was] for Everything.” The ad informed the public
as to the ‘literally thousands’ of new applications for Zoloft including anxiety associated with
swimsuit season, insecurity overall sexual potency, and a sense of hollowness stemming from
losing an online auction (News, 2003). And it was this same year that the FDA approved the
drug for predysphoric disorder and social-anxiety disorder or social phobia (News, 2014). A
spokesperson for Pfizer, Jon Pugh stated that the Zoloft campaign advertisements are intended to
let consumers know, “that it they suspect Zoloft might improve the quality of their lives, they
should contact their doctor” (News, 2014).

68

Narratives
Historical accounts naturally tell a story which are typically recounted in a narrative
form. The past is naturally revealed in a story form in which narratives provide an accurate
account in that they describe what actually occurred (Nerone, 2010). Human beings are
inherently storytellers as we grow up in a culture that is saturated with narratives. From the time
we are born, we are read bedtime stories, are lavished with fairy tales and fables and throughout
time, we learn how to craft our own narratives and we learn how to listen to others’ narratives.
In doing so, narratives become socially constructed and shared experiences. However, narrative
analysis is not a term that can be simply defined as there are a large number of descriptions
available depending upon the research approach taken. Therefore, for the purposes of this paper,
narratives are “a sequence of ordered events that are connected in a meaningful way for a
particular audience in order to make sense of the world and/or people’s experiences in it” (Bell,
2002).
The story brings temporal order to what would otherwise be experienced as a series of
chaotic events (Bleakley, 2005). Thus, narratives serve a purpose and provide a relevant point or
moral lesson. The manner in which a narrative is constructed is of central importance from the
visuals it contains and the intertwining text to the positioning of the narrator in relation to the
audience and event all convey meaning. Through narration the investigated element emerges
through the story as this becomes the object of investigation (Bell, 2013).
Narrative Inquiry
A central factor to narrative analysis is the examination of key themes that are inherent to
narratives. These themes help to provide organization to the manner in which a narrative is
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recounted and they tend to cluster around recurrent content. The key themes are identified
through their repeated mentions and typically are concerned with actions, events or processes
(Phoenix, 2013). In order to identify the primary themes, the researcher should focus upon the
small story rather than the overall story, as a whole.
Visual Analysis
During the twentieth century, there has been a noticeable decline in the amount of text
placed within advertisements while there has been a significant rise in the amount of imagery
employed in advertising. Visual imagery and text frequently work in dialogue with one another
as print text relies upon such semiotic signs of language as punctuation, graphology. Visual
images are rendered meaningful to audiences through the combination of technical and visual
codes. The way the text frames images through headlines and captions helps to construct the
overall textual message of the advertisement (Huisman, 2005). Thus, the narrative function of
advertisements introduces and leads us to the setting, characters and plot while presenting a
specific point of view. From an advertising perspective, the producer of the narrative (industry,
company, institution) is the narrator, otherwise known as the speaking subject. This character
provides the point of view or focalization for the narrative, a powerful stance to control.
The visuals contained in stories provide generally accepted symbols and signs of gender,
class, medicine, science and persuasive discourse. Visual appeals allow the researcher to gain
insight into codes of meaning and to perceive of the representation of social relations. In
addition, the study of visuals emphasizes the production, interpretation and use of visuals as well
as the social and historical context (Bell, 2013). Images constitute the arrangement of cultural
and historical change (Mittler, 2007).
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From a visual perspective, the examination of images along with text (as previously
stated) is important and the analysis of the image by itself is also essential. In today’s
technological innovations, there are many ways that imagery can be cropped, shaded, angled, etc.
in order to establish a specific position or representation. Therefore, Fulton (2005) has suggested
the manners in which camera effects communicate interpersonal meanings to the audience about
the characters and their social relationships. For example, if the camera angle is high (looking
up), this suggests power and authority while a low (looking down) means disempowerment. The
technical aspects of imagery should be considered as well as the textual elements.
Conclusion
Throughout time, DTP advertising has emphasized medical journal advertising as a
correlation has been shown between physicians’ prescribing patterns and promotions. The
advertising of psychotropic drugs has become pervasive within the U.S., including the marketing
of depression to physicians. However, previous studies have shown that a disproportionate
amount of women are featured within these ads than men, which may account for the fact that
women are two to three times more likely to be prescribed an antidepressant. The over
representation of women in advertising may result in a physician believing that the female is the
actual sufferer of the advertised condition. Consequently, this depiction may result in the
inappropriate prescribing and misdiagnosis of women.
For the following chapters, the plot and character elements of narratives will be employed
in order to analyze the advertisements. Both of these factors contribute to influencing audience
identification which for the purposes of this study is with physicians. The next chapter is
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concerned with the establishment and depiction of the depression audience and depression as a
medical condition.
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CHAPTER III: CREATING THE DEPRESSION AUDIENCE

73

Abstract
The trivialization of depression has become pervasive within American society as it is
perceived to be a condition that is trendy to possess. However, depression is a medical condition
that tends to afflict people who are subjected to greater amounts of poverty, stress,
unemployment, and discrimination. There exists an inverse relationship between depression and
wealth, thus the more affluent sectors of society are the least likely to suffer from depression.
The over depiction of prominent female characters who are flanked with an impressive lifestyle,
personal belongings, and settings in psychotropic medical journal advertisements may contribute
to the trivialization of depression and its status as a lifestyle accessory. This portrayal of the
depression candidate as being regal in social class merely inflates prescribing rates for a patient
population that does not necessarily exist. Through a narrative analysis of medical journal
advertising spanning from 1990-2010, it is concluded that the depiction of women in
advertisements for depression medications misleads readers into believing that the depression
audience is comprised of women of a certain social class. This advertised illusion contributes to
the inappropriate prescribing of antidepressants to women.
Introduction
Advertising has frequently been regarded as a sort of art form which subtly reveals stories

about society (Mittler, 2007; Ohmann, 1996; Wharton, 2015). Sometimes, these narratives are
cloaked in illusion and provide a false sense of reality (O’Sullivan, 2005). Traditional
advertising practice of segmenting audiences based upon such demographics as age, income, and
gender have invited some industries to masterfully create their own audiences (Barbercheck,
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2008; Schudson, 1984). An industry that enjoys such creation is pharmaceuticals as it has the
ability to create audiences through Direct-to-Physician (DTP) advertising.
The function of DTP advertising is to persuade physicians to prescribe, thus, there exists
an important relationship between pharmaceutical promotion and physician prescribing
behaviors. Previous research has indicated that advertising is correlated with prescribing patterns
(Pew Trust, 2012). An association that makes DTP advertising rather insidious as this form of
marketing has traditionally rewarded high decile prescribers (those physicians who write the
most prescriptions for a product). This system provides a marketing structure that is inherently
flawed as it encourages irrational prescribing behaviors (Fugh-Berman & Ahari, 2007).
Furthermore, the use of such stereotypes of the white, middle age, and middle class
female that permeates DTP medical journal advertising may encourage unwarranted physician
prescribing (Metzl, 2003; Pekkanen, 1976). Previous research has indicated that psychotropic
drugs are over prescribed 50 percent of the time. It has become easier for a physician to prescribe
than not to prescribe (Naish, 2013; Pekkanen, 1976). In addition, physicians prescribe
psychotropic drugs more liberally to women than men fostering the perception that more women
are in need for such medications as antidepressants. Thus, the incident rates for the misuse of
such drugs by women has steadily increased over time (Pekkanen, 1976). The tendency to inspire
prescription writing by advertisers may be harmful as all promotion is not necessarily truthful
nor factual, thus it can provide a distorted perspective (Kessler, 1992).
The advertisements in medical journals have frequently been called into question
regarding their accuracy. Many studies have focused upon the benefits and risks presented or
omitted within pharmaceutical advertisements and have demonstrated that these promotions tend
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to be somewhat deceptive. However, it is not simply the text that is problematic, it is the visual
depictions, as well, that may be misleading. Medical journal advertisements have the proclivity
to show gendered images of people, especially for psychotropic drugs.
Through the gendering of the marketplace, women have become the target audience for
antidepressant medications. Historically, women have consumed more psychotropic medications
as they accounted for two-thirds of the psychotropic market by the late 1960s (Tone, 2009).
Subsequently, by the late 1970s, depression was considered to be a woman’s illness. As a result,
more women were consistently featured in psychotropic medication advertisements (Herzberg,
2009). Further, print medical journal advertising has had a history of over depicting women as
patients (Metzl, 2003). This overwhelming depiction can be harmful as physicians may deem
depression as being a woman’s illness and over prescribe antidepressants to this group of people.
This chapter presents the argument that the intended audience of psychotropic medical
journal advertisements is based upon a fictional female audience that has been developed by
advertising, medical, and pharmaceutical industries in an effort to promote and sell medications
to a broader audience than actually subsists. And in doing so, psychotropic drug advertisements
in medical journals tell a distorted tale regarding the actual depression audience that could
contribute to inappropriate physician prescribing behaviors that affect women. Through a
narrative analysis of psychotropic medical journal advertising spanning from 1990-2010, it is
revealed that direct-to-physician advertising portrays the depression audience and depression as
people and a condition that have been fictionalized, glamorized, and romanticized through
audience segmentation strategies and the use of stylish models, the depiction of an acquired
lifestyle, and through the promise of an improved life.
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The Creation of the Advertised Audience
The Virtual Audience
The treatment for depression has become so widespread in America that it has been stated
that there exists an epidemic of diagnosis of depression (Naish, 2013). Currently, women are two
to three times more likely to be prescribed an antidepressant than are men (Metzl & Angel,
2004). From a historical perspective, women have been the target audience for psychotropic
drugs. The argument for the creation of this audience is two-fold. On the one hand, traditionally,
more women than men have typically consumed antidepressants (Herzberg, 2009; Tone, 2009).
And on the other hand, women are the target audience of pharmaceutical advertising, because of
this consumptive behavior.
In today’s commercial market, it has become routine to begin advertising strategies based
upon a virtual market (Frascara,1997). This virtual audience acts as the intended target audience
for advertisers and is important because it consists of the consumer that is packaged and sold to
advertisers. The purchase of this audience can be relatively risky because it may not be
representative of the actual audience (Fulton, 2005). Although market segmentation and lifestyle
data assist with creating a profitable audience.
Audience segmentation refers to the fitting of a product to the interests and needs of a
particular group of people. Segmentation strategies describe and stratify people according to
their consumption patterns (Englis & Solomon, 1995; Pope, 2003). In regard to DTP advertising,
this strategy identifies the potential target audiences through its lifestyle data that includes
economic, social, cultural, and psychological, and buying behaviors. Segmentation using
lifestyle data accomplishes two essential tasks, it divides and parcels the audience based upon
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demographic and psychographic characteristics and it informs the creative team about the
personal characteristics of the idealized consumer. Through these marketing tactics the consumer
audience is identified, categorized, and designed according to social types that are visually
represented through advertising (Goldberg, 1982).
There are two audiences that pharmaceutical companies regard as consumers, the
physician (prescriber) and the patient (consumer), and both are segmented in different manners.
Physicians are targeted and segmented in terms of their prescribing patterns and through their
medical specialty. According to Fugh-Berman and Ahari (2007), “the goal of this [physician]
demographic slicing and dicing is to identify physicians who are most susceptible to marketing
efforts” (p. 0624). Physicians are categorized based upon their prescribing patterns and are rated
on a scale from one to ten, with ten representing the highest decile prescriber. Historically,
pharmaceutical companies have segmented and advertised to the high decile prescribers since
these physicians prescribe the higher quantities of products (Fugh-Berman & Ahari, 2007).
The physicians who are considered to be low prescribers have traditionally been
somewhat snubbed by the pharmaceutical industry. However, this trend is changing as
advertisers consider that physician’s prescribing habits can be altered by being targeted and
exposed to promotions (Fugh-Bergman & Ahari, 2007). Physicians may be categorized in three
distinct manners: as the spreader, the loyalist, and the niche physician. The spreader is the
physician who utilizes portions of all pharmaceutical products. While the loyalist is the physician
who is most loyal to a product. Finally, the niche physician prescribes a product for a narrow
audience (Fugh-Berman & Ahari, 2007). Physicians are further depicted by their receptivity to
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sales representatives as the “cautious practitioner,” the “certainty seeker,” and as “Dr. High
Flyer,” and “Dr. Rule Bounds” (Applbaum, 2009).
The division of the consumer audience is accomplished through segmentation and
lifestyle data that are based upon consumption patterns. Marketers believe that purchase behavior
results from the association between an advertised product and the depicted lifestyle (Goldberg,
1982). This audience’s lifestyle data provides the information for the creation of a consumer
audience, and it provides the statistics for the development of a successful advertising campaign.
The data informs advertisers about the product, the model, and the lifestyle that should be
featured within the promotional campaign. The more congruent these three elements are
portrayed in advertising, the more persuasive the argument.
Product Placement
DTP advertising sells a product, an image, and a lifestyle that situate the consumer in a
favorable manner. Since the 1920s and the rise of photography, the purpose of advertising
changed from one in which the product’s utility was highly emphasized to one in which imagery
and upscale settings were stressed. This alteration allowed for the advertised product to be placed
in natural and social settings including the home, garden, and swanky parties attended by the
erudite sectors of society (O’Sullivan, 2005). Product placement reflected the values of the
intended audience (O’Sullivan, 2005). Additionally, the product’s personality that was featured
in advertising reflected the personal attributes of the audience that embodied the same qualities
of the advertised commodity. Therefore, people paid for product image and personality rather
than utility (O’Sullivan, 2005).
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During the 1950s and 1960s lifestyle became an important selling feature as
advertisements told stories that connected an individual to a group or an economic class that was
associated with the products used by that particular group or class. Hence, people were
identified as belonging to a certain economic group based upon the products they consumed
(O’Sullivan, 2005). Therefore, the model depicted in advertisements did not play a particular
type of person but rather was a representative of a social type or demographic category
(Schudson, 1984).
In contemporary times, this social classification tells marketers about predictable
consumer patterns that are used for the purposes of market research (Schudson, 1984). Marketers
identify the social group most likely to consume a product and, as a result, an idealized person of
that group will be characterized within advertising, thereby showing the viewer the life that is
worth emulating (Schudson, 1984). Advertising is about buying a way of life (Dyer, 2007). The
images in advertising present the ‘good life’ as it is portrayed through the setting (Belk & Pollay,
1985).
Ultimately, lifestyle data assist with providing a richer depiction of the intended target
audience that helps writers and graphic designers to imagine and depict these individuals in a
visual manner. Thus, lifestyle and consumption have the potential to influence the setting
pictured in an ad, the person featured, and his/her appearance, and the artwork itself (i.e. the
graphic design) (Plummer, 1974).
Modeled Stereotypes
The selling of an image rather than a product has become pervasive within the advertising
industry. Oftentimes, the image is created prior to the development of the product (Schroeder,
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2005). Consequently, marketers have become involved with image management as imagery has
the ability to fool the eye and to falsely persuade (Schroeder, 2005). According to Dyer (1982),
advertising presents the audience with images that makes them seem to be true in which reality is
unable to match up to the image. Therefore, the audience’s perceptions of the real world are
muddled through the advertised illusion.
Advertising emphasizes images that are directed at particular audiences (Goldberg,
1982). In terms of mental health, the models depicted in psychotropic advertising are deliberately
placed in order to engender primary audience identification with physicians. One manner in
which to foster identification is through the use of stereotypes.
Stereotypes, such as human models, are commonly utilized in advertising to emphasize
specific characteristics (Thompson, 1992). Advertised promotions continue to highlight the
beautiful people where males are strong, masculine, and upscale and women are depicted as the
classic girl next door or as being cute (Gulas & McKeage, 2000). The models portrayed in
advertisements are constructed primarily as consumers and, subsequently, are representative of
typical people as this imagery is considered to be a prototype that reflects reality (Frascara, 1997;
Schroeder & Zwick, 2004). However, there exists a caveat as viewers should realize that the
models depicted within advertisements are not replications of reality, but are rather intentionally
posed, paid, and pampered, thus they serve as cleverly arranged visual components (Schroeder &
Zwick, 2004).
According to Frascara (1997), an Art Director may promote a stereotype in order to fulfill
the fantasies of the target market. Frascara further maintains that stereotypes can be useful in
processing information, however this information should be factual and should be “achieved
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without reinforcing models of questionable value” (p. 28). Repeated exposure to such
stereotyped imagery may have effects on consumers and society as advertisements have intended
and unintended consequences. These include the attainment of business goals, as well as, the
social comparison of people depicted within advertising (Gulas & McKeage, 2000).
Gendering the Consumer Market
The models portrayed in psychotropic drug advertisements are frequently stereotyped
based upon gender. Model portrayals in advertisements tend to be gendered in order to
perpetuate traditional roles and identities associated with femininity and masculinity. These
representations allow for the construction of market segments based upon socio-demographic
characteristics thus allowing for the formulation of new markets (Cambronero-Saiz, 2013;
Schroeder & Zwick, 2004). Advertising’s primary function is to create a demand for a product
that did not previously exist. There is frequently a lack of difference between advertised
products, especially psychotropic medications, which stimulates a need to create dissimilarity
through imagery (Frascara, 1997).
The success of visual imagery is predicated upon its ability to present information that is
consistent with the interpretation according to conventional lines. Thus, almost all products are
gendered in a normative manner in which sexual duality is emphasized and maintained within
the cultural institution of advertising (Mittler, 2007; Schroeder & Zwick, 2004). Previous
research has shown that ads that reinforce conventional gendered lines and imagery are more
effective in attracting consumers than non-traditional advertisements (Morrison & Shaffer,
2003). As a result of such manipulative designs, a product’s image is most frequently related to
the sex of the end user (Whipple & McManamon, 2002).
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Fictionalization of the Audience
Gender
According to Schudson (1984), advertising consists of fictive elements, including the
models represented. Previous research has indicated that more women than men are portrayed in
psychotropic drug advertisements directed to physicians. This study corroborates that finding as
more advertisements featured women as the primary target for depression by a ratio of 6:1 than
men. This result is consistent with the findings of previous studies (Hansen & Osborne, 1995;
Munce, Robertson, Sansom & Stewart, 2004). The analysis revealed that an overwhelming 74
percent of the advertisements featured women as the primary sufferers of depression in
comparison to 13 percent which depicted men as being the primary sufferers. This over
representation may influence physician’s prescribing patterns as it leads to the assumption that
depression is a female disorder. Epidemiology reports indicate that women tend to suffer from
depression more frequently than men. However, the reports indicate that this differences in rates
range from approximately 1.7 to 2.0 for women (Pratt & Brody, 2005; Pratt & Brody, 2014).
This ratio represents a significant difference between the advertised rate and the epidemiology
data regarding women.
It is interesting to note that although the over representation of women in psychotropic
drug advertisements is consistent with prior research, the depictions of women in this study do
not necessarily correspond to the imagery found in previous studies. Many of the women were
depicted as being outside rather than situated within the home sphere. Additionally, they tended
to be portrayed in athletic attire and pursuing active interests, especially during the 2000s. In this
study, women were seen to be dining or having afternoon tea rather than cooking. Although
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women were portrayed as shopping, in this study, this activity was considered to be active rather
than passive pastime and was further an indicator of an independent status rather than a
dependent one, as discussed later in this chapter.
The men who are portrayed as primary sufferers were frequently depicted in career or
romantic scenes. While the men who were cast in a more supportive and less central role were
portrayed in career, as part of a romantic couple, and participating in more leisurely activities
including jogging, attending a school parent teacher association meeting (which implies taking
care of children), shopping and relaxation. Although these depictions of leisure were modestly
shown, they do deviate from previous studies that have found images of men to be primarily
career centered. Additionally, men were not cast as being necessarily independent nor as
representing a higher social economic background as they were frequently accompanied by other
people and held employment positions that would be considered to be blue collar.
Race
Consistent with previous studies (Ahmed, Grace, Stelfox, Tomlinson & Cheung, 2004;
Hansen & Osborne, 1995; Munce, Robertson, Sansom & Stewart, 2004), more white women and
men are depicted within the advertisements than other races and ethnicities. A small number, 13
percent, of the sampled advertisements featured a person of another race or ethnicity. For
women, there were two advertisements that featured an African American woman as the primary
sufferer of depression. In a more supporting role and not a central role, African American
women were the most frequently depicted minority, however these representations were
infrequently illustrated.
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For men, one advertisement centrally featured an African American man who was
viewed shopping with his wife at a farmer’s market. In addition, there was a small inset picture
of him in a career setting as a security guard. One advertisement that positioned a man as the
primary sufferer did not show his face and only revealed his hands and feet which made it
difficult to ascertain his race and ethnicity. Men who were in more of a supportive role tended to
also be African American. This is a similar trend to women, however, there were fewer
depictions of men than women.
Epidemiology
Epidemiology reports indicate that the people most likely to suffer from depression
include women, homemakers, the unemployed, disabled, and those living in poverty or near
poverty, and with low income (Kessler, et al., 2003). The structural impairments of depression
further include people living with low educational attainment, poor marital outcomes, and
underprivileged socio-economic status outcomes (Kessler & Wang, 2008). However, these are
not the representations that are made in advertising as people appear to lead a more regal lifestyle
and pursue careers that tend to require at least a high school education with most of the
employment depicted requiring a college degree. Additionally, minorities are invisible from
psychotropic advertising which is problematic as epidemiology reports have indicated that
African Americans and Hispanics suffer from depression.
A 2002 study showed that more Hispanics suffered from depression between 1987 and
1997, a trend that is not depicted within medical journal advertising (Olfson, Marcus, Druss,
Elinson, Tanielian, & Pincus, 2002). While a 2005-2006 study of US households revealed that
more Non-Hispanic blacks and Mexican Americans suffered from depression than Non-Hispanic
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whites (Pratt & Brody, 2008). Another 2009-2012 US study further demonstrated that more NonHispanic blacks had higher rates of depression than Mexican Americans and Non-Hispanic
whites (Pratt & Brody, 2014). The differences between the advertised depression audience and
the epidemiology data may result in the inappropriate prescribing of antidepressants to people of
different ethnicities. Further, these portrayals may lead to the marginalization and undertreatment
of minority patient populations (Hirschfeld, et al., 1997; Olfson, Marcus, Druss, Elinson,
Tanielian & Pincus, 2002).
Although the treatment for people increased from 1987 from .73 per 100 persons to 2.33
per 100 persons in 1997, the treatment of white women was also greater than for men and
minorities. Employed, white women who were privately insured had the highest rates of
treatment. However, there was a slight increase in the treatment of men and African Americans
and Hispanics in 1997 compared to 1987 (Olfson, Marcus, Druss, Elinson, Tanielian & Pincus,
2002).
Previous studies have indicated that the predictors of those who would receive treatment
for depression included non-Hispanic white women over the age of twenty-four with at least a
high school education. The emphasis upon the treatment of women resulted in increased usage
by women. In 2003- 2004, 310 out of every 1,000 women received a prescription for an antidepressant (Horwitz, 2010). One reason for the increased treatment of women is due to the
aggressive antidepressant advertising campaigns aimed toward physicians, health care
professionals, and the public. In addition, the SSRIs were featured in lead articles in national
magazines, best-selling books, and televised talk shows, thus increasing their popularity
(Kessler, et al., 2005; Olfson, Marcus, Druss, Elinson, Tanielian & Pincus, 2002).
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Finally, epidemiology reports state that many people who suffer from depression tend to
reside in the less wealthy sectors of society as there exists an inverse relationship between
depression and wealth. Higher rates for the disorder are found in people residing in the lower
classes. Depression is frequently found in people who are subjected to greater amounts of
poverty, stress, unemployment, discrimination, dangerous neighborhoods, and lower levels of
education (Brown & Scheid, 2010; Eaton, Muntaner & Sapag, 1999). The people who suffer
from depression tend to be associated with living below the poverty rates, yet advertising tends
to depict the lifestyle people would like to attain. Thus, providing the illusion of truth. The
models depicted in psychotropic medical journal advertisements represent an audience of people
who do not necessarily reflect the actual depression patient population. Thereby rendering the
storyline regarding depression as being somewhat false.
Advertising Narrative Plot
There is a strong correlation between art, culture and advertising in which advertising is
able to communicate the past and present accomplishments (Wharton, 2015). A close
relationship exists between language and advertising in which the implicit stories in advertising
are created through the development of a plot and characters which are strategically employed to
foster audience identification (Cohen, 2013; Wharton, 2015).
Historically, the basic premise of the advertised plot has been enshrouded in the message
of social attainment that is desired by the audience and achieved through consumption (Ohmann,
1996). These narratives depict the ideal consumer lifestyle that are embodied within a happy plot
(Ohmann, 1996; Thompson, 2004). The audience is presented with the grand visual imagery of
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the idealized life and social status that can be obtained through an economic exchange (Mittler,
2007; Ohmann, 1996).
There are a couple of issues that arise regarding psychotropic drug promotion directed to
physicians. First, the plot contained within the advertised narrative is typically concerned with
social advancement of the patient and not necessarily the physician. This social desirability is
reflected through such symbolic imagery as jewelry, professional attire, and comfortable home
settings that permeates such advertising (Herzberg, 2009).
The advertising industry portrays the world that people aspire to live in and not the world
they actually inhabit (Merchant, 1985; Pope, 2003). The depiction of such a world in DTP
advertising is accomplished through glamorizing and romanticizing the advertised product and
the promise of an improved life; a sort of level of social attainment that is provided by the
physician through the act of prescribing. This is a powerful position to inhabit.
In a similar vein to advertising perfumes, psychotropic DTP medical journal advertising
infuses a hint of glamor and romance to foster an emotional appeal. This sense of glamor was
engendered during the 1990s with Prozac, a product that promised to provide people with an
easy happiness (Naish, 2013). This message subsequently attracted an audience of people who
were not clinically depressed, but were simply unhappy; an audience that was representative of a
certain gender and social status (Chastain, 1993; Hicks, 1997).
The Glamorization of Depression
Prozac and SSRIs
Prozac is a drug that helped to catapult psychotropic pharmaceutical sales as it
revolutionized American society and altered the concept of mental illness, prompting it to
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become a cultural icon (Goode, 2002). Prozac hit the market in 1987 and it was projected to earn
a remarkable $175 million by 1990. However, in 1987, it earned $350 million in sales. By 1990,
it had become the most prescribed anti-depressant with 650,000 prescriptions written or renewed
every month with annual sales over $1 billion (Fitzpatrick, 2010). Since its marketing launch,
antidepressant usage has quadrupled and has become the second most prescribed class of drugs
in the U.S. (Smith, 2010).
Through its media friendly appeal and glowing testimonials, Prozac gained a sort of
prestige as it was candidly discussed at swanky dinner parties and on dates (Boyd, 2013;
Toufexis, 1993) people joked about it in cartoons and essays; and it was recommended to
stressed out family and friends (Toufexis, 1993). It has been suggested that the conversations
Prozac opened and started about depression resulted in its altering the discourse regarding mental
health (McKelvey, 2013).
Thirty years ago, the discussion regarding depression was considered to be taboo as it
was regarded as a condition that was a sign of one’s weak character, thus prompting people to
visit their family physicians for “nerves” (Naish, 2013). Prozac altered the conception of
depression as being something that was feared and shunned as it positioned the disorder as being
trendy which contributed to Prozac’s magical charm (McKelvey, 2013; Ridge, 2009). According
to Barber, “madness has become alluring, inviting and at the least enormously popular.” And as a
result of this sort of luster, antidepressants and depression have become viewed as being rather
chic and a lifestyle accessory (Boyd, 2013; Margolis, 2014). It has become regarded that
depression effects the glamorous people as it has become fashionable and turned into something
wearable (Margolis, 2014; Ridge, 2009; Stanistreet, 2008).This concept of glamor has been
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depicted in DTP advertising through a subtle combination of the product, model, and lifestyle
that have been presented within the promotion.
1990s Glamorization of the Individual
Since the beginning of melancholy and depression, it has been considered to be the
fashionable people who suffered from such mental conditions (Lawlor, 2012; Wessely, 1991).
The cause of these disorders, it has been argued, have stemmed from modern, civilized lifestyles
that develop into an intellect illness (Lawlor, 2012; Wessely, 1991). Further, these ailments
favored the higher class denizens as the labor classes were considered to be idle and not as hard
working. The productive person was the one who was perceived to be overworked and thus, was
prone to suffer from depression (Lawlor, 2012; Wessely, 1991). These ideals continue to exist in
current day society for depression.
During the 1990s, there was a feeling of psychopharmaceutical chic that permeated
American culture that was mirrored in DTP advertising. The models and imagery depicted were
cast in a grand light that presented SSRIs and its consumer as being stylish through the use of
fashion that was depicted within psychotropic drug advertisements. The attire not only defined
who the person was considered to be, but it also defined the upscale lifestyle of that person, thus
producing a perception regarding a certain social status.
The model portrayals featured an attractive, primarily white, middle aged woman who
was positioned as the patient. But she wasn’t a common patient, but a rather regal one (Kempner,
2006). The psychotropic drug advertisements featured women who were rather elegantly attired
as they were depicted wearing silk clothing, scarves, two-pieced suits, dresses, heeled shoes, and
eye-catching jewelry. Additionally, they were well made-up with perfectly coiffed hair. A certain
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opulence permeated this advertising as women were viewed as being well clothed for all aspects
of life, including working, daily activities, and a night on the town.
Prozac was regarded as a woman’s drug that made women more assertive and
competitive especially in business (Herzberg, 2009). The advertisements of the 1990s played
upon the career theme for women as they frequently depicted women engaged within a
professional setting. The career roles for women were depicted in a more proficient mode as
women were portrayed occupying the roles of manager, scientist, and productive employees.
This represented a shift away from earlier psychotropic representations that portrayed women in
more subservient roles, such as nurses (Hawkins & Aber, 1993; Leppard, Ogletree & Wallen,
1993).
The professional female character was reinforced through clothing as the manager wore
an attractive two-piece pants suit, the scientist donned the traditional white lab coat, and another
employee was nattily attired in a two-piece skirt suit that featured a striking lapel pin. These
female portrayals are depicted in Figures A-1 and A-2. The outfits can be regarded as being
relatively conservative in style, yet glamorous, as people of a certain social status could afford to
be in such employment positions and wearing complementary attire. It could be inferred from the
suits that they were made by a particular designer at the time. This further presents a more regal
feel to the advertisement, the model, the advertised condition, and to the product itself.
The perceived depression patient is further glamorized through the depiction of everyday
activities, including shopping and exercising. A 1990s Sinequan advertisement featured a woman
smiling as she was strolling along in her flowing green dress that was accented by a scarf. She is
pictured in Figure A-3 wearing black heeled shoes and carrying shopping bags. Based upon the
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woman’s appearance and the subject of the advertisement, it would appear that the character is
either shopping on her lunch hour or after work. The storyline for the psychotropic
advertisements presents the notion of women being productive at work.
By the mid-1990s, the theme of exercising becomes popular in advertising. A Wellbutrin
ad depicted several people, spanning in age from early 30s to the late 60s, engaged in various
forms of physical activity and they are smartly dressed. The depictions of people exercising
included a younger couple jogging, and they were nicely attired in stylish athletic clothing and
running shoes as shown in Figure A-4. The female jogger was further accessorized with a
headband. While a younger female tennis player was depicted holding a racquet and wearing a
specifically designed tennis outfit consisting of the traditional skirt and shirt combination as
illustrated in Figure A-5. These depictions demonstrate a couple of underlying concepts. First,
the attire is suggestive of the fact that these people are members of a gym or a club. They are not
illustrative of the person who is jogging on the street or playing tennis in the neighborhood.
Further, tennis is an expensive sport to play as it typically requires some sort of membership,
certain clothing, and sports equipment. All of these portrayals reflect a certain lifestyle, and one
that is upscale.
It is also the setting of the advertisements that presented a more opulent lifestyle. During
the 1990s, Prozac and SSRIs were commonly discussed during social events, including cocktail
parties. As Barber described, “the words Prozac, Paxil, and lithium were tossed around with the
salted peanuts and the shrimp” during a cocktail party he attended. This type of social occasion is
intimated in a Wellbutrin advertisement that depicted an older woman as she was getting dressed
up for the evening. She was portrayed in Figure A-6 as being attired in a dress, and she was
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shown smiling into her vanity mirror while she put on her pearl jewelry. Within the setting, the
viewer is invited to observe her immaculate dressing table that was lined with perfume bottles.
This presentation represents a different time period when pearl jewelry, dressing tables, and
perfume bottles signified a noble status.
The depictions of the patient population within DTP advertising during the 1990s
presents a middle class white woman patient who is well attired for all occasions. The
advertisements focused upon the individual and subtly hints as to the type of lifestyle this person
enjoys as being ritzy. The advertisements give the illusion that depression does indeed favor the
more upper class individual.
By the 2000s, the depiction of the glamorous individual was replaced by the trendy
lifestyle that was sold alongside the product. This transition makes sense as the 2000s were
dubbed as the decade of the lifestyle drugs. People were depicted less formally and more
casually and were featured engaged in more leisurely pursuits.
2000s the Glamorization of Lifestyle
Advertisements depict certain lifestyles to help sell consumers promoted products. Rather
than focus upon the product itself, consumers are invited to experience the product through a
lifestyle activity. For example, in pharmaceutical advertisements the audience is invited to
partake in the hiking, biking, and dancing experience. In pharmaceutical marketing, the
consumer lifestyle has been advertised rather than the disease itself (Editorial, 2003). The
lifestyle activities that advertised patients enjoyed included dining, traveling, hiking, and yoga.
The depiction of people dining together is provided by a Remeron advertisement that
showed in Figure A-7 two older women having afternoon tea together in a home setting. An
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interesting aspect of the imagery is the silver tea serving set that was placed upon the table. This
type of tea service is considered to be reflective of a certain time and status. In contrast to
today’s standards, the women are not shown imbibing tea from a coffee mug and a kettle. This
type of tea serving set is typically reserved for a more formal afternoon tea that is served in a
restaurant. In addition, having afternoon tea is considered to be a rather feminine type of social
occasion. Another advertised depiction of dining is for Lexapro. In Figure A-8, two women
appeared to be lunching outside during a sunny afternoon. The woman facing the camera was
smiling and laughing as she appears to be the person suffering from depression. The
sophistication of the outdoors is frequently depicted during the 2000-2010 timeframe in
psychotropic advertisements.
The theme of participating in rather expensive types of exercise continues during the
2000s. A Zoloft advertisement featured in Figure A-9 showed a triple generation relationship and
provided a portrayal of a grandmother, a mother, and a daughter sitting on top of a boulder that
was located above a beautiful body of water and surrounded by green trees. From their attire, it is
obvious that the family had been hiking through a mountainous area. There are a few scenarios
that can be inferred from this advertisement. First one suggests that depression is, in part, caused
by genetics as it is handed down through the generations. This places the illness within the
individual which provides a distorted perspective since it is not necessarily genetics that
manifests into depression. Second, the grandmother is sort of veiled within the advertisement,
thus demonstrating that the person or persons who suffers from depression are the mother and/or
the daughter. This slanted portrayal actually broadens the audience that could contribute to the
off-label promotion of the product. Third, within the larger advertisement, there is a smaller
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picture of the mother in a business setting. The contrast between the larger picture of the hike
and the smaller one of the mother suggests a balance between recreation and work. Finally,
based upon their destination, the hikers looked as if they had traveled. The scene is serene as it
does not appear to be near urban life. The concept of travel is utilized often in these series of
advertisements.
Following the pattern of outdoor exercise, is depicted in Figure A-10 of a Serzone
advertisement that depicts a woman on the beach attired in yoga workout clothing as she is
stretching in the sunlight. The picture presents an ideal image of wellness, relaxation, and a form
of exercise that is traditionally experienced by a person of an upper class lifestyle.
The viewer learns of a more cultured lifestyle in Figure A-11 that can be obtained
through a prescription through Kristen’s narrative in which she is able to resume her weekend
getaways. The picture featured an illustration of her suitcase that she is unable to close because it
is packed full of clothing. Perhaps she is going away for a long weekend. The overall message
for all of these advertisements is of social status and attainment, concepts that are further
reinforced through romancing the advertised patient and product.
The Romanticizing of Depression
The SSRIs and depression are romanticized through the portrayals of love. The
advertisements play upon the emotional appeal of love, as a Serzone ad depicted in Figure A-12,
asks the reader, “how can your depressed patients love life, without a love life?” The imagery
that complements this question, includes two couples who are connected by holding hands,
standing in the ocean in front of a large, crashing wave. The four people have their backs turned
away from the viewer, but based upon their swimsuits, there are two men and two women. This
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image lends itself to the notion that they are bracing, together, for a major storm (a depressive
episode).
The concept of love in these ads is communicated through visual actions, including the
embrace that occurs between couples. Therefore, the encirclement is not seen as occurring
between friends, which reinforces the notion of a traditional normative, romantic love. A
Remeron ad clearly demonstrated that relief from depression resulted in love as the
advertisement portrayed in Figure A-13, a hug between an older couple. In addition to the
embrace, the man is holding a bouquet of flowers that are cut in the shape of a heart; a symbolic
gesture that serves to further support the impression of love.
A Zoloft ad depicted the reverse embrace between two younger people as the woman was
depicted as hugging the man from behind in Figure A-14. In this same ad, an older couple is also
depicted as hugging in the same manner as the younger couple. In addition to the static embrace,
an Effexor promotion portrayed the hug in action. The advertisement featured a couple that was
dancing outside by a large tree as seen in Figure A-15. It is obvious that he has dipped the
woman in the dance and he was holding her in his arms. She was looking into the camera as she
was hanging upside down and smiling. By romancing the patient and the product, it would seem
that SSRIs can provide patients with a love life that could, presumably, also lead to an enhanced
or a better life.
The Promise of a Better Life
The plot and promise of a better life is made implicitly and explicitly through visuals and
textual elements. Since the 1990s, pharmaceutical companies have relied less upon the
messaging of a product’s ability to cure a disease and more upon the improvement of life
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(Raisborough, 2011, Editorial, 2003). The advertisements encourage physicians to improve their
patient’s lives by writing a prescription for an antidepressant. Thus, the physician is empowered
and called upon to act.
The theme of enjoying one’s life resonates throughout psychotropic advertisements as an
Effexor XR claimed, “your patients can now enjoy their lives again.” Lexapro guaranteed to
provide the “power to enjoy life.” While Prozac promised the enjoyment of “the simple
pleasures of life.” Wellbutrin made the bold claim that people would be “feeling better and living
better” if people were given a prescription for an antidepressant.
Through before and after sequences, it was further visually communicated that the
patient’s life would improve through the consumption of the advertised product. In a Wellbutrin
advertisement, the viewer was introduced to Janet, a 42-year old librarian who suffered from
depression. On the first page of the promotion, Janet was depicted a washed in dark colors and
looking sad. When the viewer turned the page, Janet was a happy person as she was depicted
smiling in color and smiling as she worked in the library.
A Serzone ad had an illustration of a woman curled up into a ball and proclaiming,
“Nothing I do matters… I feel jumpy…I can’t sleep at night…” After she takes her Serzone she
perked up and stated, “I’m feeling like my old self again. I’m more relaxed. I’m sleeping through
the night” and she is shown happily stretching.
Psychotropic drug advertisements offer the patient the social attainment of love and an
improved life through a prescription. A physician may feel better about him/herself by providing
this fulfilment and writing a prescription. A practice that may lead to the over prescribing of
antidepressants to women.
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Consumption and Sense of Identity
The advertised representations in this chapter accomplishes two important tasks. First,
they appeal to people’s sense of identity. Second, they empower physicians by asking them to
improve the quality or their patients’ lives through a prescription. The representations of
glamorization and romance are important because they appeal to one’s emotions and sense of
self. It has been suggested that people are able to create and transform their identity through
consumption as people are naturally identity seekers and makers (Dittmar, 2007a; Arnould &
Thompson, 2005). People engage in the act of purchasing in order to gain social status, acquire
identity, and to achieve an idealized sense of self. Typically, the act of consumption is
accomplished through the purchase of an item. For psychotropic medications, consumption can
be regarded in terms of the fulfillment of a prescription and in the actual ingesting of the product
which produces the advertised effect, and perhaps, alters one’s sense of identity. Prozac was
marketed as the personality pill that promised to make people more sociable at parties, to make
people better than well, and to be more confident, thus it promised to change people’s
personalities, and sense of identity, into one that was more desirable (Stossell, 2016).
In addition, these reviewed medical journal advertisements present images of idealized
identity and lifestyles that represent the good life that can be obtained with a prescription.
According the Dittmar (2007a & 2007b), buyers consume an advertised product and its symbolic
meaning (success, happiness, and glamour), in order to move closer to the ideal identity that is
depicted by the media models featured in the promotions. People believe that they can transform
themselves to be similar to the models who promote the products by buying the advertised
product. We buy products in order to enhance our self-worth, and the promotion for SSRI’s
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epitomizes this concept (Dittmar, 2007b). The advertisements for SSRIs plays upon the notion of
self-identity and the social attainment for the promoted lifestyle. For patients, their identities are
not only shaped by consumption, but they are also shaped by advertising that tells physicians
how to remedy identities (social, sexual, personal, and professional inadequacies) and to further
move the patient closer to achieving the idealized good life through a prescription.
Conclusion
According to epidemiology reports, depression disproportionately affects people who live
in poverty, stressful environments, are unemployed, face discrimination, or live in unsafe
neighborhoods. However, the characters, settings, and narrative regarding the depression
audience tells a different story in which the depression audience is comprised of well-attired
women who enjoy rather than fear life. The depression audience is represented through the
depiction of an idealized lifestyle that is obtained through a prescription. Based upon the notions
of consumer consumption, people buy a way of life through the purchase of more things. As
advertising celebrates the freedom of choice and consumerism and urges people to get out and
buy. This imploring is not any different from traditional products than for pharmaceutical
products with one exception, the process is mediated by the physician who is placed in a
powerful position to decide who gets to receive this perceived improved life and who does not.
Pharmaceutical advertising may influence a physician’s thinking about the depression audience
that may result in prejudicial thinking and prescribing that may inflate the treatment rates for a
fictional patient population.
Psychotropic drug advertisements in medical journals sell an image, a lifestyle, a concept
of love, and an improved life. Thus, they sell a fantasy where it is almost cool to be depressed
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which only trivializes the illness. Advertisers create the audience for depression through
segmentation strategies that allow them to be laser focused on the selling of antidepressants to
white women. Consequently, these advertisements lose their ability to properly educate and
inform physicians about the mental health condition and the promoted product.
Finally, during the 1990s and with the advent of Prozac, depression was given a sort of
chic luster that added to its allure through the promise of a new sociability, confidence, and being
better than well. Consequently, people visited their physicians in hope of obtaining a new
identity, one that was more productive and likeable. The 1990s were reminiscent of the swanky
cocktail party in which people aspired to be interesting. As a result, for the need for interest, it
became appealing to not only take Prozac but to be a part of the depression audience. Although
Prozac opened up the conversation about depression and reduced stigma, its marketing took it
one step too far, in an effort to increase sales, made it somewhat cool to be depressed. Therefore,
it has not only become a cultural icon but also a lifestyle accessory which is a rather dangerous
consideration. However, Prozac brought together the true depression audience and the fictional
one as Barber observed that the pharmaceutical industry brought the homeless mentally ill and
the cocktail set together.
The representations in pharmaceutical advertising to physicians warrant further
examination in an effort to make these forms of promotion more accurate and informative in
their visual and textual content. Additionally, the advertisements should be less inflammatory in
their effects and more effective in positively influencing prescribing to all groups of people.
Pharmaceutical companies and advertisers have been successful in creating and influencing the
depression audience, and the medical condition through ads that promise people sociability,
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confidence, and the social attainment of a glamorous life and trendy lifestyle; a promise that
naturally begs the question, who doesn’t want to be depressed?
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CHAPTER IV: THE TYPICAL ANTIDEPRESSANT PATIENT AND AT-A-GLANCE
DIAGNOSIS
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Abstract
Women are misdiagnosed for depression 30 to 50 percent of the time. One reason for this
tendency may be due to the portrayal of the antidepressant patient in psychotropic medical
journal advertisements. Through a narrative analysis of medical journal advertising spanning
from 1990-2010, it is concluded that the misdiagnosis of women is influenced by advertising.
The pharmaceutical, medical, and advertising industries create a prototypical antidepressant
patient that is a female. As physicians are pressed for time, they draw upon cognitive heuristics
when rendering a diagnosis that permits them to diagnose at-a-glance. This diagnosis is based
upon personality, behaviors, complaints, and gender.
Introduction
According to The National Academies of Science, Engineering, and Medicine (2015),
most people will experience a delayed or incorrect diagnosis during their lifetime. Such errors
may have detrimental consequences that result in negative health outcomes (Meyer & Meyer,
2009). Recently, there has been an increased concern regarding diagnostic error and the
assignment of diagnostic labels to individuals that are unlikely to positively affect their health
and well-being (National Academies of Sciences, Engineering, and Medicine, 2015). One group
of individuals who is commonly misdiagnosed are women, especially for such mental health
conditions as depression (American Psychological Association, 2016).
Women are misdiagnosed for depression approximately 30-50 percent of the time
(American Psychological Association, 2016). Additionally, it has been estimated that 70 percent
of antidepressant prescriptions are provided to women without a proper diagnosis and monitoring
(American Psychological Association, 2016). Although there is a myriad of causes for
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misdiagnosis, the primary one is cognitive errors; problems with the physician’s thinking
(Croskerry, 2013). This can occur when physicians take shortcuts that are based upon superficial
assumptions affiliated with past experience rather than current information (Sternberg, 2015).
One cognitive shortcut that may influence physicians’ thinking is the portrayal of the typical
antidepressant patient who is promoted in medical journal psychotropic drug advertisements.
The personification of the advertised antidepressant patient in Direct-to-Physician
(DTP) advertising is predicated upon the theory that the person pictured in advertisements is the
anticipated end user of the promoted product. But this individual may not be the actual
depression patient, but rather the medical consumer. Through repetitive advertised model and
lifestyle portrayals, physicians are persuaded into believing that the ideal candidate for SSRI
therapy is a middle class white woman. With this mental prototype of the antidepressant patient,
a physician is invited to simply look at a patient and diagnose at-a-glance.
The model depicted within advertisements is considered to be representative of the actual
patient. Through the congruence between the people a physician sees in his or her office and the
models portrayed in psychotropic drug advertisements, the patient and the perceived end-user
become one in the same person. This portrayal presents a distorted picture.
Pharmaceutical companies, advertisers, and physicians use narrative characters in
psychotropic drug medical journal advertisements to create a hypothetical patient profile for the
typical antidepressant patient. This hypothetical profile fosters at-a-glance diagnosis, a practice,
that may contribute to the misdiagnosis of women.
This chapter explores the typically advertised antidepressant patient and at-a-glance
diagnosis through a narrative analysis of medical journal psychotropic drug advertising during
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1990-2010. DTP advertising constructs a hypothetical patient profile that reflects the
antidepressant patient through the use of personal attributes including, individual qualities and
lifestyles, and through symptoms, and textual elements. However, these representations may be
flawed as they may not depict the truly depression patient, but rather the attractive and profitable
consumer. The chapter begins with an analysis of DTP advertising and the patient that is
followed by a discussion regarding the typical patient and at-a-glance-diagnosis. The chapter
concludes with a narrative regarding the typical patient.
Direct-to-Physician Advertising and the Patient
It is commonly regarded that advertising should be designed to fit the audience and not
vice versa (Fox, 1997). Therefore, the creative decisions regarding advertising have to be
harmonious with audience expectations (Englis & Solomon, 1995). The images and messages
contained within advertisements have to imitate the values and attitudes held by the audience
(Marchand, 1985). Hence, from an advertiser’s perspective, it is imperative to create
advertisements that mirror the cultural beliefs and the understanding of the intended audience
(Frascara, 1997; Tyler, 2006). In terms of the clinically depressed patient, advertisers are
arduously tasked with the responsibility of presenting an accurate portrayal of the patient to
physicians. A depiction that is representative of the manner in which physicians perceive patients
as looking, acting, and essentially being.
The imagery featured within the DTP advertisement is vital as it has to be accepted by the
physician as being an accurate depiction of the actual patient in order for the advertisement to be
successfully persuasive (Frascara, 1997; Tyler, 2006). This portrayal is partly accomplished
through the use of the physician who has a bird’s eye view of the typical patient on a daily basis.
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Advertisers and pharmaceutical companies retrieve information regarding patients from
physicians (Applbaum, 2009). Consequently, the promotional materials for psychotropic drugs
are frequently created on the basis of patient complaints the physician is most likely to hear in
the office. The psychotropic advertisements in medical journals mirror the actions and words a
patient is most likely to take and to say while visiting a physician (Applbaum, 2009; Pekkanen,
1976). These promotions present the patient and the complaints in a simple narrative that is easy
to read by the physician. As a result, DTP advertisements emphasize an expectation of
appearance social type and personality (Englis & Solomon, 1995; Gulas & McKeage, 2000).
The Hypothetical Patient Profile
The patient profile informs physicians about the patient’s demographic and medical
characteristics. It provides a narrative regarding a type of patient that can be used when
diagnosing individuals. Frequently advertising materials feature a hypothetical patient who is to
resemble the patient a physician would see for the advertised product. Therefore, the
hypothetical patient is created so that physicians are able to accurately identify, diagnose, and
treat the advertised disorder (Spielmans, 2009). This patient is described and defined through a
personal story that describes his or her personal qualities, symptoms, and behaviors (Applbaum,
2009; Spielmans, 2009).
The use of hypothetical profiles is to assist physicians “in recognizing symptoms and in
‘early identification of relevant patient types’” (Spielmans, 2009, p. 18). An example of a
hypothetical patient includes Eli Lilly’s character named Donna who is described as a “single
mom in her mid-30s, appearing in [the physician’s] office in drab clothing and seeming
somewhat ill at ease. Her chief complaint is, ‘I feel so anxious and irritable lately.’ Today she
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says she’s been sleeping more than usual and has trouble concentrating at work and home.
However, several appointments earlier, she was talkative, elated, and reported little need for
sleep” (Applbaum, 2009, p. 202; Spielmans, 2009, p. 16). And Michael who “is a professional in
his mid-30s. He’s highly functional, but his wife says that he’s always been prone to mood
swings, and lately things have gotten worse” (Applbaum, 2009, p. 203).
In addition to personal narratives, the hypothetical patient is described in terms of the
associated symptoms. For Donna, she was designated as suffering from mood swings, irritability,
sleep disturbances, anxiety, a lack of concentration, mood lability, and depressed mood. While
another Eli Lilly character named Ashley suffered from insomnia, irritability, distractibility, and
racing thoughts (Spielmans, 2009, p. 16). These profiles serve to ensure that the physician can
recognize the type of patient the pharmaceutical company is promoting. As pharmaceutical
companies are concerned with making sure physicians “recognize the type of patient” that it is
marketing to physicians (Spielmans, 2009, p.16). Consequently, the patient profiles are
representative of the pharmacologic consumer as they depict the anticipated product end-user.
The Product Model of Advertising and Theory of Congruence
The match-up hypothesis and product congruity theory suggest that that the perceived
congruence between the spokesperson featured in an ad and the advertised product has the ability
to affect source credibility, product evaluation, the perceived gender associated with the product,
and other measures of communication and advertising effectiveness (Lynch & Schuler, 1994).
The closer the match between the two elements results in a more favorable product evaluation,
enhances communication, creates a more appealing ad and exhibits a higher consumer rating for
the product and fosters a better reputation for the manufacturer (Lynch & Schuler, 1994). Paek,
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Nelson and Vilela (2011) further suggest that the product type determines the gender of the
advertised product. The authors conclude that the gender role portrayals and product type are
most important to correlate with one another. Therefore, it is imperative for the spokesperson
featured in the ad to match the product type and selling idea (Nelson & Paek, 2008).
Consequently, for advertisers, one of the most important decisions to make is the selection of the
appropriate model or spokesperson to represent a product or brand (Lynch & Schuler, 1994).
The Typical Patient and At-a-Glance-Diagnosis
The medical profession and drug marketers, through preconceived notions of the true
mental health sufferer, created conceptions of the typical patient based upon the science of the
brain. This was concerning as pharmaceutical companies did not necessarily scientifically
identify the actual patient. The pharmaceutical companies intending to increase profits knew who
would be the target audience for their medications, those individuals who could afford them,
which may represent a different audience than those individuals who may be in need of such
treatment (Herzberg, 2006). The depictions and descriptions of the depressed patient have been
predicated upon social status, personality, and gender, a tradition that continues today.
The Typical Patient
Blum and Stracuzzi (2004) maintain that there is an unscientific circularity that exists
between diagnosis and representation in clinical and popular images. These visuals are based
upon stereotypes that the pharmaceutical and medical institutions have provided to physicians in
order to identify the typical patient. Medical textbooks further carve distinct characterized
images and personal narratives of hypothetical patients that are parceled into mini-stories
including, the stockbroker who is distressed from uncertainty and phobias; the physician who is
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suffering from an inferiority complex; the anxious engineer who self-medicated through
drinking; the stressed out graduate student with school and family troubles; and the housewife
dealing with a husband and ornery in-laws (Herzberg, 2009).
Peppin and Carty (2001) maintain that drug companies attempt to create diagnostic
images through the use of age and lifestyle imagery for conditions and their cures. These images
serve as a shortcut for physicians in treating patients. Advertisers create a human pictorial for
prescribing which functions as a cognitive trigger for physicians to recall. This recollection
results in the categorization of the patient who enters the medical office without saying a word
(Segal, 2008). Hence, the patient who complains of sadness may expect to receive a prescription
that is shaped by the physician’s mental image of the antidepressant patient. What becomes
important is who the antidepressant patient is in the mind of the physician (Segal, 2008).
Diagnosis At-A-Glance
The precisely categorized pictorial representations allow the physician to systematically
diagnose the patient at a glance (Rubin, 2004). The at-a-glance diagnosis incorporates a verbal
aspect as the patient describes such feelings as, “I just can’t cope, doctor.” The physician looks
for the visual and verbal cues in order to ascertain the appropriate action to take (Stimson, 1975).
Drug advertisements consist of messages and images that are cognitively processed together.
The construction of a drug’s reality includes such elements as the nature of the illness, the typical
patient who has the illness, the treatment, and the typical causes of the illness. All of these visual
and textual components, taken together, lead a physician to a diagnosis (Stimson, 1975).
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Cognition
Working memory is a resource through which people actively manipulate and retrieve
information. It is activated for almost all cognitive tasks, including reading, reasoning, problemsolving, and diagnosis. However, it is limited in its capacities and can be hindered by the
materials that are presented to the audience (Wilson & Wolf, 2009). Visual cognition is the
manner in which information is conveyed through the presentation of design. Visual perception
should function to summarize and simplify the visual objects in order to reduce cognitive
overload since this can contribute to diagnostic errors (Balogh, Miller & Ball, 2015; Dongfeng,
2015). The FDA recognizes the limitations of physicians in cognitively processing information
as it has stated “research has shown that experts (in this case Healthcare Providers (HCPs)) are
subject to the same cognitive biases and processing limitations as non-experts” (Guidance for the
Industry: Presenting Risk Information in Prescriptive Drug and Medical Device Promotion,
2009, p. 6).
Further, the FDA recognizes that people have the capabilities to cognitively process a
restricted amount of information in a specific amount of time as “cognitive sciences research has
shown that all people, regardless of expertise, are only able to think through and process a
limited amount of information at a time” (Guidance for the Industry: Presenting Risk
Information in Prescriptive Drug and Medical Device Promotion, 2009, p. 6).
Finally, the amount of information presented to the viewer at one time can affect the
cognitive load of the viewer. As the FDA maintains, “the amount of information presented in
one component that, together with choice of words, color, graphics, voiceover and other aspects
of the piece, affect cognitive load, the mental effort required to understand the various
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components of information in the piece” (Guidance for the Industry: Presenting Risk Information
in Prescriptive Drug and Medical Device Promotion, 2009, p. 10-11).
The audience’s cognitive abilities to process information is an important factor in
rendering a diagnosis. Cognitive errors contribute to diagnostic errors, including the
misdiagnosis of an individual. The IOM defines an error in medicine to be the “failure of a
planned action to be completed as intended (i.e., error of execution) and the use of a wrong plan
to achieve an aim (i.e., error of planning) [commission]” (Balogh, Miller & Ball, 2015, p. 3-3).
Diagnostic error is further defined as an “error or delay in diagnosis; failure to employ indicated
tests; use of outmoded tests or therapy; failure to act on results of monitoring or testing” (Balogh,
Miller & Ball, 2015, p. 3-3).
The presentation of information affects the cognitive abilities of the intended audience
which can cause cognitive overload if presented with too much information at one time.
Information in the form of advertising can present too much or little data that are affected by
such design elements as format, white space, font size, syntactic structure, imagery, and word
choice. The presentation of material can result in cognitive overload and hinder a person’s ability
to comprehend the material’s content, thus potentially affecting diagnostic decisions (Wilson &
Wolf, 2009).
Diagnostic Heuristics
Visual cues serve as cognitive heuristics in which physicians base a diagnosis upon
personal views rather than industry guidelines. Cognitive heuristics are utilized in every facet of
life as they require less cognitive effort so that judgments may be rendered more quickly.
However, the disadvantage to heuristics is they are susceptible to creating systematic errors as
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judgments are based upon preconceptions, experience, and selective memory (Meyer & Meyer,
2009). One of the types of heuristics used in the diagnosis process is the prototype heuristic
which is founded upon the matching or similarity procedure. This occurs when a physician does
not rely upon guiding principles but rather diagnose based upon a prototype case that is
cognitively recalled.
According to Croskerry (2002 and 2003), clinicians face such heuristics and biases as
ascertainment and gender biases which cloud their judgement. The ascertainment bias occurs
when a physician’s thoughts are formed by their previous expectations. Stereotyping and gender
biases are examples of ascertainment bias in which physicians think that gender is the
determining factor in diagnosis when in fact a pathophysiological basis exists. This typically
results in the over-diagnosis of the ideal gender at the expense of the under-diagnosis of the
neglected gender (Croskerry, 2002 and 2003).
One such prototype that is easily recalled is the typical patient that is featured in
pharmaceutical advertising (Cantor, Smith, French & Mazzich, 1980). According to Segal,
physicians have a mental cast of characters from which they resource kinds of patients, such as
the headache patient or the depressed patient. The person prototype is recalled as a form of
cognitive organization that is employed to code people and their behaviors. This type of
categorization and coding can lend itself to prejudicial tendencies, as types of people are
classified based upon such subjective characteristics as social status and behaviors.
An example of a scenario that depicts a patient being misdiagnosed based upon a
physician’s personal biases includes the following:
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“A 28-year-old female patient is sent to an emergency department from a nearby
addictions treatment facility. Her chief complaints are anxiety and chest pain that have been
going on for about a week. She is concerned that she may have a heart problem. An
electrocardiogram is routinely done at triage. The emergency physician who signs up to see the
patient is well known for his views on “addicts” and others with “self-inflicted” problems who
tie up busy emergency departments. When he goes to see the patient, he is informed by the nurse
that she has gone for a cigarette. He appears angry, and verbally expresses his irritation to the
nurse. He reviews the patient’s electrocardiogram, which is normal.
When the patient returns, he admonishes her for wasting his time and, after a cursory
examination, informs her she has nothing wrong with her heart and discharges her with the
advice that she should quit smoking. His discharge diagnosis is “anxiety state.” The patient is
returned to the addictions centre, where she continues to complain of chest pain but is reassured
that she has a normal cardiogram and has been “medically cleared” by the emergency
department. Later in the evening, she suffers a cardiac arrest from which she cannot be
resuscitated. At autopsy, multiple small emboli are evident in both lungs, with bilateral massive
pulmonary saddle emboli” (Croskerry, 2012, p. 53).
This scenario illuminates many intuitive biases that lead a physician to an inadequate
assessment of the patient and, ultimately, to an incorrect diagnosis. First, he stereotypes and
labels the patient. Second, he focuses upon her disposition rather than her overall circumstances.
These oversights result in her misdiagnosis (Croskerry, 2012).
It has been contended that misdiagnosis of patients may result from physicians’
dependence upon heuristic cues from which they draw upon during the diagnostic phase of the
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patient interview that may be founded upon advertised imagery (Croskerry, 2002 and 2003). The
depicted patient in psychotropic advertisements is problematic as these representations may
provide a distorted view regarding the true mental health patient. As women are
disproportionately portrayed within this type of advertising than are men. This representation
may provide the idea that more women suffer from such mental health disorders as depression,
thus increasing diagnoses and the potential for misdiagnosis.
The Narrative of the Typical Patient
Narratives are structured to be rather predictive as they are simply comprised of
characters, a plot and a sequence of events that incorporate a beginning, a middle and an end
(Greenhill, 2013; Pace, 2008). Narratives are influential because they are able to translate
certain frightening notions such as illness and death into more mundane conceptions, which
makes their use not only practical for every day conversations but important as well (Nell, 2002).
The part of the narrative of the psychotropic drug advertising that is of interest in this
study is the character of the patient. The analyzed medical journal advertisements present a
hypothetical patient profile of the antidepressant consumer. The viewer is introduced to the
antidepressant cast of characters through such personal characteristics as names and lifestyle
demographics and through symptoms and gendered textual elements.
Introducing the Antidepressant Patient
The advertisements familiarize physicians with a particular gender that is established in
psychotropic drug advertisements as they learn about such individuals as Janet, Kristen, Nell
Barb, Sue, Chris, and Julie. Based upon the introduction to these depression characters, the
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viewer, through advertised text, is able to deduce the age of the typical depressed patient as being
between 35 and 42 years old as portrayed in Figures A-1 and A-16.
Through a series of 2000 Prozac advertisements, the lifestyle of the characters is
described as one that caters to rather whimsical activities. However, the advertisements present
an implicit view that these women are not particular proficient in these activities, thus the
advertisements subtly censure women’s overall abilities. The story unfolds with Kristen in
Figure A-11 who enjoys traveling as she is taking weekend getaways again. The picture that
accompanies the narrative about Kristen shows a suitcase that is stuffed full with clothing. The
visual depicts a suitcase that is bursting at the seams as garments appear to be sticking out of the
sides which does not permit the suitcase to close. The underlying message is that Kristen
obviously lacks keen suitcase packing and essential traveling skills. The copy reads, “like getting
away for the weekend…and taking it all along.” However, Kristen does not need to take it all
since she is going away for the weekend. The advertisement’s text further admonishes Kristen
for her inabilities to pack a suitcase.
While Nell has returned to the simple pleasure of knitting in Figure A-17. Although Nell
is not very efficient at knitting as the accompanying illustration is one of a colorful sweater that
is not in proportion. One side of the knitted sweater is clearly longer than the other side. The text
reads, “like extra care to create something unique…and ending up with something extra.” The
word extra is not used in a flattering manner as it serves to deprecate Nell’s knitting talents. Not
only do the characterizations of Kristen and Nell feature lifestyles, but they are also somewhat
centered around clothing. Thereby establishing an understated connection between women and
clothing.
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The character of Barb portrayed in Figure A-18 is slightly different in that it features a
particular sport that is rather expensive to play. Barb has started playing golf again, however, she
is not very good at the game as it is visually suggested that she fails to score above par. Her golf
ball is shown as landing into a puddle rather than a hole. The text contained within the
advertisement reads, “like golfing…with a slice.” However, golfers know that a slice is not
something that is good; instead it represents a sort of shot that should be avoided. The
advertisement implies that Barb is not really a dexterous golfer. In addition, the game of golf has
further been associated with physicians. As it has been frequently joked that physicians do not
work on certain days because they are out golfing.
Chris and Sue in Figures A-19 and A-20, respectively, present additional demographic
information because through the narrative it becomes clear that they have children, thus
suggesting that the typical antidepressant patient has children. The copy for Chris reads, “Chris is
making lunch for the kids again.” The character of Chris is complicated by the accompanying
visual in that it represents a well-made sandwich that features a smiley face. The face is cleverly
made from a piece of round lunch meat, ketchup, and mustard. The copy continues to laud
Chris’s lunch preparation efforts, “like creating lunch for the kids…that leaves everyone with a
smile.” This statement implies success. Since there is not a visual representation of the person, it
could be inferred that Chris is in fact a man. Since the sandwich is well made, it was created by a
male character rather than a female. In addition, the activity of making lunch assumes the
accomplishment of an important act; the feeding of one’s children. On the other hand, the other
characters are engaged in rather leisurely activities that do not necessarily constitute fulfilling an
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important task. Finally, according to the storyline, women are not as proficient in these leisurely
daily activities; a theme that resumes with the character of Sue.
Sue has taken up again with playing with the kids. The advertisement tells the viewer
“like showing the kids how to fly a kite…and rescuing it from the kite-eating trees.” The
illustration depicts a red kite snarled within the branches of a tree. This message accomplishes
two tasks. First it suggests that Sue is not an efficient kite flyer. Second, the word rescue plays to
the physician as Sue is the one being released, and not the kite, as she is back to enjoying the
simple pleasures of life, thanks to her physician.
This series of advertisements do not necessarily speak about depression, but rather speak
to the physician. The copy reads, “they count on you to help them feel normal again.”
Consequently, the depicted people and the patients who represent such characters may not suffer
from depression. The Prozac advertisements ask the physician to look for a certain person, the
typical patient, rather than look for any symptoms and an illness.
Through this cast of characters, the typical antidepressant patient is introduced as being a
female who is not proficient in navigating everyday life. This description of the typical patient
reinforces pharmaceutical’s intention to sell to women, as it presents a prejudicial perspective
regarding women. The advertisements depict women as needing antidepressant in order to get
through life. This account is flawed and merely exacerbates the view of women and
antidepressants; probably to the delight of the pharmaceutical, medical, and advertising
industries. However, if physicians believe this purposely constructed hypothetical patient profile,
they will unnecessarily prescribe antidepressant medications to many female patients at the
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expense of those who truly need them. Moreover, the message of functionality regarding the
Prozac characters are not entirely made explicitly, but are made implicitly as well.
Finally, the symptoms and the text reflected within these advertisements reinforce the
idea that depression is a gendered disease and that more women than men are in need of
antidepressants.
Symptoms and Text
The vague symptoms contained within the psychotropic medical journal advertisements
are primarily themed around the concepts of energy, insomnia, and pain. Energy is defined as
being low or lacking as depicted in Figures A-21 and A-22. While insomnia is termed as sleep
disturbances and fatigue. And pain is perceived to be unexplainable and as vague aches that
patients frequently complain about. From a marketing perspective, the use of these themes plays
upon the historical illness neurasthenia and it asks the physician to listen for complaints rather
than look for actual diagnosable symptoms. Subsequently, these patients’ complaints become the
advertised symptoms.
If history does repeat itself than depression looks a lot like neurasthenia. According to
the story about neurasthenia, it was an illness that was predicated upon patient complaints
regarding physical pain. These complaints lead to the creation and development of an illness, its
symptoms, and its audience. Neurasthenia favored the person in society who was viewed as
being hard working in terms of employment and social engagements. Through work, patients
became physically exhausted which created physical body pain. The patients who visited
physicians for a diagnosis and treatment for this pain tended to reside within the upper classes of
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society. As a result, acquiring neurasthenia became a social boon as only the educated and
leaders were subjected to the illness.
Based upon the historical account of neurasthenia, it would appear that contemporary
marketing strategies are loosely based upon the past as little has changed in the diagnosis and
treatment of patients. The physician-patient interview has always included some level of patient
complaint versus the examination for symptoms. Consequently, patient complaints are turned
into marketable vague emotional symptoms including, hopelessness, despair, and sadness
In a black and white advertisement for Serzone a headshot of a woman is depicted and
she is looking into the camera with a slightly tense expression. The copy provided in Figure A23 states a sort of testimonial on behalf of the advertised individual as she expresses, “I feel sad,
anxious, and agitated about everything. Hopeless. Nothing matters any more, even things I used
to love. Part of it is, I’ve been dragging around for weeks now, I can’t remember my last good
night’s sleep or what joy feels like…” By reading the advertisement, it appears that the woman is
in fact complaining about her life. This is precisely the kind of conversation a physician expects
to hear. While Janet in Figure A-1 is also suffering from such emotional ills as “crying spells,
and feelings of fatigue, hopelessness, and despair.” These female complaints are turned into the
primary symptoms for depression that are featured in psychotropic medical journal advertising.
The circulation of complaints into symptoms makes it rather convenient to diagnosis at a glance.
This diagnosis is further based upon the perceived gender of the patient that is reinforced through
the textual elements of the advertisement.
The use of text to define the female patient is reflected within a Paxil advertisement that
contains the statement, “She’s anxious. She’s agitated. She can’t sleep. She’s depressed.” This
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headline is superimposed upon a black and white photograph of a woman in Figure A-24 who is
looking down and her expression is one of sadness. The advertising copy further informs the
viewer that 80-90 percent “of depressed patients exhibit associated symptoms of anxiety such as
agitation, sleep disorders, weight loss, and gastrointestinal problems.” This ad presents both the
gender and the symptoms of the patient. The symptoms, especially for anxiety, sleep disorders,
and weight loss are also suggestive of a gender and one that is female, a connection that helps to
reinforce the visual imagery and diagnosis.
Julie is introduced in Figure A-16 as being anguished because her life is being disrupted
by Major Depressive Disorder (MDD), Panic Disorder, Premenstrual Dysphoric Disorder (PDD),
and Social Anxiety Disorder (SAD). The advertisement poses the gender-laden message, “Start
her on something she can stay with…Paxil.” The text is accompanied by a woman who looks
sad. The image is further intentionally cast to appear to be gloomy through the use of a maroon
colored photo filter. This advertisement suggests that the depicted model for Paxil is attributed to
all of the advertised conditions. The person who suffers from MDD may look like the person
who suffers from SAD. Consequently, it implies that the typical patient looks alike; she is a
white middle aged distressed woman.
Imagery and Hidden Meanings in Advertising
The pharmaceutical medical journal advertisements in this chapter are important to
consider because they represent cognitive shortcut cues for physicians, they are reflective of the
values, beliefs, and attitudes of the physician audience, and the contain hidden meanings.
Advertisers extensively research their audiences and are aware of the images that will assist
physicians with making shortcuts. Graphic design incorporates these familiar pictorials in order
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to facilitate message transmission. Human models represent certain characteristics that are
commonly understood by the audience (Thompson, 1992). Such characteristics include
appearance, behavior, gender, personality, and symptoms. For physicians, advertising reflects the
familiar that is based upon textbook and medical imagery and is representative of the knowledge
embodied within the audience. It is essential that advertising reflect the words and images that
the audience already knows (Schudson, 2013). Additionally, advertising provides simple stories
in which the values, ideals and attitudes of the audience are communicated (Dyer, 2007). The
audience comes to the advertised argument embracing the same set of cultural values that are
being transmitted.
In accepting advertising that merely mirrors an audiences’ values and ideals tend to
distort the adverting landscape as it inherently lends itself to the dominant ideology associated
with pharmaceutical advertising. Physicians perceive the typical patient to be the normalized
patient. Through the creation of an advertised patient, this person becomes the accepted patient
that is based upon the physician’s knowledge of patients, medicine, disease, and illness. This
perspective may be false, but is readily accepted as being true based upon the fact that there does
not exist another form of promotion that tells a physician a different story regarding the typical
patient. Without the presentation of alternative explanations, the culture of the audience may
become prejudicially tainted. In terms of pharmaceutical advertising, the treatment of the patient
is based upon the physician’s perception of the person and/or who the person resembles (the
depression patient, the migraine patient, the cardiovascular patient, etc.) that is based upon a
glance. This superficial account is founded upon the beliefs, values, and attitudes of the
physician audience that contribute to reinforcing and shaping the antidepressant patient as being
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naturally female. This concept of the patient may be flawed and may result in the misdiagnosis
of women.
Finally, the series of Prozac advertisements are hazardous because they contain relatively
hidden meanings. Taken upon the surface, it appears that the advertised characters, with the
exception of Chris, are encountering simple daily issues that range from packing to golfing.
However, when read at a deeper level, one can see the storyline of functionality and women.
This narrative makes sense as physicians tend to view patients in terms of functionality
(appearance, personality, behavior, and gender) during the patient-physician interview. One
caveat for physicians is the use of hidden messages by advertisers which can render them more
vulnerable to inappropriate prescribing, diagnosis, and treatment of patients. Ferner and Scott
(1994) contend that advertisers use the symbols that are consistent with physician’s subconscious
motives and aspirations. Physicians in turn may be reluctant to acknowledge these hidden
feelings which makes them susceptible to irrational prescribing. Advertising may subvert
physicians by appealing to their unconscious desires (Ferner & Scott, 1994).
Conclusion
The typical antidepressant patient is defined and constructed by pharmaceutical,
medicine, and advertising industries based upon medical and textbook imagery. The images and
words employed in pharmaceutical advertising reflect the cultural beliefs of the physician
audience and communicates the notion that the antidepressant patient is mostly a female. The
typical patient is manifested from the prototypical patient that is featured within the patient
profile and is presented within such marketing materials as DTP advertising. The pharmaceutical
companies create characters with whom the physicians can easily identify in their offices. The
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hypothetical characters are routinely presented in terms of their appearance, behaviors, social
class, personality, gender, and symptoms. These representations are ideally suited for cognitive
recall and diagnosis at-a-glance. Further, the narrative that is made explicitly and implicitly,
tends to reinforce the manner in which physicians are able to diagnose at-a-glance. Through the
general appearance of a patient’s ability to function, the physician may quickly determine the
course of treatment. In the advertisements included within this chapter, some of them contained
hidden meanings regarding the functionality of women. The advertising presents a fairly
derogatory perspective regarding women’s abilities to navigate through their daily lives and to
function in society. The narrative surrounding the advertisements suggests that women need
antidepressants in order to live. Finally, it was revealed that the symptoms that are advertised to
physicians are frequently based upon patient’s complaints and not necessarily medical conditions
which may further lead to the misdiagnosis of individuals, especially women.
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CHAPTER V: CONCLUSIONS AND IMPLICATIONS
Introduction
There are two narratives of which I am personally familiar regarding the depression and
the antidepressant patient. The first story is about a woman who is in her forties and lives at
home with her parents. She sleeps most days, she rarely leaves the house, and she barely
remembers to eat. She has been prescribed two antidepressants that she currently takes along
with an estimated additional four prescribed medications that she is unable to afford. She is
currently applying for disability. She is characteristic of a truly depressed person.
The second story is about a professional woman who is also in her forties who goes to
visit her physician for an annual checkup. During her visit, she is diagnosed with depression and
prescribed an antidepressant. Although she feels that this diagnosis is incorrect, she has the
prescription filled. After suffering from an allergic reaction to the medication, she quits taking it.
Currently, she is angry at the physician who misdiagnosed her with depression and for
prescribing her an unnecessary medication for which she paid. She is the perceived
antidepressant patient and is not representative of the depression patient. She is perceived to be
the ideal patient for the high prescribing physician and pharmaceutical companies.
Based upon these real-life scenarios and this current study, DTP advertising may
contribute to the inappropriate prescribing and misdiagnosis of individuals. There are two
distinctly different audiences for the advertising, targeting, prescribing, and diagnosis for
depression. The actual patient who tends to live in poverty and the consumer of antidepressant
medications who is portrayed as living an ideal lifestyle. According to the storyline in DTP
advertising, the depressed audience is comprised of regal individuals who enjoy the outdoors,
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athletics, and social engagements while the antidepressant patient is the consumer and the person
who warrants an antidepressant because she is unable to function without medication. In sharp
contrast, the actual depression patient who is represented in epidemiology reports is virtually
ignored and is not fairly represented within DTP advertising. Additionally, the medical condition
for depression is portrayed as being glamorous and chic. This provides a false perception of the
depression audience, of depression as a medical condition, and of women’s health because
depression is not trendy nor fashionable but is a serious mental health condition. This chapter
provides some conclusions regarding the present study and advocates for making some changes
in DTP advertising.
Direct-to-Physician Advertising
Direct-to-Physician advertising is an important field to study because it has the potential
to affect patient’s health. DTP advertising may contribute to the inappropriate prescribing and
misdiagnosis of individuals. Previous research has indicated that physicians who rely upon such
commercial promotion as medical journal advertising tend to prescribe more heavily and less
rationally (Norris, Herxheimer, Lexchin, & Mansfield, 2005). Thus, the influence of promotion
may result in a physician selecting the less than optimal medication choice. It has been
contended that one of the most important and most difficult area to study is the effect of
pharmaceutical promotion on physician behavior ((Norris, Herxheimer, Lexchin, & Mansfield,
2005). Some contend that promotion, especially physicians, has little influence on behavior.
However, this study suggests otherwise. It has been positioned in this paper that pharmaceutical
advertising does influence behavior, especially prescribing patterns associated with depression.
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Since the 1950s it has been fervently debated that advertising to physicians increases
prescription writing and irrational prescribing behaviors. The pharmaceutical companies have
structured their sales, marketing, and advertising in a manner that segments and rewards those
physicians who are most likely to favorably prescribe their products. This structure of incentive
may contribute to the detriment of the patient’s health through inappropriate prescribing and/or
the misdiagnosis of the individual. For those who contend that advertising does not influence
prescribing, the Prozac advertisement in Figure A-25 would suggest otherwise. The advertised
statements in the promotion reflect the importance of the medical community upon prescribing.
This Prozac promotion presents a warped and rather disturbing picture of pharmaceutical
advertising. This level of distortion that exists within DTP advertising may affect prescribing
behaviors is a primary topic that is addressed in this study.
The Objectives of This Study
The goal of this study was to examine the representations of the mental health patient, the
conceptions of mental health, and the consumer featured in medical journal antidepressant
advertisements. Additionally, these representations and conceptions were compared to the
epidemiology data to illuminate the differences between the advertised reality and the actual
reality regarding depression. These aspects of antidepressant advertising were studied in order to
assess the promoted representations of the mental health patient and the mental health condition
that may affect physicians’ prescribing and diagnostic decisions. This was accomplished through
a narrative analysis that commenced with a historical investigation into the background of DTP
advertising and the development of the modern day pharmaceutical psychotropic advertising
campaign.
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Representations of the Mental Health Patient and the Conceptions of Mental Health
Historical Presentation of Depression and the Advertised Patient
Patent medicines were the first medicinal type of product to be advertised and sold to
physicians and the public alike. Unfortunately, these promotions were filled with empty promises
and contained substances of alcohol, cocaine, and heroin rather than medical compounds. The
beginnings to medical advertising were rather notorious for bad practices and equivocation. In
concert with the development of these promotions, the precursor to depression, Neurasthenia was
established for nerves associated with productivity and overworking. This illness tended to favor
and to be reserved for the upper class hard working intellects and leaders in society. The
intersection between medical advertising and Neurasthenia is interesting because it is here where
physicians diagnosed and treated people medically differently according to their gender and
social class. These distinctions for diagnosis and treatment were frequently colored by the
physician’s social prejudices. The lower class denizens were considered to be idol and thus not
productive which frequently prevented them from receiving adequate health care. From this
perspective, it could be argued that little has changed in terms of pharmaceutical advertising,
physician practices, and the American health care system. The juncture between patent
advertising and neurasthenia may have simply provided the foundation upon which
contemporary pharmaceutical advertising is predicated.
Through a historical examination, it is revealed as to the ways in which psychotropic
drug advertisements for such conditions as depression were originally concepted, positioned, and
distributed. Since the mid-1950s, depression has been depicted as a panacea for vague everyday
emotional, social, and political ailments. The symptoms for depression were construed in terms
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of unruly children, singleness, traffic jams, environmental factors, and political discord
(Herzberg, 2009; Tone, 2009). These causes for depression were distributed to many specialties
of physicians through such channels as medical journal advertising. Through the 1938 WheelerLea Act, medical journal advertising was considered to be fully comprehended by physicians,
consequently, it was not federally regulated in the same way as other advertising including direct
mail. Therefore, from the beginning, medical journal advertising could be regarded as being
rather dubious in supplying medically accurate information.
Miltown further provided depression with a Hollywood shimmer and brightness that
appealed to mass consumers. This luster would later be outshined by the advent of Prozac, but
Miltown began the positioning of depression as being reserved for the glamorous and upscale
sectors of society. The advertisements of the time reflected this philosophy as pictorials of men
featured business suits and office environments while women were surrounded by symbols of
affluence including jewelry and modern appliances (Herzberg, 2009). By the 1960s and 1970s,
pharmaceuticals for depression were primarily advertised to women as they were the prime
consumers of these medications.
During the 1970s, advertisers’ appeals were primarily directed toward mothers and wives
for psychotropic medications. During this decade, it can be argued that the consumer for
psychotropic drugs was established through sophisticated segmentation practices that looked for
a particular person rather than an illness or symptoms associated with an illness. In addition,
advertised scripts were created that urged physicians to look for a particular type of patient upon
entering the office. This categorization of a person encouraged diagnosis at-a-glance through the
recall of advertised prototypes that was bases upon appearance, social class, and gender.

128

The 1990s are renowned for the marketing of Prozac and the rise of SSRIs, the
biochemical model of science, and the deregulation of pharmaceutical DTCA. These advances
contributed greatly to the current pharmaceutical advertising practices that are directed toward
and depict more white women than any other race, ethnicity, and gender. This emphasis may be
harmful to women’s health. The current study analyzed the timeframe between 1990 and 2010
and the presentation of some of the results are further reviewed and discussed.
Virtual Depression Audience
Psychotropic advertising in medical journals has been censured for its reliance upon
stereotyped imagery that over inflates the use of white women in its pictorials. In this study, it
was revealed that the representations of the depression audience were comprised primarily of
white women. In this study, it was revealed that there was a 6:1 ratio of women depicted in
antidepressant advertising compared to men. This number greatly embellishes the epidemiology
rates that range from 1.7 – 2.0 for depression in women compared to men. The inclination to
emphasize gender in advertising may be dangerous as the WHO states that the gendering of
health can have significant repercussions upon the quality of healthcare a person receives which
may be based upon gender and not necessarily upon scientific knowledge. This tendency to
promote women as the principal sufferers of depression further diminishes the need for treatment
in men.
Other groups of individuals are also virtually invisible in antidepressant advertisements
because they are not aptly targeted by advertisers, including minorities who are rarely cast in
antidepressant advertising. If physicians are influenced to prescribe based upon advertising
efforts, then minorities who suffer from depression will be undertreated as they are almost absent
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from antidepressant medical journal advertising. This undertreatment could further increase
health disparities within the U.S.
Currently, ethnic minorities are less likely to have equal access to health care and are
more likely to have inadequate health literacy, a factor associated with worse health status and
increased hospitalization (Cooper, Hill and Powe, 2002). These disparities have resulted in
minorities receiving less routine medical care and having higher morbidity and mortality rates
than non-minorities (www.ama-assn.org). By altering the perception of those who suffer from
depression in advertising, perhaps the gap in treatment would be minimized.
However, it is not simply the stereotyped imagery that is concerning, it is also the chic
gloss that is superimposed upon the advertising that leads them to be misleading. Epidemiology
reports indicate that there exists an inverse relationship between depression and socio-economicstatus. The wealthier individuals in society are the least likely to suffer from depression. The
individuals who live below the poverty level, have less education, higher amounts of stress, live
in unsafe neighborhoods, and face discrimination have a higher likelihood of suffering from
depression. One reason that the rate for depression may be higher in woman than in men, is due
to the fact that approximately 70 percent of women in the world live in poverty and earn less
money than men (WHO, 2016). However, this woman is not the one portrayed in antidepressant
advertising.
The models portrayed in the antidepressant advertising tend to be regal, athletic, social,
and lead a lifestyle that many would hope to achieve. According to Dittmar (2007), people are
identity seekers and through consumption, people acquire and transform their identity. We alter
ourselves through purchasing more (Schudson, 2013). People seek to become like the models
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portrayed in advertising through consumptive behavior. Based upon the ideal that advertising
lionizes the freedom and desire of consumer choice, pharmaceutical companies make depression
and the depression audience appear to be trendy and fashionable so that people will purchase and
consume the advertised product (Schudson, 2013).
The advent of SSRIs brought forth an increase in the treatment of depression and in
prescriptions. According to Kessler, the prevalence of depression did not increase during the
1990-2003 timeframe, rather it was the treatment of depression that was significantly elevated.
Epidemiology data suggest that white women were the primary targets of treatment for
depression. During 2003-2004 310 out of 1,000 female patients received a prescription for an
antidepressant. By 2006, more than 227 million prescriptions for antidepressants were received
by Americans which was an increase of 30 million prescriptions since 2002 (Horwitz, 2010).
Further, the 2005-2006 epidemiology survey of American households for depression also
concluded that more women were not suffering from depression (Pratt & Brody, 2005). A
conclusion that seems to bolster Kessler’s claim that it was not the prevalence of women that
increased but the treatment for depression that was raised.
One SSRI that helped to change the landscape surrounding depression was Prozac as it
facilitated the conversation about depression, decreased stigma, and increased the treatment rates
of mental illness. It was perceived to be acceptable to take an antidepressant and for some,
depression was worn as a badge of honor (Grohol, 2014). The Prozac campaign informed the
public that depression was not due to personal or moral failure or a sign of weak character, but
instead was attributed to a biochemical cause in the brain (Grohol, 2014; Rottenberg, 2009).
Advertising campaigns declared that depression was a flaw in chemistry and not in character.
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(Schwartz & Corcoran, 2010). Thereby establishing the basis of depression in the biomedical
realm.
The marketing of the SSRIs in medical journal advertisements tended to retreat from the
biomedical messages and brain imagery and provided a more glamorous world that was replete
with well attired women. The marketing of depression and antidepressants presents an idealized
lifestyle that is obtained by the few rather than the many. This portrayal has lead depression to
become associated with a rather swanky lifestyle and thus, associated with a fashionable
existence. For some, depression has become regarded as a lifestyle accessory which is a concept
that only trivializes the condition as being something less than serious. In exalting depression
and the depression audience, the disorder becomes a rather sought after and desired product.
Representations of the Consumer in Antidepressant Advertisements
The Antidepressant Patient
The DTP advertising creates the antidepressant patient through repetitive representations
of female characters. The narrative is about women who are not able to function at an optimal
level without antidepressants. The advertisements contain the message of functionality because
physicians often diagnose people based upon their appearance, behavior, symptoms, and gender
(i.e. their functionality). Physicians perceive the limitations associated with depression as being
more of a subjective and less of a clinical sign those illnesses affiliated with a major physical
chronic condition (Wells, 1989). This storyline of functionality necessarily plays into the
cognition of the physicians who is asked to recall the typical patient, and for this study the
antidepressant patient, and to diagnose the patient at a glance. Physicians have a limited amount
of time with each patient, these cognitive shortcuts may be handy, yet faulty. This tendency may
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lend itself to the misdiagnosis of women for depression. The pictures and images in medical
journal advertising may assist physicians with the way they view patients. These pictorials
remind physicians about what they already know (Schudson, 2013).
Finally, previous research has indicated that physicians may be unaware of the hidden
messages contained within advertisements. This study showed that the message of functionality
was not made explicitly through the promotions, but when read together, the advertisements
implicitly stated the message. Physicians may be unaware, consciously, that this message is
being made. This unconscious oversight may make them more vulnerable to mis-prescribing and
misdiagnosing individuals, especially women.
Through a review of the specific results of this study it is concluded that the
pharmaceutical, medical, and advertising industries intentionally create audiences and rather
attractive illnesses, and patients in an effort to increase sales of products. A practice that may be
harmful as there have been a considerable number of lawsuits regarding the marketing and
advertising of pharmaceutical products. In addition, it is important to note that most people are
undertreated for depression. Some of the reasons for this include such barriers to treatment
including the lack of resources, trained help, and social stigma. Another barrier is inaccurate
diagnosis, misdiagnosis, and the prescription of an antidepressant. Another reason is the lack of
understanding that depression is caused by a multitude of factors including the social,
psychological and biological elements (WHO, April, 2016). In concluding this research
recommendations are made for DTP advertising.
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Recommendations for Changes in Medical Journal Antidepressant Advertising
Biomedical Model of Medicine and the Brain
From its inception, Prozac and the brain have been inextricably linked. Based upon the
biomedical model of science, depression is caused by misfiring neurotransmitters in the brain.
The notion that SSRIs can level serotonin levels in the brain has become the unique selling
proposition for these drugs. The SSRIs advertising capitalizes upon the biomedical model.
However, this model presents a narrow view as it supports an empirically and objectively based
evidence that points to an organic or physical cause based upon biological science (McLeod,
2014). Consequently, the model places the causes of depression upon the individual and his or
her biology rather than upon societal determinants of health which can cause a distorted view
regarding the depression patient and depression as a mental health condition (Grow, Park & Han,
2006).
This study reveals that pharmaceutical advertising reflects the biomedical model in that it
places the cause of depression upon the individual as the models portrayed within the promotions
tell the story about the depression audience and the mental health condition. The individual
portrayal that is featured in advertising tells the physician about the patient’s life. Based upon
this study, pharmaceutical advertising, through the over representation of the female gender,
leads the physician to believe that the advertised condition is affiliated with women. Marketers
intentionally create images that reflect the intended product end user and her lifestyle. The
antidepressant advertisements included in this study depicted a woman who was well-attired,
athletic, enjoyed leisurely pursuits, and lived a life to be aspired. These portrayals were less than
accurate regarding the actual depression patient and may encourage inappropriate prescribing
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and misdiagnosis to those individuals who physicians perceive to be depressed based upon the
model and lifestyle depicted within antidepressant advertising.
The emphasis upon individuals also encourages physicians to look for a specific person
or type of person and not necessarily an illness. Through the creation of characters, physicians
are asked to observe the person who walks into the office, and to categorize him or her based
upon his or her personality, behavior, appearance, and gender. The focus upon the individual
encourages the physician to diagnose at-a-glance based upon individualistic impressions.
The biomedical model is too restrictive in its perspective and may contribute to the
inappropriate prescribing and misdiagnosis of depression in women. It is predicated upon
biology that naturally necessitates the prescription of medications as the treatment. It does not
promote the psychosocial treatment of depression. Thus, it serves the pharmaceutical industry’s
need to make a profit. However, in order to provide a more comprehensive understanding about
depression, the model needs to be expanded to include additional determinants of health
including social and psychological factors. As the epidemiology data in this study indicate,
people who face certain inequalities such as poverty, stress, employment, and discrimination
tend to suffer from depression. This finding suggests that depression is caused by other factors
besides biology.
Depression is considered to be multifactorial health problem that is founded within the
complex interactions of biological, psychological, and social variables in which lifestyle factors
contribute to its onset (Weil, 2015). Yet, depression is not advertised as a multifactorial health
problem, but rather an individualistic one. Therefore, it is recommended that the biomedical
model be expanded to include social and psychological factors. The Biopsychosocial (BPS)
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provides a scientific basis that adds the psychological and social factors to the traditional
biomedical model. The addition of the psychological and social factors is crucial for effective
diagnosis and treatment of patients. Further, the BPS model provides a more integrative systems
approach to medicine that provides a less mechanical method to patient care (Ormstad &
Eilersten, 2015).
In addition, based upon this study, pharmaceutical advertising perpetuates the biomedical
model that basis the cause of depression upon the individual. This message is communicated to
physicians through depictions of the depression audience and the antidepressant patient that
prominently features a woman. This focus upon individuals fails to take additional causes of
depression into consideration. Until the biomedical model expands its scope, pharmaceutical
advertising needs to move away from presenting a biomedical individualistic depiction of
depression and to incorporate more societal determinants of health into their textual and visual
elements that help to properly educate physicians about depression.
Medical School Education Regarding Advertising
Medical school training regarding pharmaceutical promotion could beneficially assist
with educating physicians about the correlation between pharmaceutical promotion and
physician prescribing behaviors, the quality of information presented in pharmaceutical
promotions, and the marketing and advertising structures of the pharmaceutical industry. This
education may be helpful as health care professional students form their attitudes and knowledge
about the pharmaceutical industry prior to graduating from medical school and these attitudes
effect future behaviors associated with making prescribing decisions (Monaghan, Galt, Turner,
Houghton, Rich, Markert & Bergman-Evans, 2003).
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Physicians deny the effects of pharmaceutical promotion while pharmaceutical
companies devote most of their marketing budgets to advertising to physicians. And,
promotional budgets are well spent as they successfully influence physician’s behaviors, even
while attending medical school (Wilkes & Hoffman, 2001). One reason pharmaceuticals place a
large emphasis upon physicians is because pharmaceutical promotion is one of the primary
sources of information for physicians and they rely upon these promotions to help them with
making drug choices and learning about unfamiliar medications (Wilkes & Hoffman, 2001).
One way that physicians learn about medications is through medical journals. However,
over the past 100 years, an argument has ensued over the quality of information that is presented
in medical journal advertising. Critics claim that this information is misleading and can be
harmful as it may result in the inappropriate prescribing of medications. This study revealed that
not all antidepressant advertising is educational and that the quality of information in medical
journal advertising provides a distorted view of depression. In addition, the advertised textual
and visual claims may incorporate hidden meanings that may be subconsciously received by the
physician. Physicians need to be provided medical school training regarding pharmaceutical
promotions and to learn the ways in which to critically evaluate advertising. To continue to deny
the effects of pharmaceutical advertising upon prescribing patterns will only continue to harm
certain segments of society. In order to provide improved health care, physicians need to be
aware of the quality of and the educational value of the information they are receiving by the
pharmaceutical industry and to be able to critically assess these promotional materials.
Furthermore, as this study indicates, there are hidden meanings contained within advertising
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which can be received subconsciously. Physicians should be aware that the messages contained
in advertising are made explicitly as well as implicitly.
Historically, the marketing and advertising structure of the pharmaceutical industry
segments and rewards those physicians who are high decile prescribers. These individuals are
most frequently targeted by advertisers because they sell the most products. Medical schools
should train physicians about their roles not just as medical practitioners, but also as sales people
and as the audience for the pharmaceutical industry. Pharmaceutical companies specifically
target physicians and intentionally craft their advertising in a manner which fosters identification
with this segmented audience. Based upon this study, physicians are provided with a
hypothetical patient profile that quickly informs them about the promoted patient. These
portrayals can be misleading as they represent an idealized profile that is created by the
pharmaceutical and advertising industries to increase product sales. As a former director of
design, I have created these profiles that feature stock photography of the intended patient
population that is strategically connected with scientific data. Physicians need to be educated
about the marketing and advertising intentions and structures of the pharmaceutical industry and
to realize that they are perceived to be much more than medical experts. Medical school training
would provide a foundation for physicians to learn about prescribing patterns, pharmaceutical
promotion, and the physician audience.
The Creative Side
A final recommendation for helping to present a more accurate picture of the depression
person and the disorder is through responsible graphic design. Poor graphic design can result in
harmful consequences, and pharmaceutical advertising is an area that is of concern in terms of
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bad design. One important aspect of graphic design lies in its power to transform social injustices
and to help with solving social problems through conscientious design (Barnard, 2005; Frascara,
1997).
According to the Executive Director for Frost*Collective, “graphic design can make a big
difference in the world…it can help improve the quality of people’s lives” (Frost, 2016, p. 23).
In stimulating change, graphic design is concerned with the practice of designing for “public
good” (Hancock, 2016, p. 26). This study supports the notion that pharmaceutical advertising
provides an unequal perspective that favors white women and virtually ignores portrayals of
other races, ethnicities, and genders. It offers a slanted view of the world that marginalizes
groups of people in society. Graphic designers and creative teams have the power to assist with
balancing these representations and in providing an improved and more responsible narrative
regarding depression. Through the representation of a myriad of races, ethnicities, and genders,
graphic design can paint an enhanced picture of depression and the depression audience while
minimizing the role of the antidepressant patient.
The results in this study suggest that the graphic design featured in medical journal
antidepressant advertising is making some progress as the depictions of women tended to show
people who were outside of the home sphere, engaged in sports, and productively employed.
These depictions, although they are distorted, have evolved from previous antidepressant
advertisements that portrayed women in the home, cooking, and working in the garden. In
addition, in this study, men depicted in antidepressant advertisements were portrayed as
shoppers, joggers, and PTA participants which suggests that men had a more involved social role
than has been previously defined by pharmaceutical advertisers. Graphic designers should take
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an active role in helping to improve lives through responsible depictions of patient populations,
to continue to push the limits, and to create advertising that provides a balanced perspective and
takes the audience’s knowledge and cognition into consideration.
Designers need to be concerned with producing materials that do not contribute to
cognitive overload by physicians as this may lead to diagnostic errors. Graphic designers and
creative teams for pharmaceutical advertising can educate themselves regarding the FDA
standards for developing compliant advertisements through the FDA recommended guidelines.
For example, guidance materials educate creative teams and designers about the elements the
FDA considers to be important in advertising including the format of a printed piece. The format
is defined as the shape, size, and layout of all of the elements and the plan of the organization,
arrangement, and theme of the promotional material. Further, the FDA recognizes the cognitive
limits of people, including physicians and has established guidelines to assist designers,
marketers, advertisers, compliance teams, etc. for creating effective materials. Directors of
design and creative teams should take the FDA guidelines and create manuals and easy to read
documents that can be used for training, for continuing education purposes, and for the
establishment of best pharmaceutical design practices.
Concluding Remarks
Previous research has demonstrated that people with depression are frequently
misdiagnosed, receive inappropriate, or improper treatment or are not provided with treatment,
thus, many people are left undertreated. One reason for this lack of treatment may be due to the
overrepresentation of women in DTP antidepressant advertising. Women tend to be depicted in a
trendy fashion as they lunch in the afternoon sunshine, hike through the wilderness, enjoy
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afternoon tea and cookies, dress for an entertaining evening, and leisurely shop, practice yoga,
and play sports. A depiction that distorts the reality of depression and epidemiology reports that
suggest that people who suffer from depression do not experience such a lifestyle.
These representations may contribute to the societal belief that depression is trendy rather
than being a serious mental health condition. The promise of an improved life through the
consumption of a pill that will alter one’s sense of self and identity is explicitly and implicitly
made by antidepressant advertisements. The social attainment of the good life is provided by the
physician who is rewarded for writing the prescription by the pharmaceutical industry. These
elements work in tandem in order to increase antidepressant sales. It still holds true, that if the
ugly, poor, and old were featured in advertising, products would not continue to be sold. Because
of this very notion, advertising distorts the picture of depression and the depression audience as it
does not reflect epidemiology trends, but creates its own character, the antidepressant patient as
the consumer.
Advertising reflects the assumptions, attitudes, and social values held by the members of
the intended audience. Naturally, advertisements are designed to reflect the ideals of the viewer
in order to provide a more persuasive argument. For pharmaceutical advertising, the patient
depicted within the promotion needs to mirror the one who enters the physician’s office. These
representations should resemble one another. To achieve this consistency, pharmaceutical
companies listen to physicians’ descriptions of patients and their complaints. This information is
regarded as being the “epidemiology data” that assists with constructing the hypothetical patient
profile. For depression, the hypothetical patient is the antidepressant patient who is characterized
as being a female who is unable to accomplish simple tasks and is further unable to function
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without a pill. This typification is helpful to the physician as it allows for the cognitive recall of
the patient type and at-a-glance diagnosis which are shortcuts that can facilitate diagnosis.
However, this practice may lead to the reliance upon social prejudices and the coloring of
judgment on the part of the practitioner and the misdiagnosis of women for depression.
However, it is not all gloomy for the state of DTP advertising as it can contribute to
improving American health care through the creation of more responsible advertising. The
analysis in this study centered around depression, but there are other medical conditions that are
gendered and thus, are regarded as being either male or female illnesses. This perception is
misleading and can lead to detrimental consequences including the lack of help seeking,
inappropriate prescribing, misdiagnosis, and the undertreatment of groups of people in society.
Through a re-evaluation of advertising practices and design, through the education about the
pharmaceutical industry to medical students and residents, and through the addition of
psychological and social components to the biomedical model of medicine, the concept of
depression and those who are most vulnerable to suffering from the condition can be more
efficiently and accurately communicated in advertising.
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Figure A-1 Wellbutrin Janet the Librarian Advertisement
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Figure A-2 Pamelor Laboratory Scientist Advertisement
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Figure A-3 Sinequan Woman Shopping Advertisement
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Figure A-4 Wellbutrin Advertisement of Jogging Couple
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Figure A-5 Wellbutrin Advertisement of Woman Playing Tennis
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Figure A-6 Wellbutrin Advertisement of Woman Dressing for the Evening
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Figure A-7 Remeron Advertisement of Ladies Having Afternoon Tea
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Figure A-8 Lexapro Advertisement of Ladies Lunching
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Figure A-9 Zoloft Advertisement of Family Hiking
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Figure A-10 Serzone Woman Exercising on the Beach
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Figure A-11 Prozac Advertisement of Kristen’s Travels
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Figure A-12 Serzone Advertisement Featuring a Love Life
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Figure A-13 Remeron Advertisement of Couple with Flowers in Heart Shape
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Figure A-14 Zoloft Advertisement of Couples Embracing
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Figure A-15 Effexor Advertisement of Dancing Couple
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Figure A-16 Paxil Advertisement of Julie
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Figure A-17 Prozac Advertisement of Nell Knitting
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Figure A-18 Prozac Advertisement of Barb Golfing
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Figure A-19 Prozac Advertisement of Chris Making Lunch for the Kids
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Figure A-20 Prozac Advertisement of Sue Playing with the Kids
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Figure A-21 Prozac Advertisement of Fatigue
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Figure A-22 Prozac Advertisement for Energy
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Figure A-23 Serzone Advertisement that Lists Vague Symptoms
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Figure A-24 Paxil Advertisement of a Depressed Female Patient
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Figure A-25 Prozac Thank You Advertisement to Physicians
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